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RESUMEN  
INTRODUCCIÓN GENERAL 
La osteoartritis (OA) es la causa principal de dolor, discapacidad y pérdida de calidad 
de vida en las personas mayores que afecta a más del 80% de la población a partir de los 
55 años de edad [1, 2]. Si bien la presentación clínica de OA es muy variable, el dolor 
es el principal síntoma y los niveles elevados de dolor se asocian a niveles mucho más 
bajos en la función física, la autoeficacia y la calidad de vida [3, 4]. La OA es una 
enfermedad que se caracteriza inicialmente por la degeneración del cartílago, a menudo 
precedido por cambios en el hueso subyacente. Es el resultado de una inadecuada 
regeneración de daños producidos en la articulación por las tensiones relacionadas con 
factores biomecánicos, bioquímicos y genéticos [5]. Algunos estudios han demostrado, 
sin embargo, que, además de la continuada destrucción articular, la producción y 
remodelación de tejido nuevo se evidencia por el aumento de la síntesis de proteínas por 
los condrocitos, especialmente en las primeras etapas de OA [6]. Aunque la artrosis se 
ha considerado tradicionalmente una patología de la población anciana, puede también 
afectar a personas jóvenes [7]. En concreto, la presencia de obesidad y una historia de 
lesión traumática en la rodilla (p.e.j. rotura del ligamento cruzado anterior o lesión 
meniscal) son factores de riego clave que favorecen el desarrollo de artrosis en la rodilla 
[8]. Por otro lado, la presencia de deformidades estructurales en la cadera (p.e.j. 
deformidad tipo CAM o tipo PINCER), pueden favorecer la progresión hacia una 
artrosis de cadera [8]. Las articulaciones que soportan peso, como la cadera y la rodilla, 
y las articulaciones periféricas menores, incluidas las manos, son las más afectadas por 
la artrosis [9].  
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Históricamente, la artrosis se ha considerado un problema estructural secundario a una 
lesión degenerativa del cartílago articular [10]. Sin embargo, puesto que el cartílago es 
un tejido avascular y aneural, el cartílago articular dañado no puede generar dolor 
directamente [11]. Hay estudios que han demostrado cómo la presencia de inflamación 
en estructuras no cartilaginosas como la membrana sinovial o lesiones en la médula 
ósea, pueden contribuir al dolor crónico de la artrosis [12-15]. De hecho, la hipertrofia y 
derrames de la membrana sinovial y las anomalías en el hueso subcondral se han 
asociado al dolor crónico de la artrosis de rodilla en estudios de cohorte de gran tamaño 
[16]. Aedmás, se ha constatado una liberación de diferentes mediadores pro-
inflamatorios en la articulación afectada por artrosis, como el factor de crecimiento 
nervioso o el óxido nítrico [6], que podrían contribuir un al dolor de la artrosis. Del 
mismo modo, la literatura científica muestra como la expresión de determinados 
factores de crecimiento, en particular el factor de crecimiento endotelial vascular 
(VEGF vascular endothelial growth factor) y el factor de crecimiento derivado de las 
plaquetas (PDGF platelet derived growth factor), pueden inducir una 
neovascularización en la articulación afectada por artrosis [14]. La angiogénesis 
osteocondral se ha relacionado con el dolor crónico de la artrosis [17]. Sobre la base de 
todos estos hallazgos, resulta incuestionable la presencia de un fenómeno local de 
inflamación de los tejidos blandos en la artrosis, lo que contribuye a la gravedad y 
frecuencia de dolor en dicha patología [6, 18]. 
La discordancia que se observa a menudo entre la gravedad del dolor reportada por los 
pacientes con artrosis y el grado de patología articular (evaluada según los criterios de 
clasificación radiológica de Kellgren-Lawrence) [19], en particular durante las etapas 
crónicas de la artrosis, ha cuestionado la idea de que el dolor de la artrosis sea 
meramente secundario a un daño estructural de la articulación [10]. La alteración del 
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procesamiento del dolor a nivel del sistema nervioso central (sensibilización central) ha 
cobrado importancia en los últimos años como un factor que puede contribuir al dolor 
de la artrosis [5, 7, 10, 20-23]. Si bien se ha considerado durante mucho tiempo que el 
dolor asociado a la artrosis tiene una naturaleza puramente nociceptiva, la creciente 
evidencia científica indica que la sensibilización central parece desempeñar un papel 
muy importante en el dolor experimentado por un subgrupo de pacientes con artrosis en 
la rodilla [20-33]. Sin embargo, en el momento de iniciar la presente Tesis Doctoral, no 
se disponía de una revisión sistemática de la literatura en cuanto al papel de la 
sensibilización central en personas con artrosis de rodilla. 
 
Los mecanismos fisiopatológicos subyacentes a la sensibilización central son complejos 
y numerosos, pero el efecto neto es una amplificación de las señales nerviosas dentro 
del sistema nervioso central que provoca una hipersensibilidad al dolor [34, 35]. La 
sensibilización central es un concepto amplio que refleja no sólo una amplificación del 
dolor a nivel de la médula espinal (fenómeno de wind up), sino también una mayor 
actividad de las vías nociceptivas de facilitación descendente [36, 37], la pérdida de 
mecanismos anti-nociceptivos descendentes [38, 39], la hiperactividad en la 
neuromatriz del dolor [40], y la potenciación a largo plazo de las sinapsis neuronales en 
el córtex cingulado anterior [41]. Por lo tanto, el término sensibilización central implica 
cambios en el procesamiento del dolor que ocurren a diferentes niveles del sistema 
nervioso central. Actualmente, sin embargo, no existe un término universalmente 
aceptado para el fenómeno de la sensibilización central y su uso en la literatura 
científica aún es controvertido [42-44]. Además, la sensibilización central no es una 
única entidad o fenómeno que puede existir o no existir, estar presente o ausente, sino 
que se produce a lo largo de un continuo. De hecho, un estudio reciente demostró que 
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aunque la hipersensibilidad central generalizada o sensibilización central es prevalente, 
no está presente en todos los pacientes con dolor crónico [45]. Aunque generalmente la 
sensibilidad al dolor es más acusada en ciertas condiciones de dolor crónico, igualmente 
es un continuo en estas condiciones [46]. En algunos pacientes, la sensibilización 
central puede ser la característica principal del trastorno doloroso (por ejemplo, en la 
fibromialgia). Sin embargo, en otros cuadros clínicos de doloro como la artrosis de 
rodilla, no todos los pacientes tienen sensibilización central, sino tal sólo un subgrupo. 
Se ha estimado que alrededor del 30% de los sujetos con artrosis de rodilla tienen 
sensibilización central como parte de su cuadro clínico [47, 48]. 
 
A pesar de los conocimientos cada vez más amplios sobre la importancia de los 
mecanismos de centrales en el dolor de la artrosis de rodilla, la evaluación sistemática 
de la sensibilización central aún no se ha incorporado en la práctica clínica. Esto podría 
deberse en parte al hecho de que la investigación de la sensibilización central se ha 
realizado fundamentalmente en el ámbito del laboratorio, donde los equipos y los 
protocolos utilizados para identificar la sensibilización central (por ejemplo, análisis 
cuantitativo sensorial [49, 50], reflejo nociceptivo de retirada [51], técnicas de 
neuroimagen [52, 53]) son relativamente sofisticados, requieren una gran inversión de 
tiempo, tienen un elevado coste y no son adecuados para el entorno clínico. 
 
La clasificación de los pacientes con artrosis de rodilla en función de los mecanismos de 
dolor dominante, incluyendo aquellos pacientes con dolor por sensibilización central 
"como mecanismo dominante", está generando cada vez más interés en la literatura tal 
como demuestra el creciente número de propuestas de clasificación publicadas en los 
últimos años [54-56]. La ausencia de este tipo de clasificaciones por subgrupos en 
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ensayos clínicos previos podría explicar la escasa eficacia observada con la mayoría de 
de los tratamientos disponibles para la artrosis de rodilla. [57]. Así pues, caracterizar o 
fenotipar el dolor en la artrosis de rodilla se ha convertido en una prioridad básica, no 
sólo para comprender mejor la experiencia del dolor de cada paciente, sino también para 
enfocar mejor el tratamiento de forma individual [58]. La identificación temprana del 
dolor por sensibilización central en personas con artrosis de rodilla es fundamental ya 
que su presencia puede predecir la obtención de peores resultados con Fisioterapia [59] 
o cirugía [60,61].  
 
Identificar la sensibilización central en un paciente con artrosis de rodilla supone un reto 
a nivel clínico, ya que actualmente no existe una definición de consenso internacional ni 
un conjunto de criterios clínicos válidos para el diagnóstico de la sensibiliación central 
[34,43,44]. Algunos autores han propuesto que la información derivada del diagnóstico 
médico, la anamnesis, la exploración física y la respuesta al tratamiento, puede ser útil 
para identificar la sensibilización central en la práctica clínica [62]. Recientemente, se 
han publicado criterios clínicos de clasificación para ayudar a los fisioterapeutas a 
distinguir y diagnosticar el mecanismo dominante del dolor incluida la sensibilización 
central en sujetos con trastornos musculoesqueléticos crónicos [63]. Dado que como 
hemos mencionado anteriormente, las pruebas utilizadas para identificar la 
sensibilización central son básicamente tests de laboratorio no accesibles en el ámbito 
clínico, se requieren protocolos más cortos y equipos menos costosos que permitan la 
identificación clínica de los mecanismos del dolor incluyendo la sensibilización central 
en pacientes con dolor por artrosis de rodilla [64]. 
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A pesar de que hay cada vez más publicaciones que subrayan la importancia de la 
sensibilización central en la artrosis de rodilla, los tratamientos de rehabilitación que se 
utilizan para esta patología no suelen considerar las posibles alteraciones en el 
procesamiento central del dolor relacionados con el dolor en la artrosis de rodilla. De 
hecho, las estrategias convencionales de rehabilitación para la artrosis de rodilla se 
centran en gran parte en los mecanismos de entrada (p.e.j. reducir la inflamación 
articular) y mecanismos de salida (p.e.j. mejorar la fuerza muscular, control motor, 
propiocepción) asociados a la enfermedad [65]. Por lo general, las estrategias de 
tratamiento que se dirigen a las estructuras locales son poco eficaces en pacientes cuyo 
cuadro clínico está caracterizado por un mecanismo dominante de sensibilización 
central [66,67]. De hecho, la presencia de sensibilización central en un paciente con 
artrosis de rodilla puede implicar una mayor complejidad del cuadro clínico y menos 
posibilidades de lograr resultados positivos con las intervenciones de fisioterapia 
convencionales [59]. Por lo tanto, un enfoque dirigido mayormente a desensibilizar el 
sistema nervioso central parece estar más justificado para el tratamiento de la 
sensibilización central en la artrosis de rodilla [29]. Se han publicado en los últimos 
años varias guías de práctica clínica informando de las opciones disponibles para el 
tratamiento de la sensibilización central en pacientes con dolor crónico de diversa 
etiología [65, 68-70]. Éstas abarcan entre otras intervenciones como la educación en 
neurociencia del dolor, las terapias cognitivo-conductuales, la imaginería motora 
graduada,  la discriminación sensorial, la terapia manual o la terapia con ejercicios 
[65,68-70]. La aplicación de programas de tratamiento fisioterápico que combinasen el 
abordaje de la lesión estructural periférica en la rodilla a la vez que los cambios 
neuroplásticos derivados de la sensibilización central en áreas distribuidas del sistema 
nervioso, podrían ayudar a mejorar los resultados obtenidos en pacientes con artrosis de 
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rodilla con un mecanimo central dominante [29, 65]. Sin embargo, la combinación de 
tratamientos dirigidos al sistema nervioso central con tratamientos tradicionales 
dirigidos a la articulación de la rodilla, es un enfoque prometedor para la artrosis de 
rodilla que a día de hoy todavía no se ha investigado. Se argumenta, que debido a la 
compleja naturaleza multidimensional del dolor en la artrosis de rodilla y los efectos 
moderados que ejerce la Fisioterapia de forma aislada en dicha patología, la 
combinación de tratamientos dirigidos tanto a la rodilla como al sistema nervioso 
central podrían reforzarse mutuamente mejorando así los resultados obtenidos en estos 
pcientes [29,58,65]. 
 
OBJETIVOS 
El primer objetivo de la presente Tesis Doctoral fue revisar la evidencia disponible en la 
literatura científica relacionada con la presencia o ausencia de sensibilización central en 
pacientes con artrosis, incluyendo personas con artrosis de rodilla, y las opciones 
disponibles para el tratamiento de la sensibilización central en dicha patología. En 
segundo lugar, se buscó evaluar si diferentes medidas de sensibilización central en 
pacientes con artrosis de rodilla guardaban alguna correlación con el área del dolor y los 
síntomas clínicos del paciente (grado de dolor de rodilla, discapacidad y variables de 
índole psicosocial) registrados durante la evaluación subjetiva. En tercer lugar, se 
investigó el efecto antes y después de la cirujía de un programa de Fisioterapia 
combinada dirigida al sistema nervioso central (educación en neurociencia del dolor) y a 
la rodilla (terapia manual de la rodilla) en sujetos con artrosis de rodilla que estaban 
esperando a ser operados. Esta Tesis Doctoral se divide en tres partes, cada una de ellas 
dirigida a uno de estos tres objetivos. 
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La siguiente pregunta de investigación se abordó en la primera parte: 
- ¿Cuál es el papel que desempeña la sensibilización central en las personas con 
artrosis, incluidas aquellas con artrosis de rodilla y cuáles son las opciones disponibles 
para el tratamiento? 
Para examinar esta pregunta de investigación se realizó una revisión narrativa y una 
revisión sistemática de la literatura relacionada con la presencia de sensibilización 
central en la artrosis y las opciones actuales para el tratamiento de la sensibilización 
central específicamente en pacientes con artrosis. Los resultados de dicha investigación 
se presentan en el capítulo 1, que comprende 2 artículos publicados. 
 
La siguiente pregunta de investigación se abordó en la segunda parte: 
- ¿Están asociadas las medidas de sensibilización central con el área de dolor y los 
síntomas clínicos en sujetos con artrosis de rodilla? 
El capítulo 2 presenta un estudio experimental que analiza si el área de dolor de los 
pacientes con artrosis de rodilla recogida mediante mapas o dibujos de dolor se 
relaciona con diferentes medidas de sensibilización central y los síntomas clínicos 
referidos por estos pacientes durante el examen subjetivo.  
 
La siguiente pregunta de investigación se abordó en la tercera parte: 
- ¿Resulta eficaz para las personas con artrosis de rodilla un programa de Fisioterapia 
que combina la terapia manual dirigida a la rodilla con la educación en neurociencia 
del dolor dirigida al sistema nervioso central? 
El capítulo 3 incluye dos estudios para tratan de responder a esta pregunta. El primer 
estudio presenta los fundamentos teóricos para la aplicación simultánea de un programa 
de Fisioterapia que combina la terapia manual y la educación en neurociencia del dolor 
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en pacientes con artrosis de rodilla. En el segundo estudio se presentan los resultados de 
un ensayo clínico aleatorizado que evalúa los efectos de un programa de tratamiento 
fisioterápico preoperatorio que combina la educación en neurociencia del dolor con la 
movilización de la articulación de la rodilla en sujetos con artrosis de rodilla. 
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Capítulo 1. ¿Cuál es el papel que desempeña la sensibilización central 
en las personas con artrosis, incluidas aquellas con artrosis de rodilla y 
cuáles son las opciones disponibles para el tratamiento? 
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RESUMEN 
Introducción y objetivos: La sensibilización central se sugiere que juega un papel 
importante en el dolor crónico que experimentan los pacientes con artrosis. Se llevó a 
cao una revisión sistemática siguiendo la guía PRISMA para evaluar la evidencia 
existente en la literatura relacionada con la presencia de sensibilización central en 
pacientes con artrosis. 
Bases de datos y tratamiento de los datos: Se realizó una búsqueda bibliográfica en 
las bases de datos Pubmed y Web of Science con el objetivo de identificar los artículos 
más relevantes utilizando palabras claves predeterminadas relacionadas con la artrosis y 
sensibilización central. Se incluyeron artículos a texto completo que habían investigado 
la sensibilización central en sujetos adultos con artrosis. La calidad metodológica de 
todos los artículos fue evaluada por dos investigadores de forma independiente.  
Resultados: De los 40 artículos que fueron elegidos inicialmente para la evaluación de 
la calidad metodológica, 36 consiguieron una puntuación suficiente y fueron discutidos 
en esta revisión. La mayoría de los estudios fueron estudios de casos-controles y 
dirigidos a la articulación de la rodilla. Se encontraron distintos parámetros subjetivos y 
objetivos considerados manifestaciones clínicas de sensibilización central en los 
pacientes con artrosis de rodilla. Dichos parámetros se han encontrado previamente en 
otras poblaciones con dolor crónico como sujetos con latigazo cervical o artritis 
reumatoide. En general, los resultados de esta revisión sugieren que aunque mecanismos 
periféricos están envueltos en el dolor de la artrosis, la sensibilización central juega un 
papel importante en un subgrupo de pacientes dentro de esta población. 
 
 
 XXI 
Enrique Lluch Girbés 
Conclusiones: Aunque la mayoría de la literatura pone de manifiesto la presencia de 
sensibilización central en el dolor crónico de la artrosis, la identificación clínica y el 
tratamiento de la sensibilización central en la artrosis todavía está en su infancia. 
Futuros estudios con buena calidad metodológica son necesarios en este sentido. 
Palabras clave: osteoarthritis, pain, central sensitization, neuroscience education, 
exercise therapy, graded activity. 
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RESUMEN 
La artrosis es una de las patologías más frecuentes, discapacitantes y costosas de la 
sociedad moderna. Uno de los principales objetivos del tratamiento de la artrosis es el 
control del dolor y la mejora de la capacidad funcional del paciente. La causa exacta de 
la artrosis todavía se desconoce a día de hoy. Además de los cambios que se producen a 
nivel de las estructuras articulares, parece ser que se produce una alteración en el 
procesamiento del dolor a nivel del sistema nervioso o sensibilización central que puede 
estar envuelto en el dolor que refieren los pacientes con artrosis. Este último punto 
alerta de la necesidad de utilizar un abordaje más amplio en el tratamiento de los 
pacientes con artrosis de rodilla que incluya estrategias de desensibilización del sistema 
nervioso. Sin embargo, la literatura científica evaluada en esta revisión narrativa ofrece 
poca información relativa al tratamiento de la sensibilización central en pacientes con 
artrosis. Intervenciones como la terapia cognitiva-conductual y la educación en 
neurociencia potentialmente van dirigidas a la sensibilización cognitiva-emocional 
(facilitación descendente), mientras que los medicamentos de acción central como la 
duloxetina o la terapia por ejercicios son capaces de mejorar los mecanismos de 
analgesia endógena o inhibitorios descendentes del dolor. Futuros estudios deberían 
valorar la eficacia de estas nuevas estrategias de ratamiento en pacientes con artrosis. 
 
Palabras clave: osteoarthritis, pain, central sensitization, neuroscience education, 
exercise therapy, graded activity. 
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Capítulo 2. ¿Están asociadas las medidas de sensibilización central con 
el área de dolor y los síntomas clínicos en sujetos con artrosis de 
rodilla? 
 
Contenido: 
 
Expanded distribution of pain as a sign of central sensitization in individuals with 
symptomatic knee osteoarthritis 
Lluch E, Dueñas L, Barbero M, Falla D, Baert I, Meeus M, Sánchez-Frutos J, Aguilella 
L, Nijs J. 
Phys Ther. 2016;96(8):1196-207. 
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RESUMEN 
Introducción: La expansion del área del dolor hcaia areas difusas o extensas se 
considera uno de los signos de sensibilización central. La relación entre los síntomas 
clínicos referidos por los pacientes con artrosis de rodilla y la sensibilización central ha 
sido poco investigada en la literatura científica. 
Objectivo: Examinar si el área de dolor dibujada por los pacientes con artrosis de 
artrosis se relaciona con medidas de sensibilización central y con distintos síntomas 
clínicos recogidos durante el examen subjetivo incluyendo el grado de dolor de rodilla, 
discapacidad y variables de índole psicosocial.  
Diseño: Estudio transversal observacional. 
Métodos: Se estudiaron 53 sujetos con artrosis de rodilla que estaban en lista de espera 
para operarse de una prótesis de rodilla. Todos los sujetos completaron un mapa del 
dolor utilizando un dispositivo digital novedoso y diferentes cuestionarios relacionados 
con el dolor y discapacidad de rodilla y factores de índole psicosocial. Además, se 
realizó un análisis cuantitativo sensorial a todos los sujetos que incluía el cálculo de los 
umbrales de dolor a la presión, la sumación temporal al dolor y la analgesia 
condicionada. Se generaron mapas de frecuencia del dolor de forma separada para los 
hombres y mujeres que formaban parte de la muestra de estudio. Se calculó el 
coeficiente de correlación de Spearman para ver posibles correlaciones entre el área del 
dolor y el análisis cuantitativo sensorial y los síntomas clínicos de los pacientes. 
Resultados: Los mapas de frecuencia del dolor mostraron áreas de dolor más extensas 
especialmente en las mujeres. La presencia de áreas de dolor extendidas se asoció a una 
mayor severidad de dolor en la rodilla (rs= .325, P < 0.05) y rigidez (rs=.341, P < 0.05), 
menor umbral de dolor a la presión en la rodilla (rs=-.306, P < 0.05) y el epicóndilo (rs=-
.308, P < 0.05) y puntuaciones más elevadas en el cuestionario Central Sensitization 
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Inventory (rs=.456, P < 0.01). No se encontró una correlación significativa entre el área 
del dolor y el resto de síntomas clínicos y medidas de sensibilización central. 
Limitationes: Debido al diseño de este estudio, no se pueden extraer conclusiones 
firmes sobre la capacidad predictiva de los mapas de dolor a la hora de determinar la 
presencia de sensibilización central. Se necesitan mayor investigación para determinar 
la fiabilidad y la validez de los mapas de dolor en los pacientes con artrosis de rodilla.   
Conclusiones: La extension del área del dolor hacia zonas difusas o extendidas se 
correlacionó con algunas medidas de sensibilización central en sujetos con artrosis de 
rodilla. Los mapas de dolor pueden ser una herramienta útil para identificar de forma 
precoz la presencia de sensibilización central en sujetos con artrosis de rodilla, pero se 
necesita mayor investigación en este sentido.  
 
Palabras clave: Knee osteoarthritis, chronic pain, pain location, central nervous system 
sensitization. 
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Capítulo 3. ¿Resulta eficaz para las personas con artrosis de rodilla un 
programa de Fisioterapia que combina la terapia manual dirigida a la 
rodilla con la educación en neurociencia del dolor dirigida al sistema 
nervioso central? 
 
 
Contenido: 
 
Balancing “hands-on” with “hands-off “ physical therapy interventions for the treatment 
of central sensitization pain in osteoarthritis 
Lluch Girbés E, Meeus M,
 
Baert I, Nijs J. 
Man Ther. 2015;20(2):349-52. 
 
Preoperative pain neuroscience education combined with knee joint mobilization for 
knee osteoarthritis: a randomized controlled trial 
Lluch E, Dueñas L, Falla D, Baert I, Meeus M, Sánchez-Frutos J, Nijs J. 
Under review 
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RESUMEN 
La forma tradicional de entender la artrosis de rodilla como un problema meramente 
relacionado con los tejidos articulares se ha puesto en tela de juicio, en vista de la 
evidencia que apoya un papel de la sensibilización central en un subgrupo de pacientes 
afectos de esta patologia. Este hecho puede conducir de forma errónea a los 
fisioterapeutas a concluir que las intervencions manuales no tienen cabida en el 
tratamiento de la artrosis de rodilla y que solo deben de aplicarse técnicas de tratamiento 
“hands off”. El objetivo de este articulo es animar a los clínicos a encontrar el equilibrio 
entre técnicas manuales y técnicas “hands off” durante el tratamiento de los pacientes 
con artrosis de rodilla cuyo clínico doloroso esté dominado por la sensibilización 
central. Se presentan los fundamentos teóricos para la aplicación simultánea de un 
programa de Fisioterapia que combina la terapia manual y la educación en neurociencia 
del dolor en pacientes con artrosis de rodilla, así como los problemas que se puede 
encontrar el fisioterapeuta en la práctica clínica cuando trate de aplicar esta estrategia 
combinada de tratamiento. Futuros estudios deberían explorar los efectos terapeúticos 
de estas estrategias de tratamiento combinadas para valorar si los resultados son 
superiores a los tratamientos actuales empleados para la artrosis de rodilla.   
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RESUMEN 
Objectivos: Comparar los efectos sobre la sensibilzaición central de un tratamiento 
aplicado en la fase pre-operatoria que combina educación en neurociencia del dolor con 
terapia manual de la rodilla con un tratamiento que combina educación basada en un 
modelo biomédico con terapia manual de la rodilla, en pacientes con artrosis de rodilla. 
Secundariamente, los efectos de los dos programas de tratamiento en el dolor de rodilla, 
discapacidad y variables psicosociales también serán investigados.  
Métodos: Cuarenta y cuatro sujetos con artrosis de rodilla que estaban esperando a ser 
operados de una prótesis de rodilla fueron aleatoriamente asignados a recibir 4 sesiones 
de educación en neurociencia del dolor con terapia manual de la rodilla o educación 
basada en un modelo biomédico con terapia manual de la rodilla antes de la cirujía. 
Todos los sujetos completaron diferentes cuestionarios y se les realizó un análisis 
cuantitativo sensorial que incluía el cálculo de los umbrales de dolor a la presión, la 
sumación temporal al dolor y la analgesia condicionada. Todas estas variables se 
midieron al inicio, después de las 4 sesiones de tratamiento, al mes (antes de la cirujía) 
y a los 3 meses después de la cirujía.  
Resultados: Se encontraron diferentes estadística y clínicamente significativas en el 
tiempo después de los dos ratamientos para el dolor y discapacidad de la rodilla y para 
algunas de las medidas evaluadas de sensibilización central (hiperlagesia generalizada, 
cuestionario Central Sensitization Inventory), sin diferencias significativas entre grupos. 
Otros indicadores de sensibilización central (analgesia condicionada, sumación 
temporal del dolor) no cambiaron con ningún tratamiento o incluso los cambios 
observados no fueron en la dirección prevista. Los sujetos que recibieron educación en 
neurociencia del dolor con terapia manual de la rodilla mostraron una mayor mejoría en 
las variables de índole psicosocial (catastrofismo, kinesiofobia) en relación al grupo que 
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recibió educación basada en un modelo biomédico con terapia manual de la rodilla, en 
las mediciones de tanto antes como después de la cirujía. 
Conclusiones: La aplicación de un programa pre-operatorio de educación en 
neurociencia del dolor junto con terapia manual dirigida a la rodilla no produce ningún 
efecto beneficioso adicional en el dolor, discapacidad y medidas de sensibilización 
central en comparación con el mismo tratamiento de terapia manual pero combinado 
con educación basada en un modelo biomédico. Sólo se obtuvieron efectos superiores 
en el grupo que recibió educación en neurociencia del dolor junto con terapia manual de 
la rodilla en las variables psicosociales relacionadas con el catastrofismo y la 
kinesiofobia. 
 
Palabras clave: Knee osteoarthritis, central sensitization syndromes, physical therapy, 
education 
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CONCLUSIONES 
 
Las conclusiones generales de esta tesis doctoral son las siguientes: 
 
1. La evidencia científica actual indica que la sensibilización central juega un papel 
importante en un subgrupo de pacientes con artrosis, incluyendo la artrosis de rodilla. 
Sin embargo, es necesario desarrollar estrategias de valoración que permitan identificar 
de forma fiable y sistemática a aquellos pacientes con artrosis cuyo mecanismo 
dominante del dolor sea la sensibilización central. 
 
2. El tratamiento fisioterápico de los pacientes con artrosis de rodilla requiere de un 
enfoque biopsicosocial, dónde se determinen en qué medida los factores periféricos y 
centrales contribuyen al dolor en cada paciente, con el fin de poder establecer las 
estrategias de tratamiento más adecuadas. Los fisioterapeutas están bien posicionados 
para ofrecer una intervención individualizada en estos pacientes porque son 
conocedores de la necesidad de un abordaje biopsicosocial. 
 
3. El área de dolor que refieren los pacientes con  artrosis de rodilla se relaciona con 
algunas medidas de sensibilización central. Los clínicos deben estar atentos ante 
aquellos pacientes con artrosis de rodilla que presenten áreas extendidas de dolor, ya 
que esto puede ser un indicador de la presencia de mecanismos alterados de 
procesamiento central de la información nociceptiva. Los mapas de dolor son una 
herramienta fácil y económica que puede ayudar a identificar de forma precoz la 
presencia de sensibilización central en pacientes con artrosis de rodilla.  
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4. Se anima a los fisioterapeutas a buscar un equilibrio entre las intervenciones 
manuales y las no manuales en pacientes con artrosis de rodilla cuyo mecanismo de 
dolor dominante es la sensibilización central. A la luz de la evidencia existente sobre el 
papel clave que puede jugar la sensibilización central en un subgrupo de pacientes con 
artrosis de rodilla, es fundamental que los fisioterapeutas reconsideren el uso de las 
intervenciones manuales empleadas para la artrosis de rodilla y enfaticen el uso de 
intervenciones no manuales con el objetivo de mejorar el dolor, la autoeficacia y las 
cogniciones y conductas ante el dolor de los pacientes. 
 
5. Se han desarrollado bases científicas sólidas y directrices prácticas para la aplicación 
de un enfoque combinado de terapia manual y educación en neurociencia del dolor en 
pacientes con artrosis de rodilla y sensibilización central como mecanismo dominante 
del dolor. 
 
6. Una intervención pre-operatoria de Fisioterapia dirigido a pacientes con artrosis de 
rodilla que combina la educación en neurociencia del dolor junto con terapia manual 
dirigida a la rodilla no produjo ningún beneficio adicional en cuanto a dolor de rodilla, 
discapacidad o medidas de sensibilización central frente a un tratamiento combinado de 
educación biomédica y terapia manual de rodilla. Sólo se observaron mayores efectos 
con la educación en neurociencia del dolor y terapia manual de rodilla en las variables 
psicosociales relacionadas con el catastrofismo y la kinesiofobia. 
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GENERAL INTRODUCTION 
OSTEOARTHRITIS 
 
Osteoarthritis (OA) is the main cause of pain, disability and loss of quality of life in the 
elderly affecting over 80% of the population beyond the age of 55 [1, 2]. Although the 
clinical presentation of OA can be very variable, pain is the primary symptom in OA 
and high levels of pain are associated with much lower levels of physical function, self-
efficacy, and quality of life [3, 4]. OA is a disease characterized initially by cartilage 
degeneration, often preceding changes in the underlying bone. It is the consequence of a 
failed regeneration of damage to the joint due to stresses from biomechanical, 
biochemical and the influence of genetic factors [5]. Some studies have shown however 
that, besides ongoing joint destruction, new tissue production and remodeling occurs 
evidenced by increased protein synthesis by chondrocytes, especially in the early stages 
of OA [6]. OA affects at least 50% of people >65 years of age, but also occurs in 
younger individuals following joint injury [7]. The weight-bearing joints such as the hip 
and knee and smaller peripheral joints, including the hands, are the most commonly 
affected by OA [8]. Significant disability and healthcare costs are derived from OA, 
especially when affecting the elderly population.  
 
Historically, OA has been considered a primary disorder of the cartilage. However, 
since cartilage is an avascular and aneural tissue, damaged articular cartilage is not 
capable of directly generating nociception, and hence a pain experience [9]. Studies 
using ultrasound and MRI have demonstrated how the presence of inflammation in non-
cartilaginous structures such as synovial membrane and bone marrow are important 
factors contributing to chronic pain in OA [10-13]. In fact, synovial hypertrophy, 
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synovial effusions, and abnormalities in the subchondral bone have been associated 
with chronic knee OA pain in large cohort studies [14]. Different pro-inflammatory 
mediators may be released into the OA joint with damage such as nerve growth factor, 
nitric oxide and prostanoids [6], each of which can have a role in OA pain. In addition, 
studies indicate that expression of grown factors, in particular vascular endothelial 
growth factor (VEGF) and platelet derived growth factor (PDGF), can induce 
neovascularization in the OA joint [12]. Osteocondral angiogenesis, in turn, has been 
linked to chronic OA pain [15]. Based on all this findings, the presence of a 
phenomenon of local soft tissue inflammation in OA is unquestionable, contributing to 
the severity and frequency of OA pain [6, 16].  
 
Discordance between pain severity reported by patients and the degree of articular 
pathology (assessed by the Kellgren-Lawrence radiologic classification criteria) [17], in 
particular during the chronic stages of OA, have raised the issue of centrally-mediated 
mechanisms contributing to pain in OA [5, 7, 18-21]. In fact, it is estimated that up to 
40% of individuals with severe radiological damage have no pain, and many individuals 
with severe OA pain have normal radiographs [22, 23]. Dieppe [24] indicated that only 
half of patients with radiographic OA have pain, and that there is a weak correlation of 
pain severity to radiographic features. Hence radiography seems to be an imprecise 
guide to predict the likelihood that pain or disability will be present with OA, and its use 
in isolation has been discarded when assessing patients with OA pain [17]. However, 
other studies have demonstrated a positive correlation between OA pain severity and 
radiological changes [25, 26]. Poor correlation between pain intensity and peripheral 
joint damage seems to be only found on a population level [17] but, within individuals, 
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pain severity may be strongly associated with radiographic damage [26], especially if 
one uses more sensitive imaging techniques like MRI instead of conventional 
radiography [13,14,27,28]. Using these techniques, synovitis of the joint and bone 
marrow lesions seem to demonstrate a robust correlation with symptoms in people with 
knee OA [28-30]. 
 
Above all, taking together the overall results of the above studies, other mechanisms of 
pain that are not joint specific (i.e., altered central nociceptive processing mechanisms) 
seem to play a role in the variability in pain severity observed across individuals with 
OA. While pain associated with OA has long been considered purely nociceptive in 
nature, mounting scientific evidence indicates that pain in OA can be centrally-mediated 
as well [18-21, 31-40]. More specifically, altered central nociceptive processing [i.e., 
central sensitization (CS)] seems to play a key role in a subset of people with knee OA 
pain [18-21, 31-40]. However, at the time of initiating this PhD, a systematic review of 
the literature addressing the role of CS in people with knee OA was not available.  
 
CENTRAL SENSITIZATION AND KNEE OSTEOARTHRITIS PAIN 
Persistent nociceptive input from knee OA is deemed to be responsible of inducing not 
only peripheral sensitization (increased responsiveness to stimuli in nociceptive afferent 
neurons), but also CS [36, 41]. Pathophysiological mechanisms underlying CS are 
complex and numerous, but the net effect is an amplification of neural signaling within 
the central nervous system (CNS) than elicits pain hypersensitivity [41, 42]. CS is a 
broad concept reflecting not only spinal cord sensitization, but also enhanced activity of 
nociceptive descending facilitation pathways [43, 44], loss of descending anti-
nociceptive mechanisms [45, 46], overactivity in the pain neuromatrix [47], and long-
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term potentiation of neuronal synapsis in the anterior cingulate cortex [48]. Therefore, 
the term CS involves several changes in central nociceptive processing occurring at 
different levels of the central nervous system. Currently, however a universally accepted 
term for the phenomenon described as CS is not available and its use in the scientific 
literature is still under debate [49-51]. In addition, CS is not a yes/no or present/absent 
single entity or phenomenon but it occurs over a continuum. In fact, a recent study 
demonstrated that although prevalent, generalized central hypersensitivity or CS is not 
present in every patient affected by chronic pain [52]. While generally higher in certain 
chronic pain conditions, pain sensitivity is also along a continuum in these conditions 
[53]. In some patient populations, CS may be the characteristic feature of the disorder 
(e.g., fibromyalgia). In others, such in knee OA, not all patients have CS, but only a 
sub-group. It has been estimated that around 30% of subjects with knee OA have CS 
contributing to their clinical picture [40, 54, 55].  
 
Altered CNS pain processing or CS does not exclusively affect knee OA [18-21, 31-40], 
but has been demonstrated in other chronic musculoskeletal pain conditions (i.e., 
fibromyalgia [56-58], chronic low back pain [59], reumathoid arthritis [60], chronic 
fatigue syndrome [61], chronic whiplash associate disorders [62], chronic pelvic pain 
[63] and shoulder pain [64]). Many of these conditions have been grouped together 
under the unifying term of central sensitivity syndromes, to make reference to the 
shared mechanism of CS underlying these chronic conditions [65, 66].  
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Regarding knee OA pain, it has been suggested that, the more chronic the pain becomes, 
the more this pain is related to neuroplastic changes in the nervous system than to an 
inflammatory condition of the joint [67]. Ivanivicius and colleagues [67] showed in a rat 
model of OA how the maximum efficacy of non-steroid anti-inflammatory drugs 
(NSAIDs) over time reached its peak at 14 days post-injury. Beyond this time, the 
effects of NSAIDs became minimal, and other (centrally acting) drugs like amitriptyline 
and gabapentin become more efficacious [67]. This seems to support the theory that 
joint pathology is responsible of the initial trigger for knee OA pain, but subsequent 
(chronic) pain is mostly mediated by neuronal plasticity (CS). The role of peripheral 
nociceptive input (i.e., OA joint damage) on the development and maintenance of CS 
has been supported by several studies, where removal of the inciting pain stimulus (i.e., 
prosthetic substitution) led to normalization of central pain processing [37, 68]. On the 
other hand, persistent pain following joint replacement of the damaged joint is not 
uncommon and has also been linked to CS [69]. This may be explained because once 
the CNS is sensitized, either no or minimal tissue damage is necessary to perceive pain 
and CS can persist in time despite the lack of new painful stimuli from the periphery 
[41]. 
 
RECOGNIZING CENTRAL SENSITIZATION IN PATIENTS WITH KNEE 
OSTEOARTHRITIS  
Despite growing awareness of the important contribution of central pain mechanisms to 
knee OA pain, routine evaluation of CS is yet to be incorporated into clinical practice. 
This is likely due in part to the historical laboratory-based focus of CS research, where 
the equipment and protocols used to identify features of CS (e.g. quantitative sensory 
testing (QST) [70, 71], nociceptive reflex testing [72], brain neuroimaging techniques 
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[73, 74]) are relatively sophisticated, time-consuming, expensive and not well-suited for 
clinical settings. 
 
The development of patient profiles to subgroup individuals with knee OA in terms of 
pain mechanisms, including those with “dominant” CS pain, is gaining attention in 
research as reflected by the increasing number of pain phenotyping proposals which 
have been published in recent years [75-77]. The lack of subgrouping in previous 
clinical trials has been proposed as an explanation for the modest efficacy of available 
treatments for KOA. [78]. In line with this, "phenotyping" or characterizing knee OA 
pain has become a research priority, not only to better understand the patients’ pain 
experience, but also to better target pain therapies to individual patients [79]. The 
biomedical model (i.e. pain is a reliable “informant” of what is happening at the 
peripheral tissue level) fall short in explaining chronic musculoskeletal pain, including 
knee OA pain [80]. Hence, a focus shift from a tissue disease (i.e. joint damage) 
towards identifying and targeting underlying pain mechanisms in knee OA is 
recommended [78, 81]. As knee OA results from a complex interaction between 
structural changes, physical impairments and psychological factors, three domains (knee 
pathology, psychological distress and pain neurophysiology) should be considered to 
understand pain phenotypes in knee OA [77, 79].  
 
Early identification of dominant CS pain in people with knee OA is crucial as the 
presence of pain sensitization may predict poorer outcomes following physiotherapy 
treatment [82] or surgery [32, 35, 69, 83, 84]. For instance, a less favorable outcome 
after operation was observed for patients with knee OA with a high pre-operative score 
for pain at rest and a low pain threshold to an electrical stimulus, both features 
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interpreted as reflecting a CS mechanism [69]. Similarly, pre-
operative widespread pain sensitization measured using pressure algometry [83] or the 
pre-surgical presence of an enhanced temporal summation of pain which is a hallmark 
sign of CS [84], have been  associated with chronic pain after total knee replacement. 
 
Technically, CS is a neuronal response that can only be measured in animals [41, 50, 
51].  All of the QST protocols that have been developed in the scientific literature are 
indirect analog measures of CS that are believed to be analogs of these animal 
assessments [i.e. wind up phenomenon]. To be honest, we don't have widely accepted 
terminology for humans to reflect what we believe to be centrally-mediated facilitated 
pain responses [49-51]. Therefore, classifying a patient with knee OA as having a 
dominant CS pain is challenging clinically since there is currently neither an 
international consensus definition nor a set of valid clinical criteria for the diagnosis of 
CS [41, 49-51]. The diagnosis of CS in patients with chronic musculoskeletal pain, 
including those with knee OA, is thus not straightforward and clinicians are forced to 
rely on symptoms and signs suggestive of CS pain in this regard. Some authors have 
proposed that information derived from the medical diagnosis, subjective assessment, 
physical examination and treatment response, can be useful to clinically identify CS 
[85]. Recently, clinical classification criteria have been published that can assist 
clinicians to differentiate and diagnose the dominant pain mechanism in people with 
chronic musculoskeletal disorders [86]. Clinicians are advised to screen their patients 
for 3 major classification criteria, and use them to complete a classification algorithm 
for each patient [86]. The first and obligatory criterion for dominant CS pain entails 
disproportionate pain, implying that the severity of pain and related reported or 
perceived disability are disproportionate to the nature and extent of injury or pathology. 
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The two remaining criteria are 1) the presence of diffuse pain distribution, allodynia and 
hyperalgesia and 2) hypersensitivity of senses unrelated to the musculoskeletal system 
such as high sensitivity for noise, heat or cold or bright light (defined as a score of at 
least 40 out of 100 on the Central Sensitization Inventory (CSI) [87]. However, the 
suitability of this clinical algorithm for the knee OA pain population is unknown. 
 
  
QST is a semi-subjective method suggested to be in detection of altered central 
nociceptive processing [70, 71, 88]. However, laboratory QST is not clinically 
pragmatic and test modalities and protocols are heterogeneous, which makes it difficult 
for the clinician to determine which is the best QST measure for diagnosing CS [88]. 
Shorter and less expensive protocols and equipments that permit clinical identification 
of pain mechanisms including CS in patients with knee OA pain are thus needed [88]. 
What follows is a summary of clinical criteria derived from subjective assessment and 
physical examination that may aid clinicians in identifying a dominance of CS pain in 
patients with knee OA. These clinical criteria have been developed here by using the 
current understanding of CS within the context of knee OA pain. Importantly, these 
criteria should not be viewed as unique signs indicating CS, but they should rather be 
integrated into the clinical reasoning process, since they indicate a possible contribution 
of central pain mechanisms to knee OA, which can affect the appropiate treatment 
approach for the individual. It should be therefore made clear that the criteria proposed 
are not necessarily CS, but appears to be consistent with CS. They are not intended to 
replace the laboratory-based investigation of CS, but rather to bridge the gap between 
research findings and clinical practice by translating the clinical and laboratory-based 
studies of CS in knee OA into a broader and more clinically-relevant perspective. In 
addition, the psychometric properties (i.e. inter- and intra-examiner reliability, 
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sensitivity, specificity) of the criteria proposed for identifying CS in knee OA, either 
when used alone or in combination, should be the subject of future research. Clinical 
criteria for the recognition of a dominance of CS pain in patients with knee OA will be 
structured into two categories for a better overview: criteria derived from the subjective 
assessment and criteria extracted from the physical examination. 
 
The subjective assessment 
Pain intensity and its association with structural joint changes and duration of pain  
Individuals with knee OA presenting with altered central processing of pain are 
significantly more likely to report moderate to severe levels of pain [31, 33, 75, 89, 90]. 
Therefore, a moderate to severe intensity of self-reported knee pain (e.g. pain on a 
visual analogue scale >5/10 [91]) can be a first indicator of CS in knee OA. However, 
this finding in isolation is insufficient as moderate to severe intensity of self- reported 
knee pain defined as >5/10 likely encompasses many cases with and without CS. 
Additionally, studies reporting an association between higher levels of pain and more 
pain sensitization are not clear and consistent as to whether pain intensity is related for 
instance to the “worst pain", "usual pain", "current pain" or “pain with movement”.  
 
Unlike severity of pain, the presence of more severe structural changes in the knee joint 
on imaging is not associated with CS [31, 75, 89]. An inconsistent correlation between 
the degree of structural damage and pain and disability [17, 34] could be an indicator of 
CS in people with knee OA, albeit the discrepancy between structural and clinical 
findings is well known in OA in general [17]. Indeed CS is especially apparent among 
patients with knee OA with high levels of pain but low levels of imaging structural 
damage [34, 75]. Therefore, if clinicians find insufficient evidence of injury or 
Effect of neuroscience education on subjects with chronic knee pain related to osteoarthritis 
 
 
 Enrique Lluch Girbés  
14 
pathology at the knee both at imaging findings and clinical examination that is likely to 
contribute to the self-reported pain and disability, it should raise suspicion about the 
presence of altered central pain mechanisms [86].  
 
Regarding the duration of symptoms, there is controversy in the literature, with some 
studies reporting an association between a long history of symptoms and CS [75] while 
others do not [89]. It is assumed that the lack of association between CS and disease 
duration may indicate that some individuals are predisposed to CS irrespective of the 
duration of knee OA [89].   
 
Pain distribution 
Several methods and instruments have been used to record the patient’s pain location 
and to classify the pattern of knee OA pain. The most common method is asking people 
to draw the area where they feel pain on a body chart [92, 94]. Amongst people with 
knee OA, the medial knee region is the most frequently reported pain location [93, 94] 
though generalized or diffuse knee pain is also commonly reported [92, 94, 95]. 
 
In relation to knee OA, several studies have specifically investigated the association 
between central pain mechanisms and a widespread distribution of symptom location 
[95-97]. They concluded that a widespread, non-anatomical distribution of pain seems 
to be a strong indicator of altered central nociceptive processing [95-97]. Accordingly, 
aggravation and expansion of existing symptoms to sites around and remote to the knee 
joint may be a clinical sign of CS. Occurrence of contralateral symptoms, commonly 
reported by people with knee OA, should not be therefore automatically attributed by 
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clinicians to altered weight bearing or biomechanics due to compensation, as mirror 
symptoms may also been explained through spinal and supraspinal mechanisms [98]. 
 
To capture and objectify the presence of widespread pain clinicians can calculate the 
total number of bodily pain sites in a region divided body chart [38, 77] or ask the 
patient to complete a pain drawing (e.g. in a digital tablet) and subsequently compute 
the total area of pain (e.g. total number of pixels inside the digital chart)
 
[99]. When 
looking for a widespread distribution of pain, one should be cautious and bear in mind 
other explanations for an expanded distribution of pain outside the knee, such as chronic 
multisite joint pain which is frequent in patients with knee OA [100]. Indeed joint pain 
spreading to areas other than the knee joint is considered a valid indicator of joint-pain 
comorbidity in knee OA [101]. 
 
In summary, clinicians should obtain the area of pain of their patients with knee OA 
using pain drawings and if possible quantify that area, as the presence of extended areas 
of pain may be an indicator of CS. However, although there have been attempts to 
define widespread pain which serves as an indicatior of CS (e.g. Widespread Pain Index 
score) [102] there is no validated cutoff score for inferring whether pain is widespread 
or not [103]. 
 
Behaviour of knee pain 
Knee OA is commonly associated with pain-at-rest (or stimulus-independent pain) and 
pain-on-movement (mainly during weight-bearing activities) resulting in difficulties 
with walking and climbing stairs [92]. In the context of knee OA, pain-on-movement is 
often more severe than pain-at-rest in the early stages of the disease and has an earlier 
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onset in the disease course [104, 105]. There is a growing recognition of the importance 
of distinguishing between these two types of pain due to different mechanistic pathways 
and clinical implications [105, 106]. 
 
Pain on-movement has been linked to CS in people with knee OA [107]. In particular, 
increased sensitivity to physical activity (measured by evaluating changes in patient 
self-reported pain over the course of a 6-minute walk test) is associated with 
psychophysical indices of CS such as temporal summation of pain [107]. In addition, 
dysfunctional exercise induced hypoalgesia/analgesia is present in different chronic pain 
populations where CS is a key characteristic [108]. One could argue therefore that the 
same would be applicable to the subgroup of patients with knee OA where CS is 
dominant. Previous studies reported normal exercise induced analgesia in patients with 
knee OA following lower [109]
 
and upper body exercises [110]. However, in these 
studies no attempt was made to classify the patients in terms of pain mechanisms. 
Rather pressure pain thresholds instead of self-reported pain
 
[107] were used to quantify 
sensitivity to physical activity. Clinicians may therefore look for a disproportionate self-
reported increase in knee pain after physical activity tests or activity-based interventions 
to infer the possible presence of altered central nociceptive processing mechanisms.  
 
Asking about easing and aggravating factors for knee OA pain may also be helpful to 
distinguish between those individuals with either a more dominant nociceptive or CS 
pain. A clear, proportionate mechanical/anatomical nature to aggravating and easing 
factors was associated with nociceptive pain in people with low back (± leg) pain [111]. 
In that same population, a lack of clear proportionate mechanical nature to aggravating 
and easing factors was considered a predictor sign of CS pain [112]. Therefore a 
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“disproportionate, non-mechanical, unpredictable pattern of pain provocation in 
response to multiple/non-specific aggravating/easing factors” [112] may indicate the 
presence of CS pain in people with knee OA. 
 
Presence of neuropathic-like symptoms 
A growing level of evidence suggests that knee OA pain has a neuropathic component 
in some individuals [113, 114] previously approximated to be 30% [115]. Presence of 
neuropathic-like symptoms in people with knee OA has been associated with CS [54, 
55, 116]. It is well established that patients with chronic joint injury may present with 
signs and symptoms typically associated with neuropathic injury (especially with 
progression to chronic stages), due to changes in nociceptive processing [70, 117]. 
Clinical presentation of neuropathic pain in knee OA may include the use of pain 
descriptors such as burning, pins and needles, sensitivity to heat and/or cold, numbness 
or spontaneous electric-shock like pain to describe the pain associated with OA [54, 55, 
116, 118]. Evidence for neuropathic pain components has also been provided in knee 
OA animal models besides humans [67], but the exact molecular mechanisms 
contributing to neuropathic-like pain in knee OA remain unclear. Because many of the 
joint structures are richly innervated, it has been hypothesized that local damage to these 
and other joint structures could cause damage to the peripheral nerves [119, 120]. 
Indeed animal models of knee OA have shown that sensory nerve fibers innervating the 
knee are significantly damaged with destruction of subchondral bone junction, and 
induce neuropathic pain [67]. Valdes et al. [120] established a cross-sectional 
association between previous history of knee surgery (arthroscopy, ligament repair or 
meniscectomy), and “possible” neuropathic pain (assessed with the 
PainDetect questionnaire), in people with knee OA. It was suggested that some of the 
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neuropathic-like symptoms observed in people with knee OA may result from nerve 
damage as a consequence of previous surgery [120]. Finally, positive treatment outcome 
after administration of intravenous lignocaine, a sodium channel blocker and neuronal 
membrane stabilizer commonly used for neuropathic pain, was reported by Duarte et al 
[114] in a group of knee OA patients.  
 
Identification of neuropathic pain in subjects with musculoskeletal pain including knee 
OA pain has been done through QST [70, 71, 121] and questionnaire-based assessments 
[54, 55, 73, 116, 120, 122, 123]. Findings from both tools of assessment have 
demonstrated significant overlap in subjects with joint pain, demonstrating that the 
same underlying concept (neuropathic pain) is being assessed [124]. Patient-report 
questionnaires have been developed to help identify neuropathic-like symptoms in 
general population such as the (modified) painDETECT [(m)PD-Q], the Leeds 
assessment of neuropathic symptoms and signs (LANSS), Douleur Neuropathique en 4 
questions (DN4), ID pain or Neuropathic Pain Questionnaire (NPQ) [125]. Of those, 
some of them have been used specifically in people with knee OA pain. For instance, 
the mPD-Q has demonstrated face and content validity for identifying neuropathic-like 
symptoms in people with knee OA [55]. In that study conducted by Hochman and 
colleagues, approximately one quarter of the total sample had symptoms of neuropathic 
pain (mPD-Q score ≥19/38). Moreover, higher mPD-Q scores were significantly and 
independently associated with high pain intensity, high OA severity and long OA 
duration [55]. Recently, the same group of researchers has further validated the mPD-Q, 
analyzing the relationship between mPD-Q scores and signs of CS obtained with QST 
[116]. It was found that 45% of a sample of symptomatic knee OA had findings 
consistent with CS (≥1 sign of CS) and people with higher scores on mPD-Q (>12.0) 
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were more likely to have QST signs of CS [116]. Another study by Ohtori et al [122] 
aimed at examining neuropathic pain in patients with knee OA using the PDQ. In 
addition, the relationship between neuropathic pain, pain intensity (using VAS and 
WOMAC pain subscale), and stage of OA through the Kellgren-Lawrence system was 
also evaluated. A total of 5.4% of subjects resulted to have “likely” and 15.2% 
“possibly” neuropathic pain, according to the painDETECT score. The painDETECT 
score was significantly correlated with higher severity of pain and increased stage of 
OA, although in this latter case only a tendency for positive correlation was determined 
[122]. Valdes et al [120] also reported a percentage of 34% of a sample of subjects with 
knee OA as having “possible” neuropathic pain, using the PD-Q. Neuropathic 
symptoms were strongly associated to worse quality of life and higher pain intensity.  
 
Although the PainDETECT and modified PainDETECT questionnaires have been used 
to screen neuropathic-like symptoms in people with knee OA, they may also function as 
measures of characteristics that indicate augmented central nociceptive processing 
[123]. Like the original PainDETECT, the modified PainDETECT is comprised of nine 
items but with some modifications adapted to people with knee OA, such as framing of 
questions to ask about symptoms ‘in or around’ the worst knee, over a specific time 
frame. Therefore, this modified version of the PainDETECT seems more suitable for 
patients with knee OA.  
 
Presence of centrally-mediated symptoms 
Comorbid presence of some symptoms commonly associated with CS during subjective 
assessment, such as widespread pain, fatigue, sleep disturbance or cognitive difficulties, 
has been interpreted as a reflection of alteration of central pain processing in subgroups 
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of patients with knee OA [39, 40]. Murphy et al. [39] measured pain severity and 
presence of (centrally- mediated) symptoms suggesting CS in a sample of patients with 
knee OA. A 27% of the variance in pain severity reported by the patients was explained 
by age, radiographic severity, and centrally-mediated symptoms. Interestingly, after 
entering age and radiographic severity as variables, centrally-mediated symptoms 
explained an additional 10% of the variance in pain [39].  
 
Two questionnaires have been developed for assessment of pain sensitivity and 
screening of CS, the Pain Sensitivity Questionnaire (PSQ) [126, 127] and the CSI [87, 
128]. These self-rating measures have been proposed as useful alternatives to objective 
experimental pain testing (which requires more time and equipment resources and is 
painful for the tested subject), for determining pain hypersensitivity. Reliability and 
validity of both questionnaires have been demonstrated [87, 126, 127]. The CSI is a 
self-reported screening instrument that helps to identify key symptoms associated 
with CS [87, 128]. The CSI evaluates hypersensitivity of senses unrelated to the 
musculoskeletal system such as noise, heat or cold or bright light. People with knee OA 
scoring more that 40 (out of 100) before surgery, considered the cuttoff value to affirm 
that key symptoms associated to CS are present, reported higher pain intensity, lower 
satisfaction and increased analgesic requirements in the early phase after total knee 
replacement surgery [130]. Recently, the following CSI severity levels have been 
established: subclinical = 0 to 29; mild = 30 to 39; moderate = 40 to 49; severe = 50 to 
59; and extreme = 60 to 100 [131]. The concurrent validity of the CSI severity levels 
was then confirmed in a separate chronic pain patient sample (58% with a central 
sensitivity syndromes diagnosis and 42% without). Compared to the non-central 
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sensitivity syndromes patient subsample, the score distribution of the central sensitivity 
syndromes patient subsample was skewed toward the higher severity ranges. In 
addition, patients scoring in the extreme CSI severity level were more likely to report 
previous diagnoses of fibromyalgia, chronic fatigue syndrome, temporomandibular joint 
disorder, tension/migraine headaches, and anxiety or panic attacks (P < 0.01). CSI 
severity levels were also associated with patient-reported depressive symptoms, 
perceived disability, sleep disturbance, and pain intensity (P ≤ 0.02) [131]. All the 
above mentioned studies highlight the value of the CSI to identify CS and predict 
poorer outcomes after surgery in people with knee OA. 
 
Responsiveness to previous treatment 
It has been argued that an inconsistent, unpredictable or unsuccessful response to local, 
nociception-targeted treatments or a strong exacerbation of symptoms severity post-
treatment may aid in recognition of CS in patients with chronic musculoskeletal pain 
[85]. There is evidence that the presence of CS is a prognostic factor for poor outcomes 
in response to locally-applied physical therapy interventions in some chronic pain 
conditions such as lateral epicondylalgia [132] or whiplash associated disorders [133]. 
Although it is conceivable that the presence of CS might also affect physical therapy 
treatment outcomes negatively in people with knee OA, this hypothesis is not yet 
proven [82]. An inability to endogenously modulate nociception (dysfunctional 
endogenous analgesia) may explain the disproportionate increase in pain often observed 
in people with knee OA after locally applied interventions (e.g. knee joint mobilization) 
[134]. 
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Less responsiveness to analgesic and non-steroidal anti-inflamatory pain medications 
together with better outcomes with administration of centrally acting drugs (i.e. 
duloxetine), is another criteria that can further consolidate the role of CS in knee OA 
pain [135]. Therefore physiotherapists should routinely ask about medications and 
responsiveness to them.   
 
Persistent post-surgical pain occurs in approximately 20% of patients with knee OA 
after total knee replacement [136] and it has been linked to the presence of CS [32, 83]. 
An unfavorable symptom outcome after surgery should thus alert physiotherapists to the 
potential presence of CS amongst other factors [32, 83]. Therefore, assessment of 
persistent post-surgical pain in a consistent and standardized way by mean for instance 
of a core outcome set [137] is considered essential for recognizing the presence of CS. 
Furthermore, the relatively high proportion of patients with persistent pain after total 
knee replacement highlights the importance of diagnosing (central) pain mechanisms 
before patients undergo surgery and revision surgery [32]. 
 
The physical examination 
Response to clinical tests 
Several types of information obtained from the physical examination can be of value in 
recognizing dominance of CS in individuals with knee OA pain [85]. In particular, an 
inconsistent or confusing response to clinical tests applied to the knee joint during the 
physical examination (i.e. the majority of assessment techniques provoke symptoms), 
may be suggestive of the presence of CS. This clinical finding has not yet been 
investigated, but might be plausible based on our current understanding of the 
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mechanism and clinical expression of CS, where a nonpainful mechanical stimulus can 
be interpreted as nociceptive [70]. 
 
Widespread mechanical hyperalgesia and allodynia  
Research has shown evidence in support of generalized or widespread hypersensitivity 
to mechanical stimuli in people with knee OA as compared to healthy controls [33, 30, 
71]. In particular, a systematic review and meta-analysis conducted by Suokas et al [71] 
addressing the use of QST in pain characterization in OA has concluded that pressure 
pain thresholds demonstrate a good ability to differentiate between people with OA and 
healthy controls. The majority of studies included in that systematic review examined 
pressure pain, while few studies applied electrical and/or thermal stimuli. People with 
OA had lower PPTs both at the affected joint and in remote sites compared to controls 
which was interpreted as a sign of peripheral and CS, respectively [71]. 
 
Widespread mechanical hyperalgesia is a well-recognized clinical manifestation of CS 
[5, 70, 71]. Hyper-responsiveness to mechanical stimuli includes exaggerated responses 
to pressure and touch. To apply this to clinical practice with patients with knee OA, 
lower pressure pain thresholds as assessed by a pressure algometer at sites around 
(localized pain sensitization) and remote to the knee (widespread pain sensitization) 
may imply hyperexcitability of central nociceptive pathways. However, as normative 
data or valid cuttoff values for diagnosing CS are currently lacking for knee OA, 
interpretation of pressure pain thresholds within an individual is challenging.  
Normative values are available for healthy subjects [138] which could potentially serve 
as a comparator when assessing patients with knee OA. 
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In the absence of a pressure algometer, physiotherapists can also use manual palpation 
(examiner’s thumb) to evaluate widespread mechanical hypersensitivity. A moderate 
correlation between manual pressure and pressure algometry was found in people with 
chronic neck pain [139], albeit the suitability of this finding to patients with knee OA is 
unknown. Diffuse non-anatomical tenderness on manual palpation is a clinical criterion 
that was shown to be predictive of CS pain in patients with low back (±leg) pain [112] 
and chronic neck pain [139]. An expansion of receptive fields, which is characteristic of 
CS [70], may lead to the patient experiencing increased tenderness to palpation well 
outside of the painful knee joint. A novel alternative to pressure algometry is a spring 
clamp, as used in a previous study in patients with low-back pain. By placing the spring 
clamp on the thumbnail for 10 seconds and asking the patients to assess pain intensity, 
O’Neill et al. were able to assess the pain response of the patients [140]. 
 
The presence of mechanical (tactile) allodynia (pain due to a stimulus that would not 
normally provoke pain) is associated with with knee OA [54] and is considered a 
hallmark sign of CS [70]. Heightened sensitivity to cutaneous light touch can be 
assessed in the clinical setting using both static or dynamic stimuli by gently touching 
or brushing/stroking the skin with a cotton wisp, a cotton wool tip or a brush.  
 
Widespread thermal hyperalgesia 
Besides widespread mechanical hyperalgesia, greater pain sensititivity to heat and cold 
stimuli
 
at remote sites from the knee are considered clinical indicators of deficient 
central processing of nociception in knee OA [141]. Hypersensitivity to heat or cold 
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stimuli is normally demonstrated in laboratory conditions by using a computer-
controlled thermotester. However, clinical tests for thermal sensitivity have been 
developed in other chronic pain populations (e.g. chronic neck pain) with good 
correlations with quantitative measures [139, 142] 
 
When clinically testing thermal sensitivity, the cold or hot item is placed on the skin for 
some seconds (e.g. 10 seconds
 
[142) and it should be perceived as cold or hot 
respectively, but should not elicit pain. If it does trigger pain, then hypersensitivity to 
cold or heat is established and the individual can be asked to rate the pain experienced 
during the test on an numerical rating scale [139, 142]. 
 Maxwell and Sterling suggested 
that pain>5/10 on a numeric rating scale after 10s of ice application should alert 
clinicians to the presence of cold hyperalgesia in whiplash thus aiding in prognosis and 
treatment decisions [142]. 
 
Hypoesthesia and reduced vibration sense 
Hypoesthesia (increased perception threshold) to tactile and vibration stimuli has been 
found in people with knee OA pain, at both local and remote sites from the knee [54, 
143]. Clinical finding of tactile hypoesthesia adjacent to the injured knee joint has been 
considered a clinical indicator of CS [70, 144]. When mapping the region of altered 
sensation, the pattern of sensory deficit in individuals with knee OA does not follow a 
nerve root or peripheral nerve distribution
 
[70, 144], thus enabling differentiation of 
sensory changes secondary to nerve injury. For assessing tactile hypoesthesia, the 
mechanical detection threshold is calculated using calibrated and standardized von Frey 
utilizing a series of ascending and descending stimulus intensities [121]. As an 
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alternative, the clinician can use a cotton wool or cotton tipped applicator. Typically, 
assessment is initiated in the area of most pain and the distribution of hypoesthesia is 
determined by repetitively stimulating the skin, moving outward in a wheel spoke 
pattern. 
 
Like altered mechanical detection threshold, reduced vibration sense may be indicative 
of CS in people with knee OA [70, 144]. In particular, a reduced vibration detection 
threshold has been demonstrated in people with knee OA at different sites of the lower 
extremity [145]. Vibration detection threshold is measured using a biothesiometer or 
vibrometer, although neither tool is commonly used in a clinical setting. As an 
alternative, the clinician can use a Rydell Seiffer graded tuning fork placed against 
different bony sites of the lower extremity
 
[145] (i.e. first metatarsophalangeal joint, 
medial and lateral malleolus, medial and lateral femoral condyle). The tuning fork can 
be placed there and record time until the vibration can no longer be perceived by the 
subject. The presence of any pain with the vibration stimuli can also be recorded. A 
painful response with testing (vibration allodynia) has been reported as reflecting 
central nociceptive changes [70, 144]. 
 
A summary of clinically-relevant criteria usable during the subjective assessment and 
physical examination to identify the presence of a dominant CS pain in patients with 
knee OA has been presented. Future studies are urgently needed to empirically test 
validation and metrics of these criteria including cut-offs and diagnostic accuracy (i.e. 
sensitivity, specificity) before it can be confidently adopted in clinical practice. 
Unfortunately, most of our understanding of these measures from research is based on 
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correlational and regression type analyses. To move this field forward into the clinical 
application, the ability to identify true and false positives/negatives regarding CS pain is 
highly important. Meanwhile, this set of clinical criteria derived from subjective 
assessment and physical examination can facilitate the acknowledgment and recognition 
of CS in clinical practice by physiotherapists. As previously mentioned, clinicians 
should be attentive for patients with signs of CS as they might be at risk for 
unfavourable outcome after locally-applied interventions to the knee. A broader 
therapeutic approach aiming to desensitize the central nervous system, in contrast to 
therapeutic modalities that are only directed to structural knee joint pathology, might be 
more beneficial for these patients. 
 
TREATING OPTIONS FOR CENTRAL SENSITIZATION IN PATIENTS 
WITH KNEE OSTEOARTHRITIS   
Historically, knee OA pain has been considered a nociceptive pain related to the degree 
of structural damage to the affected joint, that is, pain is considered a reliable 
“informant” of what is happening at the peripheral tissue level. This means that greater 
joint degeneration would be associated with greater pain and the diagnosis of knee OA 
relied heavily on radiographic evidence of osteoarthtitic changes in the joint, with the 
rationale that joint degeneration was the primary contributor to the experience pain. 
This traditional view of knee OA merely reflects the biomedical model so commonly 
rooted among healthcare professionals dealing with knee OA pain [80].  
Fortunately, this traditional view is changing and nowadays the pain experience in knee 
OA is considered a black box, where pain appears to be influenced by several factors 
including pathological changes occurring at a peripheral level, the influence of 
psychosocial factors and changes in pain processing occurring within the peripheral and 
central nervous system. However, the precise contribution of each factor to an 
individual pain experience is very difficult to determine [79]. This change in the view of 
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knee OA pain as a complex biopsychosocial phenomenon has prompted a paradigm 
shift in the treatment of knee OA pain. In particular, the treatment strategies for knee 
OA have been broadened to include not only physiotherapy interventions addressed to 
the knee, as further emphasized and studied in the present thesis, but also to the 
psychosocial factors or to changes in CNS sensitivity [36]. 
 
Despite the increase in publications emphasizing the importance of CS in knee OA pain, 
current interventions for rehabilitation of knee OA don’t usually address altered central 
pain processing or CS mechanisms associated with knee OA pain. In fact, conventional 
rehabilitation strategies for knee OA are in large part directed toward input mechanisms 
(i.e., joint inflammation) and output mechanisms (i.e., muscle strength, motor control, 
propioception) associated with the disease [146]. Many guidelines and 
recommendations for the management of knee OA have been published and updated by 
various professional organizations such as the ACR [147], EULAR [148] or OARSI 
[149]. All these set of recommendations and guidelines are based on results from 
existing clinical trials, which vary greatly in methodological rigour and quality, and they 
also include expert opinion to varying degrees. Overall all of them strongly support the 
efficacy of non-surgical treatments for knee OA pain despite recent data suggesting that 
other than exercise the role of physical therapies in the treatment of knee OA is 
questionable [150, 151]. Interestingly, if we have a look at what patients with knee OA 
actually use for treatment, the results of the study by Hinman and colleagues [152] is 
overwhelming: in contrast to the evidence-based guidelines, the use of non-surgical  
interventions is low among people with knee OA despite. Also striking is the fact that 
none of the evidence-based recommendations gives substantial consideration to which 
pain mechanism might be modulated by treatment. For this reason, it seems interesting 
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to investigate new avenues for treating central pain processing mechanisms in people 
with knee OA pain. 
 
Treatment strategies that aim at targeting local structures are typically of little value in 
patients with predominant CS pain [153, 154]. In fact, the presence of CS in a patient 
with knee OA may entail greater complexity of the clinical picture and less possibilities 
of achieving positive results with conventional physiotherapy interventions [82], 
although this needs to be further investigated. Hence a more “central” approach 
targeting brain and top-down mechanisms seems warranted for treating CS in patients 
with knee OA [36]. Several reviews have been published about options for treating CS 
in patients with chronic pain of different etiologies [146, 155-157]. Physiotherapists 
have at their disposal several tools to address neurophysiological changes across 
different areas of the peripheral and central nervous systems characteristic of CS pain in 
people with knee OA pain. They include top-down cognitive-based interventions (e.g., 
pain neuroscience education, cognitive-behavioral therapies such as pain coping skills 
training, acceptance-based interventions such as acceptance commitment therapy, 
mindfulness therapies, graded motor imagery, repetitive Transcranial Magnetic 
Stimulation; transcranial Direct Current Stimulation) and bottom-up physical 
interventions (e.g., motor learning, peripheral sensory stimulation, manual therapy, 
exercise therapy) [146, 155-157]. Comprehensive treatment approaches 
addressing peripheral structural injury (i.e., the knee joint) as well as 
neurophysiological changes occurring at distributed areas of the nervous system may 
help to improve outcomes in patients with knee OA with a predominant CS pain [36, 
146]. However, combination of treatments targeting CNS function with traditional 
treatments directed towards functioning of the knee is a promising approach that has to 
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be further tested. It is argued that due to the complex multidimensional nature of knee 
OA pain and the moderate effects that physiotherapy treatments have in isolation in 
knee OA, combination of treatments addressing both the knee and the CNS may bolster 
each other thus further improving outcomes [36, 79, 146].  
OUTLINE OF THE DISSERTATION 
The primary aim of the present dissertation was to investigate the existing evidence 
from the literature related to the presence or absence of central sensitization in patients 
with osteoarthritis including people with knee OA and the current options for treating 
central pain processing mechanisms in this population. Secondly, it was aimed at 
evaluating whether measures of central sensitization are associated with the area of pain 
and clinical symptoms (including the level of knee pain, disability and psychosocial 
variables) recorded during the subjective assessment in subjects with knee osteoarthritis. 
Thirdly, the effect of a combined intervention addressing the central nervous system 
(pain neuroscience education) and the knee (knee joint mobilization) in subjects with 
knee OA was investigated. This thesis consists of three parts each targeting one of these 
aims. 
The following research question will be addressed in the first part: 
- What is the role central sensitization plays in people with osteoarthritis 
including those with knee OA and which options do we have for treatment? 
To examine this research question, a narrative and systematic review of the 
literature related to the presence of central sensitization in osteoarthritis pain and 
current options for treatment of central sensitization specifically in osteoarthritis 
patients was performed. The results  are presented in chapter 2, comprising of 2 
published papers. 
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The following research question will be addressed in the second part: 
- Are measures of central sensitization associated with the area of pain and 
clinical symptoms in subjects with knee osteoarthritis? 
Chapter 3 presents an experimental study which evaluated whether the area of 
pain assessed using pain drawings relates to correlates of central sensitization 
and clinical symptoms in people with knee OA. 
 
The following research question will be addressed in the third part: 
- Is a combined intervention of manual therapy addressing the knee and pain 
neuroscience education targeted to the central nervous system effective for 
people with knee osteoarthritis? 
Chapter 4 includes two studies in order to answer this question. The first 
manuscript presents the theoretical rationale for simultaneous application of 
manual therapy and pain neuroscience education in people with knee 
osteoarthritis. The second manuscript reports the results of a randomized 
controlled trial assessing the effects of a pre-operative treatment combining pain 
neuroscience education with knee joint mobilization in subjects with knee 
osteoarthritis. 
 
The final parts of the thesis include a general discussion of the study results and a 
general conclusion.  
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CHAPTER 2 
What is the role central sensitization plays in people with 
osteoarthritis including those with knee osteoarthritis and which 
options do we have for treatment? 
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ABSTRACT 
Background and objective: Hyperexcitability of the central nervous system has been 
suggested to play an important role in the chronic pain experienced by patients with 
osteoarthritis. A systematic review following PRISMA guidelines was performed to 
evaluate the existing evidence from the literature related to the presence of central 
sensitization in patients with osteoarthritis. 
Databases and data treatment: Electronic databases Pubmed and Web of Science 
were searched to identify relevant articles using predefined keywords regarding central 
sensitization and osteoarthritis. Full text clinical reports addressing studies of central 
sensitization in human adults with chronic complaints due to osteoarthritis were 
included and screened for methodological quality by two independent reviewers. 
Results: From the 40 articles which were initially eligible for methodological quality 
assessment, 36 articles achieved sufficient scores and therefore were discussed. The 
majority of these studies were case-control studies and addressed OA of the knee joint. 
Different subjective and objective parameters considered manifestations of CS, which 
have been previously reported in other chronic pain conditions such as whiplash or 
rheumatoid arthritis, were established in subjects with OA pain. Overall results suggest 
that, although peripheral mechanisms are involved in OA pain, hypersensitivity of the 
central nervous system plays a significant role in a subgroup of subjects within this 
population.  
Conclusions: Although the majority of the literature provides evidence for the presence 
of CS in chronic OA pain, clinical identification and treatment of CS in OA is still in its 
infancy, and future studies with good methodological quality are necessary. 
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INTRODUCTION 
Osteoarthritis (OA) is one of the most frequent, disabling and costly pathologies 
affecting modern society. Subjects with OA pain often suffer from chronic pain leading 
to important disabilities and associated costs for the public health system (Jinks et al., 
2007). During the last years, a growing body of research suggesting central sensitization 
(CS)in OA has been developed (Lluch Girbés et al., 2013). According to Woolf (2011), 
CS is “operationally defined as an amplification of neural signaling within the central 
nervous system that elicits pain hypersensitivity”. CS is a broad concept reflecting not 
only spinal cord sensitization, but also enhanced activity of pain descending facilitation 
pathways (Staud et al. 2007, Meeus & Nijs 2007), loss of descending anti-nociceptive 
mechanisms (Meeus et al., 2008), overactivity in the pain neuromatrix (Seifert et al., 
2009) and long-term potentiation of neuronal synapsis in the anterior cingulate cortex 
(Zhuo, 2007).  Wind-up, activation of collateral synapses, apoptosis of gABAergic 
inhibitory interneurons, sprouting of Aß fibers in lamina II or glial activation, are also 
important functional changes observed in the central nervous system with CS (Woolf, 
2011).  
 
Changes which have been associated with central sensitization (CS) in OA patients 
include extended and remote areas of hyperalgesia from the affected joint (O’Driscoll 
and Jayson, 1974; Kosek and Ordeberg, 2000a; Bajaj et al., 2001; Imamura et al., 2008; 
Arendt-Nielsen et al., 2010), a loss of descending pain inhibitory mechanisms (Kosek 
and Ordeberg, 2000a; Arendt-Nielsen et al., 2010; Graven-Nielsen et al., 2012), and an 
increase of temporal summation (TS) (Arendt-Nielsen et al., 2010) and spatial 
summation (SS) (Graven-Nielsen et al., 2012). All these changes are recognized 
indicators of the presence of CS (Graven-Nielsen et al., 2012). Moreover, positive 
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effects of centrally acting drugs (Chappell et al., 2009), use of neuropathic pain 
descriptors (Hochman et al., 2010, 2011), presence of symptoms suggesting CS (i.e. 
widespread pain, fatigue, sleep disturbance and cognitive difficulties) in subgroups of 
patients with OA (Murphy et al., 2011b),
 
and results from several functional brain 
neuroimaging studies (Kulkarni et al., 2007; Gwilym et al., 2009; Parks et al., 2011), 
support the role of CS in chronic OA pain.  
 
Currently, however, it remains unclear whether sufficient evidence is available in favor 
of CS in chronic pain related to OA. Although narrative reviews regarding CS in OA 
exist (Lluch Girbés et al., 2013), there are no studies that systematically reviewed the 
literature regarding CS in chronic OA pain. Recent systematic reviews have 
demonstrated that CS plays a role in other chronic pain conditions like whiplash (Van 
Oosterwijck et al., 2013), and rheumatoid arthritis (Meeus et al., 2012). If CS is 
dominating the clinical picture of patients with chronic OA pain, then treatment 
programs should be adapted accordingly (Lluch Girbés et al., 2013). Hence, the aim of 
this study was to systematically review and evaluate the existing evidence from the 
literature, in order to establish if there are enough arguments to support the role of CS in 
chronic pain related to OA.  
 
LITERATURE SEARCH METHODS 
Search strategy 
To identify relevant articles concerning central pain processing in patients with OA, a 
systematic search of the literature using the PRISMA guidelines (Liberati et al., 2009) 
was performed in databases Pubmed (http://www.ncbi.nlm.nih.gov/sites/entrez) and 
Web of Science (http://apps.isiknowledge.com), in January 2013. The results for every 
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database and combination of keywords and MeSH terms used in the search strategy are 
represented in Supplementary Table 1. In addition, reference lists from relevant articles 
were checked to obtain as complete information as possible.  
 
Table 1. Total of hits for every keyword combination that was used at the Pubmed and 
Web of Science search databases. 
Entry Terms Pubmed Web of Science 
Osteoarthritis 
(MeSH)  
  
AND Central Nervous System Sensitization 
(MeSH) 
13 11 
AND sensitization 65 99 
AND central sensitivity 66 47 
AND central hyperexcitability   3 6 
AND central sensitization 36 61 
AND pain modulation 51 70 
AND neural inhibition (MeSH) 5 6 
AND hyperalgesia (MeSH) 87 154 
AND nociception (MeSH) 54 85 
AND pain threshold (MeSH)  171 212 
AND algometry   7 15 
AND hypersensitivity (MeSH) AND pain (MeSH) 57 42 
Total hits 615 808 
 
 
Study selection 
Initially, all titles and abstracts of the retrieved articles were screened to identify 
relevant papers related to CS in OA using predefined inclusion criteria. In case of 
uncertainty regarding appropriateness of the paper after reading title and abstract, the 
full version of the text was retrieved and checked for fulfillment of inclusion criteria. To 
be included in the review, an article had to meet all the following criteria: (1) to be 
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reported in a peer-review academic journal; (2) the author(s) studied the phenomenon of 
CS in human adults (18 years or older) with chronic pain due to OA; (3) the article was 
a full-text original research report, and not an abstract, letter, editorial or review; and (4) 
the study was presented in English. No limitation regarding year of publication was 
used and all clinical study designs were eligible. 
Although review articles were not eligible for inclusion, their reference lists were 
screened to collect relevant articles which were not initially retrieved by the systematic 
search. The full text version of all the articles that met the inclusion criteria were 
retrieved and methodological quality assessment and data extraction was performed. 
 
Quality assessment 
To evaluate the methodological quality of the full text papers we used a checklist of 18 
criteria, which was composed and used previously by Van Oosterwijck et al. (2013) (see 
Table 2). We chose to use these criteria as they have proven to generate reliable risk of 
bias scores for papers reporting studies examining the presence of central sensitization 
in chronic pain patients (Van Oosterwijck et al., 2013). Indeed, the intertester reliability 
of the risk of bias scores was high, reflected by the 96% (416 out of 432 items) 
agreement in scoring between the two researchers conducting the systematic review 
(Van Oosterwijck et al., 2013). The quality criteria were developed by selecting criteria, 
of relevance to the research question of the literature review, from established risk of 
bias scoring lists. This is important as the present study addresses a similar research 
question (i.e. examining whether central sensitization is present in a specific chronic 
pain population) in a different patient population (chronic whiplash associated disorders 
versus osteoarthritis).  
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Two independent and blinded researchers (ELL and RT), scored the studies and 
assessed whether each of the evaluation criteria was fulfilled. After rating the selected 
articles, they compared the results and, in the case of disagreement, the article was 
screened a second time and the point of difference was discussed. Both reviewers could 
argue and convince the other to obtain a consensus. When consensus could not be 
reached, a third researcher (JN) was called upon to make the final decision. Besides 
evaluating the overall quality, articles were categorized according to purpose (etiology, 
prevalence, incidence, prevention, treatment, case report, diagnosis), and study design 
(prospective, clinical trial, hypothetical, cohort, case-control, cross-sectional).    
 
Only those criteria that were applicable for the study design were taken into 
consideration. One point was given in case a study met with the related criterion, no 
point in case it did not fulfill the criterion. A total score was calculated as the sum of all 
the evaluation criteria that was fulfilled and then transformed into a percentage. For 
example, if only 14 out of the 18 criteria were applicable, and 7 of the 14 criteria were 
fulfilled, this resulted in a score of 7/14 or 50%. Papers that did not reach the minimum 
threshold of 40% on methodological quality scoring were not considered in this review. 
Finally, the results were analyzed and the existing evidence regarding CS in OA 
summarized.  
RESULTS 
Search strategy  
The selection process of the articles is represented in Figure 1. The initial search 
resulted in 1423 hits. After removal of duplicates, 737 articles remained. Four additional 
references were retrieved from the reference lists of papers selected. Titles, abstracts 
and full text papers, if necessary, were then screened for inclusion criteria fulfillment. 
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After screening, 697 studies were excluded and 40 articles were initially eligible for 
methodological quality assessment as presented in Table 2. 
 
Figure 1. Flowchart study selection 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
808 hits in Pubmed 615 hits in Web of Science 
Total of 1423 hits 
After removing duplicates 737 studies remain 
After screening in- and exclusion criteria 40 studies 
Reasons for exclusion: 
not humans: 198 articles 
not clinical reports: 208 
articles 
not CS as topic: 511 
articles 
not OA population: 136 
articles 
40 studies eligible for methodological quality assessment  
36 studies remain and were included and discussed in this systematic review 
4 articles excluded because of low 
methodological quality  
(total score ≤ 40%) 
4 studies identified from reference 
lists retrieved using the systematic 
search strategy and which fulfill the 
in- and exclusion criteria 
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Table 2. Evaluation scores on methodological quality 
Criteria 
methodological 
quality 
Criterion 
1 
Criterion 
2 
Criterion 
3 
Criterion 
4 
Criterion 
5 
Criterion 
6 
Criterion 
7 
Criterion 
8 
Criterion 
9 
Criterion 
10 
Criterion 
11 
Criterion 
12 
Criterion 
13 
Criterion 
14 
Criterion 
15 
Criterion 
16 
Criterion 
17 
Criterion 
18 
Total 
score 
% 
Abou-Raya et al 
2012 
1 1 1 1 1 1 1 0 1 1 1 0 1 1 1 1 1 0 15/18 83.3 
Arendt-Nielsen et 
al 2010 
0 1 1 - 1 1 1 1 - 0 - - - - 1 1 - 0 8/11 72.7 
Bajaj et al 2001 0 1 1 0 1 0 1 1 - 0 - - - 1 1 1 - 1 9/13 69.2 
Chapell et al 2009 1 1 1 1 1 0 1 1 1 1 1 0 1 1 1 1 1 - 15/17 88.2 
Courtney et al 
2009 
0 1 1 - 1 0 1 - - 0 - - - 1 1 1 - - 7/10 70 
Courtney et al 
2010 
0 1 1 - 1 1 1 - 1 0 0 0 - 1 1 1 - 0 9/14 64.2 
Emery et al 2006 0 0 1 - - 1 1 0 - 0 - - 0 - 1 1 - 0 5/11 45.4 
Farrell et al 
2000a 
0 1 1 - 1 0 1 - - 0 - - - - 1 1 - 0 6/10 60 
Farrell et al 
2000b 
0 1 0 - 1 0 1 - 1 0 - 0 0 - 1 1 - - 6/12 50 
Finan et al 2013 0 1 1 - 1 0 1 - - 0 - - - - 1 1 - - 6/9 66.6 
France et al 2004 0 1 1 - 1 0 1 - - 0 - - - - 1 1 - - 6/9 66.6 
Gerecz-Simon et 
al 1989 
0 1 0 - 1 0 0 0 - 0 - - 0 - 1 1 - 0 4/12 33.3 
Goodin et al 2012 0 1 1 - - 1 1 - - - - - 0 - 1 1 - - 6/8 75 
Graven-Nielsen et 
al 2012 
0 1 1 - 1 0 1 - - 0 - - - - 1 1 - 1 7/10 70 
Gwilym et al 2009 0 0 1 - 1 1 0 - - 0 - - 1 - 1 1 - - 6/10 60 
Gwilyn et al 2010 0 0 1 - 1 0 0 0 - - - - - - 1 1 - 1 5/10 50 
Hendiani et al 
2003 
0 1 1 - 1 0 1 - - 0 - - 1 - 1 1 - - 7/10 70 
Hochman et al 
2010 
0 1 1 - 1 0 0 - - 1 - 0 1 - 1 1 - - 7/11 63.6 
Hochman et al 
2011 
0 1 1 - - 1 - - - 0 - - 1 - 1 1 - - 6/8 75 
Howard et al 
2012 
0 1 1 - 1 1 1 - - - - 0 1 - 1 1 - 1 9/11 81.8 
Imamura et al 
2008 
0 1 1 - 1 1 0 0 - 0 - - 0 - 1 1 - - 6/11 54.5 
Kavchak et al 
2012 
0 1 1 - 1 0 1 - 1 0 - 0 - - 1 1 - - 7/11 63.6 
Kosek et al. 
2000a 
0 1 0 - 1 0 0 - - 0 - - - - 1 1 - 1 5/10 50 
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Table 2 (continued) 
Criteria 
methodological 
quality 
Criterion 
1 
Criterion 
2 
Criterion 
3 
Criterion 
4 
Criterion 
5 
Criterion 
6 
Criterion 
7 
Criterion 
8 
Criterion 9 
Criterion 
10 
Criterion 
11 
Criterion 
12 
Criterion 
13 
Criterion 
14 
Criterion 
15 
Criterion 
16 
Criterion 
17 
Criterion 
18 
Total 
score 
% 
Kosek et al  
2000b 
0 1 0 - 1 0 0 - - 0 - - 0 - 1 1 - 1 5/11 45.4 
Kulkarni et al 
2007 
0 1 1 - - 0 1 - - - - - - - 1 1 - - 5/7 71.4 
Lee et al 2011 0 1 1 - 1 0 1 - - 0 0 - 0 - 1 1 - - 6/11 54.5 
Lundbland et al 
2008 
1 0 0 - - 1 1 - - 0 - - 0 - 1 1 - 1 6/10 60 
Lundborg et al 
2010 
0 0 1 - 1 0 1 - - - - - - - 1 1 - - 5/9 62.5 
Moss et al 2007 0 1 1 1 - 1 1 0 1 1 0 1 1 1 1 1 - 0 12/16 75 
Murphy et al 
2011a 
0 1 1 - 1 0 0 - - - - - 1 - 1 1 - 1 7/10 70 
Murphy et al 
2011b 
0 1 1 - - 0 0 - - - - - 1 - 1 1 - 0 5/9 55.5 
O'Driscoll et al 
1974 
0 1 0 - 1 1 0 0 - 0 - - 0 - 0 1 - 1 5/12 41.6 
Parks et al 2011 0 1 1 - 0 0 1 - - 1 - 0 0 1 1 1 - 1 8/13 61.5 
Quante et 
al 2008 
0 1 1 - - 0 0 - - - - - - - 1 1 - - 4/7 57.1 
Vance et al 2012 0 1 1 1 0 1 1 1 1 1 1 1 1 1 1 1 0 0 14/18 77.7 
Westermann et al 
2011 
0 0 1 - 1 0 0 - - 0 - - 0 - 1 1 - 0 4/11 36.3 
Wilder-Smith et 
al 2001 
0 0 1 1 1 0 1 1 1 0 0 0 1 1 1 1 0 1 11/18 61.1 
Wood et al 2007 0 1 1 - 1 0 - - - 1 - 0 1 - 1 1 - 0 7/11 63.6 
Wylde et al 2011 0 - 0 - 0 0 0 - - - - - 1 - 1 1 - - 3/8 37.5 
Wylde et al 2012 0 0 1 - 1 0 0 - - 0 - - 0 - 1 1 - 0 4/12 33.3 
0: criterion not fulfilled; 1: criterion fulfilled;  –: criterion not applicable; papers with red shaded percentage scores were excluded from the review because scores were < 40%. 
Criterion 1: The sample size was sufficient and justified (using a priori or post hoc analysis) 
Criterion 2: Diagnostic criteria described? 
Criterion 3: Inclusion and exclusion criteria clearly described? 
Criterion 4: Randomised allocation with description of the randomization procedure? 
Criterion 5: Groups were comparable at baseline (regarding demographic data)? 
Criterion 6: Valid and reliable outcome measures used? -AND- Validity and reliability of every  
                      outcome measure described? 
Criterion 7: Co-interventions avoided or accounted for? 
Criterion 8: Wash-out period before data collection started? 
Criterion 9: Blinding of all subjects? 
Criterion 10: Blinding of all assessors who measured at least one key outcome? 
Criterion 11: Blinding of all therapists who administered the therapy? 
Criterion 12: Effectivity of the blinding procedure evaluated? 
Criterion 13: Drop-outs and reason for drop-out mentioned? 
Criterion 14: Treatment of both the experimental and the control group clearly described? 
Criterion 15: Statistical procedure described? 
Criterion 16: Outcome measures clearly described? 
Criterion 17: Intention-to-treat analysis? 
Criterion 18: Follow-up? 
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Methodological quality assessment 
There was 96,5% agreement (695 of the 720 items) between the two researchers on 
scoring the selected papers on methodological quality. After a second review, the 
reviewers reached a consensus in all except for 4 items. Final decision on these 4 items 
was resolved by a third researcher.  
 
Table 2 provides the details regarding fulfillment of the methodological quality criteria 
for each analyzed study. In only 3 out of the 40 studies the sample size was sufficient 
and justified for (criterion 1). Eight out of the 40 studies did not describe the diagnostic 
criteria for OA, while 7 research papers did not clearly describe inclusion and exclusion 
criteria used for patient’s selection (criteria 2 and 3). Groups were comparable at 
baseline regarding demographic data in 29 studies (criterion 5). The validity and 
reliability of the outcome measures used was only described in 13 out of the 40 studies 
(criterion 6). Co-interventions were taken into account in 24 studies (criterion 7), 
whereas only 5 out of the total studies selected included a washout period before 
starting the study (criterion 8). Subjects were blinded in 8 studies, assessor(s) in 7 
studies, and therapist who administered the therapy in 3 studies, although these criteria 
were not always applicable. Although 3 studies performed a double-blinded design (i.e. 
subjects and therapists), only 2 studies examined and reported whether the blinding 
procedure was effective (criterion 12). Eleven studies included a follow-up period 
(criterion 18).    
 
To be further considered in this review, articles were required to have a score of ≥40% 
on methodological quality. If this score was not achieved, the study was rejected 
because of poor methodological quality. Four studies (Gerecz-Simon et al., 1989; 
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Westermann et al., 2011; Wylde et al., 2011, 2012)
 
were excluded for this reason. In 
conclusion, 36 studies with sufficient methodological quality were considered, and the 
characteristics and findings of these studies are discussed below. 
 
Study characteristics 
Of the 36 selected studies, most were categorized as case-control (n=19) or cross-
sectional studies (n=12). Five research papers were randomized controlled trials.  
Twenty-two out of the 36 studies investigated the etiology of OA, 5 were treatment-
focused and 5 were classified as mixed etiology-treatment. Only 2 studies were 
classified as prevalence studies, and 2 more as diagnosis studies (Table 3). 
 
OA of the knee joint was examined in 24 studies, while 5 focused their interest on the 
hip, 3 on the 1
st
 carpo-metacarpal (CMC) joint, and 3 examined both hip and knee OA. 
One study recruited subjects with OA in the lower extremities. 
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Table 3. Characteristics of included studies. 
 
Article Purpose Design Sample 
characteristics 
Joint studied Criteria for 
OA 
diagnosis 
Inclusion/exclusion 
criteria 
Assessment 
regarding CS 
Time of follow-up 
assessments 
Results regarding 
CS 
Limitations of 
the study 
Abou-Raya 
et al.2012  
 
 
 
 
 
  
Treatment 
 
RCT 288 subjects with 
knee OA 
receiving two 
different 
treatments during 
16 weeks: 
 
144 receiving 
duloxetine 
 
144 receiving 
placebo 
 
 
Knee ACR  and 
radiographic 
criteria  
 
Inclusion: OA with 
knee pain [>4 on the 
24-h VAS using 
mean of daily ratings 
from week preceding 
randomization], for 
>14 days/month 
during three 
consecutive months 
preceding enrolment.  
 
Exclusion: morbid 
obesity (BMI greater 
than 32 kg/m2), joint 
inflammatory 
diseases and or 
crystal-induced 
arthropathies, any 
other concomitant 
disease (such as 
neuropsychiatric 
disease including 
cognitive 
impairment, 
Alzheimer’s disease, 
Parkinson’s disease, 
cerebrovascular 
disease, 
cardiovascular 
disease, liver and 
renal disease), or use 
of other 
antidepressants that 
could interfere with 
the evaluation of the 
intervention 
Primary outcome 
measures:  
 
Percentage of 
patients with a 
clinical response 
according to the 
Osteoarthritis 
Research Society 
International 2004 
criteria at the end 
of 16 weeks (pain 
or physical 
function score 
decreased by 50% 
or more and at least 
20 mm on the 
VAS) 
  
Secondary 
outcome 
measures: 
 
WOMAC 
 
Use of OA rescue 
medication 
(NSAID and 
paracetamol) 
 
Modified version 
of the Katz activity 
of daily living 
scale  
 
Geriatric 
Depression Scale 
 
Incidence and type 
2 assessments: at 
baseline and at 16 
weeks 
 
 
Significant 
reduction at 16 
weeks on pain 
(VAS, WOMAC), 
function 
(WOMAC), 
NSAID and 
paracetamol use 
and depression 
(GDS) in the 
duloxetine group 
compared with the 
placebo group 
Possible 
selection bias 
from sample 
selected (more 
women than 
men; 
relatively young 
patients (68 
years);mean 
BMI of 27.6) 
 
Only 16 week of 
treatment) with 
results not 
generalizable to 
a longer duration 
of treatment: 
lack of follow-up 
after 16 week 
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of adverse events 
with treatment 
Arendt-
Nielsen et 
al. 2010 
Etiology Case-
control 
48 subjects with 
different degrees 
of knee OA and 
24 healthy 
controls  
 
Patients were in 
turn divided into 
two age- and sex-
matched groups: 
those with 
strong/severe pain 
(VAS≥6) and 
those with 
mild/moderate 
pain (VAS < 6)  
Knee ACR criteria Inclusion: knee OA 
diagnosed with ACR 
criteria 
 
Exclusion: use of 
medication 24h 
before the 
experiment, pain 
problems or sensory 
dysfunctions (e.g. 
nerve damage), or 
mentally impaired 
PPTs at different 
sites (peripatellar 
region, tibialis 
anterior and 
extensor carpi 
radialis longus 
muscles); 
spreading 
sensitization; 
temporal 
summation to 
repeated pressure 
pain stimulation; 
pain responses and 
referred pain areas 
after intramuscular 
hypertonic saline; 
and pressure pain 
modulation by 
heterotopic DNIC 
1 assessment, no 
follow-up 
No correlation 
found between 
radiological 
findings and 
experimental or 
clinical pain 
parameters 
 
Significant 
negative 
relationships 
between the 
degree of local 
(knee) 
sensitization and 
spreading (leg, 
arm) sensitization 
and the patients’ 
clinical pain 
intensity (VAS) 
(more pain, more 
sensitization/less 
PPT) 
Enhanced 
temporal 
summation of pain 
and impaired 
DNIC in OA 
subjects compared 
to controls 
Not specified 
Bajaj et al. 
2001 
Etiology Case-
control 
14 subjects with 
OA in the lower 
extremities and 14 
healthy controls 
 
 
10 OA subjects 
(10/14) had 
pain in the knee 
joint and 8 
(8/14) also had 
pain in the 
thigh, leg or 
foot 
ACR criteria Inclusion for 
experimental group: 
OA in the lower 
extremities 
 
Inclusion for 
control group: 
absence of pain areas 
at the time of 
enrolment 
Muscle 
hyperalgesia: VAS 
and assessment of 
pain areas before 
and immediately, 
2, 5, 10 and 20 min 
after intramuscular 
infusion of 0.5 ml 
hypertonic saline 
(6%) into the 
tibialis anterior 
muscle and then 
every 10 min, until 
experimentally 
1 assessment, no 
follow-up 
Significant higher 
local pain duration 
and intensity, 
larger pain areas 
and  increased 
referred and 
radiating pain 
intensity after 
intramuscular 
infusion in the OA 
subjects compared 
with controls 
The chronic OA 
and healthy 
controls included 
subjects both 
with and without 
a past history of 
trauma 
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induced pain 
disappeared 
Chapell et 
al. 2009 
Treatment 
 
 
RCT 231 OA subjects 
receiving two 
different 
treatments during 
13 weeks: 
 
120 receiving 
placebo 
 
111 receiving 
duloxetine (60–
120 mg/day)  
Knee ACR criteria  
 
Inclusion: pain for 
≥14 days of each 
month for 3 months 
before study entry, 
with a mean score ≥4 
on the 24-h VAS  
 
Exclusion: BMI>40 
kg/m2, confounding 
painful condition that 
would interfere with 
assessment of the 
index joint, 
inflammatory 
arthritis or an 
autoimmune 
disorder, invasive 
therapies to the knee 
in the past 3 months, 
knee arthroscopy 
within the past year, 
joint replacement  at 
anytime, prior 
synovial fluid 
analysis indicative of 
a diagnosis other 
than OA, to be non-
ambulatory, use of 
crutches or a walker, 
psychiatric disorders  
including major 
depressive disorder 
(as identified using 
the Mini 
International 
Neuropsychiatric 
Interview), previous 
exposure to 
duloxetine, pregnant 
or breastfeeding 
women, history of 
substance abuse or 
dependence, positive 
Primary outcome 
measure 
 
Weekly mean 24-h 
pain scores  
 
Secondary 
outcome measures  
 
Patients’ perceived 
improvement 
 
WOMAC  
 
Weekly mean of 
the 24-h worst pain 
score 
 
Several secondary 
outcome measures 
(quality of life, 
safety and 
tolerability of 
duloxetine, etc.) 
 
5 visits*:  
Visit 1: week -1 
Visit 2: week 0 
Visit 3: week 4 
Visit 4: week 7 
Visit 5: week 13 
 
*A 2-week taper 
phase was added to 
minimize 
discontinuation 
emergent adverse 
events 
Duloxetine group 
demonstrated 
statistically 
significant 
pain reduction 
compared with 
placebo on the 
primary efficacy 
measure of the 
weekly mean 24-h 
average pain score 
 
Duloxetine group 
also 
demonstrated 
superiority over 
placebo on most 
secondary efficacy 
measures 
 
 
Not specified 
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urine drug screen for 
any substance of 
abuse, existence of 
any serious medical 
or psychiatric 
condition that could 
compromise 
participation in the 
study, history of 
recurrent seizures, 
uncontrolled narrow- 
angle glaucoma, 
acute liver injury or 
severe cirrhosis, 
known 
hypersensitivity to 
duloxetine or any of 
the inactive 
ingredients, or 
frequent or severe 
allergic reactions to 
multiple medications 
Courtney 
et al. 2009 
Etiology Case-
control 
20 subjects with 
OA of the tibio-
femoral joint and 
20 healthy control 
subjects 
 
Knee Radiographic 
criteria  
Inclusion: OA of the 
tibio-femoral joint 
 
Exclusion: previous 
total knee 
arthroplasty in either 
knee, history of any 
diagnosed 
neurological or 
rheumatoid 
condition, history of 
ligamentous 
deficiency, or 
BMI>30 
NFR threshold 
 
VAS: previous 
week pain  
1 assessment, no 
follow-up 
NFR threshold 
was significantly 
diminished in OA 
subjects versus 
controls, as 
evidenced by a 
reduced current 
amplitude and 
latency of reflex 
responses (tibialis 
anterior responses) 
at NFR threshold 
 
Increased 
excitability of 
NFRs was evident 
in subjects with 
chronic knee OA, 
even in the 
absence of pain at 
the time of testing 
Despite use of a 
specific protocol 
of increasing 
current intensity 
to determine 
NFR threshold, 
the 
detection of 
threshold during 
experimental 
testing was 
initially 
performed 
visually using 
tibialis anterior 
EMG activity 
 
EMG activity 
was not 
normalized 
between subject 
groups using 
electrophysiologi
cal assessments 
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(maximal M 
wave), and 
accurate 
comparison of 
EMG 
amplitudes was 
not performed 
Courtney 
et al. 2010 
Etiology-
treatment 
Case-
control 
10 subjects with 
OA of the tibio-
femoral joint and 
10 healthy control 
subjects 
Knee Radiographic 
criteria 
Inclusion: OA of the 
tibio-femoral joint 
 
 
Exclusion: previous 
total knee 
arthroplasty in either 
knee, history of any 
diagnosed 
neurological or 
rheumatoid 
condition, history of 
ligamentous 
deficiency, or 
BMI>30 
NFR threshold at 
baseline and after 
three conditions: 
joint compression, 
joint mobilization 
and sham 
intervention. 
 
VAS: present pain 
level  
 
*Sham and 
mobilization 
interventions were 
not performed on 
control subjects in 
light of previous 
research which has 
demonstrated little 
modulation when 
the intervention 
was applied to a 
healthy pain-free 
peripheral joint 
1 assessment, no 
follow-up 
NFR threshold 
was significantly 
diminished at 
baseline in OA 
group versus the 
control group  
 
After applying 
joint compression 
NFR responses 
markedly 
augmented, mostly 
in OA subjects, 
whereas joint 
mobilization (but 
not sham 
intervention) 
reduced NFR 
excitability in OA 
group 
 
 
Influence of the 
order of 
experimental 
intervention 
(first joint 
compression; 
then joint 
mobilization) on 
the results 
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Emery et 
al. 2006 
Etiology-
treatment 
Cross-
sectional 
62 subjects with 
knee OA  
 
Knee Radiographic 
criteria 
Inclusion: 
radiographic 
evidence of OA 
affecting one or both 
knees, complaints of 
knee pain persisting 
for 6 months or 
longer, and 
postmenopausal 
status for women 
 
Exclusion: known 
organic disease that 
significantly affect 
function (e.g., 
chronic obstructive 
pulmonary disease) 
or preclude safe 
Participation, 
rheumatic disorders 
other than OA, 
evidence of cognitive 
impairment as 
indicated by a score 
of less 
than 24 on a mini-
mental status exam, 
current use of a 
selective serotonin 
reuptake inhibitor, 
BMI ≥35, or lack of 
NFR response during 
the initial NFR 
procedure 
NFR threshold  
  
Questionnaires/self
-reported measures 
evaluating pain and 
state anxiety (Mc-
Gill Pain 
Questionnaire, 
State-Trait Anxiety 
Inventory, Daily 
Coping Inventory, 
Pain 
Catastrophizing 
Scale) 
 
 
 
2 assessments, 
before 
and after a 45-
minute coping 
skills training 
session 
Increased NFR 
thresholds and 
decreased pain 
ratings following 
coping skills 
training for both 
men and women 
 
Women reported 
more significant 
reductions in 
anxiety following 
coping skills 
training 
intervention 
compared to men 
 
Women and men 
did not differ 
significantly in 
terms of the 
effects of 
intervention on 
NFR threshold or 
pain ratings 
Inclusion of only 
two NFR 
assessments, 
scheduled before 
and after the 
intervention 
 
Lack of a no-
treatment  
control condition  
 
Small sample 
size 
Farrell et 
al. 2000a 
Etiology Case-
control 
80 subjects 
divided in 3 
groups: 
 
1) Subjects with 
ACR clinical 
criteria for OA of 
the hands and 
symptoms related 
to OA of the 1st 
CMC. These, in 
turn, were divided 
1st CMC joint ACR criteria Exclusion: use of 
medication which 
was likely to 
influence pain 
perception, or history 
or signs of any 
disorder of sensation 
Thermal and 
mechanical 
detection and pain 
thresholds  
over the forearm 
and the 1st CMC 
joint 
 
Intensity ratings for 
3 types of pain: 
continuous pain, 
incident pain and 
1 assessment, no 
follow-up 
Lower thermal and 
mechanical pain 
thresholds were 
found over the 
thumb relative to 
the forearm in 
groups with 
persistent pain 
(CP, MP and CMP 
groups). Persistent 
pain was therefore 
associated with 
Great risk of 
spurious findings 
accompanying 
stepwise 
regression 
techniques used 
in this study 
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in 4 groups 
presenting with: 
- Continuous and 
incident pain (CP) 
(n=10) 
-Movement and 
incident pain 
(MP) (n=10) 
-Continuous, 
movement and 
incident pain 
(CMP) (n=18) 
-Incident pain (IP) 
(n=12) 
 
2) Subjects with  
features of OA of 
the 1st CMC but 
not pain in the 
hand in the last 
month (no pain 
group, NP group) 
(n=15) 
 
3) Pain-free age 
subjects without 
OA of the hand 
(no OA group, 
NOA group) 
(n=15) 
movement pain local hyperalgesia 
at the thumb 
 
IP, NP and NOA 
groups didn’t 
exhibit regional 
differences in 
sensitivity to 
thermal and 
mechanical 
stimuli. Incident 
pain was therefore 
not associated 
with local 
hyperalgesia. 
Increased ratings 
of continuous pain 
were associated 
with lower thermal 
and mechanical 
pain thresholds 
 
Variance in 
movement pain 
ratings was 
predicted by 
mechanical 
forearm pain 
thresholds 
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Farrell et 
al. 2000b 
Etiology Cross-
sectional 
24 women with 
OA 
of the hands 
distributed in two 
groups:  
 
1) 12 women with 
movement-related 
pain in at least 
one 1st CMC joint 
(movement pain 
group, MP group)  
 
2)12 women with 
no pain in either 
hand (no pain 
group, NP group)  
1st CMC joint ACR criteria Inclusion for the 
movement pain 
group: presence of 
symptoms (pain, 
stiffness) or signs 
(nodes, deformity, 
restricted or aberrant 
movement) 
associated with the 
1st CMC joint 
 
 
Two experiments 
were conducted: 
 
First experiment: 
Mechanical and 
thermal pain 
threshold  over the 
skin of the thumb 
measured 3 times: 
pre-movement pain 
provocation, post-
movement pain 
provocation and 30 
minutes post-
movement pain 
provocation 
 
*Movement pain 
provocation was 
achieved with 
resisted active 
movement of the 
thumb 
 
 
Second 
experiment: 
Mechanical and 
thermal pain 
threshold  over the 
skin of the thumb 
after movement 
pain provocation 
with blockade of 
Aβ fibers 
1 assessment, no 
follow-up 
  
Decrease in 
mechanical pain 
thresholds (not 
thermal) over the 
1st CMC joint and 
increase in thermal 
pain thresholds at 
distant sites (i.e. 
the contralateral 
thumb) 
in the MP group 
after resisted 
thumb movement 
 
The increased 
mechanical 
sensitivity after 
resisted active 
movement of the 
thumb was 
alleviated by Aβ 
fiber blockade in 
the MP group 
 
The NP group 
didn’t show any 
changes in 
sensitivity to 
either thermal or 
mechanical stimuli 
after resisted 
movement 
 
 
 
 
Not specified 
Finan et al. 
2013 
 
 
 
 
  
Etiology Cross-
sectional 
113 subjects with 
knee OA divided 
in 4 groups: low 
pain/low knee OA 
grade (n=24), 
high pain/high 
knee OA grade 
(n=32), low 
pain/high knee 
OA grade (n =27), 
Knee ACR criteria Inclusion: ACR 
criteria for knee OA, 
score of at least 1 on 
the 
Kellgren/Lawrence 
scale in one or both 
knees, knee pain 
scored >2 on a 10-
point scale on a near-
daily basis (>4 
WOMAC 
 
Kellgren/Lawrence 
scale (OA grade) 
 
PPT at local (i.e. 
insertion point of 
quadriceps of the 
affected knee) and 
remote unaffected 
1 assessment, no 
follow-up 
After adjusting for 
differences on 
psychosocial 
measures, as well 
as age, sex, and 
race, significantly 
heightened pain 
sensitivity across 
measures distal to 
the affected knee 
Analyses were 
performed on a 
secondary data 
set: the majority 
of participants 
were recruited 
for the presence 
of comorbid 
insomnia 
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and high pain/low 
knee OA grade 
(n=30) 
days/week) for at 
least 6 months prior 
to entering the study 
 
Exclusion: serious 
medical illnesses (i.e. 
congestive heart 
failure, history of 
cerebrovascular 
accidents, cancer, or 
other chronic pain or 
rheumatic disorders), 
joint replacement, 
severe or unstable 
psychopathology, 
cognitive 
impairment/dementia
, current substance 
abuse disorder, or 
positive findings on 
toxicology screening 
 
anatomic sites (i.e. 
trapezius muscle 
bilaterally) 
 
Repeated phasic 
suprathreshold 
mechanical and 
thermal pain 
  
Tonic 
suprathreshold pain 
(cold pressor test) 
 
CPM 
 
Anxiety (State-
Trait Anxiety 
Inventory) 
 
Depression (Center 
for Epidemiologic 
Studies Depression 
Scale) 
 
Daily Coping 
Inventory 
 
Pittsburgh Sleep 
Quality Index: 
sleep disturbance   
was found in the 
high pain/low 
knee OA grade 
group, while the 
low pain/high 
knee OA grade 
group was less 
pain-sensitive* 
 
*The results 
suggested that 
central 
sensitization in 
knee OA was 
especially 
apparent among 
subjects with 
reports of high 
levels of clinical 
pain in the 
absence of 
moderate-to-
severe 
radiographic 
evidence of 
pathologic 
changes of knee 
OA 
 
 
 
Small sample 
size 
France et 
al. 2004 
Etiology Cross-
sectional 
74 post-
menopausal 
women and 58 
age-matched men 
both with OA of 
the knee  
Knee Radiographic 
criteria 
Inclusion: 
radiographic 
evidence of OA 
affecting one or both 
knees, complaints of 
knee pain persisting 
for 6 months or 
longer, and 
postmenopausal 
status for women (to 
provide age 
matching, men were 
recruited if they were 
between 50 and 75 
years of age) 
NFR 
 
Electrocutaneous 
pain threshold and 
tolerance at knee 
 
Daily Coping 
Inventory: problem 
and emotion-
focused pain 
coping strategies 
 
Pain 
Catastrophizing 
Scale 
1 assessment, no 
follow-up 
 
Women were 
more likely than 
men to report 
using emotion-
focused pain 
strategies and 
emotion-focused 
coping was 
associated with 
more arthritic pain 
and lower 
electrocutaneous 
pain tolerance 
 
Catastrophizing 
Lack of control 
in women over 
the different 
forms of 
hormonal 
replacement 
therapy, doses of 
estrogen and 
progestin, 
continuous or 
cyclic protocols, 
or length of 
exposure to the 
medications.  
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Exclusion: known 
organic disease that 
significantly affect 
function (e.g. chronic 
obstructive 
pulmonary disease), 
affect reflex testing 
or preclude safe 
participation,  
rheumatic disorders 
other than OA, or 
cognitive impairment 
as indicated by a 
score of less than 24 
on a mini-mental 
status exam 
 
Mc-Gill Pain 
Questionnaire: 
overall pain 
ratings for the 
experimental 
laboratory session 
 
Arthritis Impact 
Measurement 
Scales 
was associated 
with greater 
arthritis pain and 
lower pain 
threshold and 
tolerance levels 
 
Catastrophizing 
was not related to 
NFR threshold 
 
No significant 
group differences 
in arthritis pain, 
electrocutaneous 
pain threshold or 
tolerance, or NFR  
threshold were 
observed between 
men, post-
menopausal 
women 
receiving hormone 
replacement 
therapy, and post-
menopausal 
women not 
receiving hormone 
replacement 
therapy  
Potential 
differences as a 
function of 
natural or 
surgical 
menopause were 
not examined 
 
Unable to record 
NFR thresholds 
in a large 
proportion of the 
sample 
Goodin et 
al. 2012 
Etiology Cross-
sectional 
140 older, 
community-
dwelling adults 
with symptomatic 
knee OA 
Knee ACR criteria Inclusion: 45-85 
years of age, 
unilateral or bilateral 
symptomatic knee 
OA based upon ACR 
criteria, and 
availability to 
complete the 2-
session protocol 
 
Exclusion: prosthetic 
knee replacement or 
other clinically 
significant surgery to 
the affected knee, 
uncontrolled 
Temporal 
summation of heat 
pain 
 
Measures of 
dispositional 
optimism and pain 
catastrophizing 
(Life Orientation 
Test-Revised and 
Coping Strategies 
Questionnaire) 
 
Center for 
Epidemiological 
Studies Depression 
1 assessment, no 
follow-up 
 
Greater 
dispositional 
optimism was 
found to be 
associated with 
less pain 
catastrophizing 
and less temporal 
summation of heat 
pain 
 
Pain 
catastrophizing 
significantly 
mediated the 
association 
Cross-sectional 
nature of the 
current study 
allows for the 
possibility that 
the associations 
among 
dispositional 
optimism, pain 
catastrophizing, 
and temporal 
summation of 
heat pain may be 
bidirectional or 
co-occurring 
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hypertension, heart 
failure, or history of 
acute myocardial 
infarction, peripheral 
neuropathy, systemic 
rheumatic disorders 
including rheumatoid 
arthritis, systemic 
lupus erythematosus, 
and fibromyalgia, 
chronic daily opioid 
use, cognitive 
impairment (Mini-
Mental Status Exam 
[MMSE] score), 
excessive anxiety 
regarding protocol 
procedures (eg, 
refusal to complete 
controlled noxious 
stimulation 
procedures), or 
hospitalization within 
the preceding year 
for psychiatric illness 
 
 
Scale 
 
WOMAC 
between 
dispositional 
optimism and 
temporal 
summation of heat 
pain 
Pain 
catastrophizing 
was assessed 
according to the 
‘‘standard’’ 
means of 
measurement 
(i.e. recall of 
catastrophizing 
in daily life), 
rather than the 
‘‘situation-
specific’’ means 
of measurement 
(i.e, 
catastrophizing 
measured during 
or directly after 
the 
administration of 
noxious 
stimulation) 
 
Possible bias  
due to sample 
selectivity 
 
Lack of 
matching the 
characteristics 
of the 
experimenters 
(e.g, sex, 
ethnicity/race) 
that facilitated 
the QST sessions 
to 
those of the 
participants 
 
Possible report 
biases of 
temporal 
summation 
procedure due to 
subjectivity of 
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self-reported 
pain 
Graven-
Nielsen et 
al. 2012 
Etiology Case-
control 
48 subjects with 
knee OA either 
unilaterally or 
bilaterally and 21 
healthy control 
subjects  
 
*20 out of 48 
patients with OA 
were scheduled 
for and further 
evaluated 5–28 
weeks following 
surgery  
 
 
 
 
Knee ACR criteria Inclusion:  severe 
pain for >3 months 
and pain score of ≥4 
on VAS 
 
Exclusion: pain 
problems or sensory 
dysfunctions (e.g. 
nerve damage) or 
mental impairment 
PPT over several 
local sites in the 
knee (i.e. in the 
peripatellar region) 
and control/remote 
sites (forearm and 
lower leg)  
 
Cuff PPTs at the 
lower leg 
 
Spatial summation 
of pressure-pain 
 
CPM 
1 assessment (pre-
surgery), no 
follow-up 
 
 
2 assessments at 
baseline and 
follow-up at 5–28 
weeks following 
surgery, on a 
subgroup of 20 OA 
patients who 
underwent knee 
replacement 
surgery 
Reduced PPTs at 
the knee and at 
control/remote 
sites (forearm and 
lower leg), 
reduced Cuff PPTs  
and enhanced 
spatial and 
temporal 
summation of pain 
in OA subjects as 
compared with 
control subjects 
 
Loss of CPM in 
OA patients 
 
Reduction in the 
widespread 
mechanical 
hyperesthesia, 
normalization of 
spatial summation 
ratios and 
restoration of 
CPM in the 
subgroup of 20 
OA subjects who 
underwent knee 
joint replacement  
Lack of 
reassessment of 
the healthy 
controls or the 
OA subjects who 
didn’t undergo 
surgery 
Gwilym et 
al. 2009 
Etiology Case-
control 
20 subjects with 
hip OA and 20 
controls 
 
 
 
Hip  Not specified Inclusion: hip pain 
secondary to primary 
OA of the hip 
 
Exclusion: any 
previous form of 
orthopedic surgery, 
presence of other 
chronic pain 
conditions, diabetes, 
and 
neurologic or 
psychiatric disorders, 
or exclusion criteria 
Punctate stimulus 
detection threshold, 
punctate 
hyperalgesia, cold 
perception 
thresholds, and 
cold pain threshold 
levels in area of 
referred pain 
 
fMRI: 12 patients 
and 12 controls 
underwent fMRI 
while their areas of 
1 assessment, no 
follow-up 
 
OA subjects 
showed 
significantly lower 
threshold 
perception to 
punctate stimuli 
and hyperalgesia 
to the noxious 
punctate stimulus 
in their areas of 
referred pain, 
compared to 
controls 
 
There were 
differences in 
medication use 
by the various 
groups of 
patients (controls 
versus patients, 
high 
PainDETECT 
versus low 
PainDETECT 
scores) 
 
Although both 
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for magnetic 
resonance 
experimentation 
referred pain were 
stimulated using 
cold stimuli (12°C) 
and punctate 
stimuli (256 mN). 
The remaining 8 of 
20 patients 
underwent punctate 
stimulation only 
due to equipment 
failure during the 
research period 
 
Beck Depression 
Inventory 
Pain 
Catastrophizing 
Scale 
 
Tampa Scale of 
Kinesiophobia 
 
State Anxiety 
Index  and Trait 
Anxiety Index 
 
PainDETECT 
Greater activation 
in the brainstem 
(i.e. 
periaqueductal 
grey matter) of 
OA subjects in 
response to 
punctate 
stimulation of 
their referred pain 
areas compared 
with controls. The 
magnitude of this 
activation 
positively 
correlated with the 
extent of 
neuropathic pain-
like elements to 
the patient’s pain, 
as indicated by the 
PainDETECT 
score 
the patients and 
controls were 
excluded from 
the study if they 
were taking 
neuroleptic 
medications, 
there were 
predictable 
differences in the 
uptake of other 
categories of 
medications 
between patients 
and controls 
Gwilyn et 
al. 2010 
Etiology Case-
control 
16 subjects with 
hip OA and 16 
controls 
 
Hip Not specified Inclusion for 
patients: unilateral 
right-sided hip pain 
of sufficient 
magnitude to warrant 
total hip arthroplasty 
 
Inclusion for 
controls: free of 
chronic pain 
conditions and not 
regularly use of 
analgesic 
medications or 
alternative therapies 
for pain 
 
Exclusion: chronic 
neurologic or 
MRI: voxel-based 
morphometry 
 
Oxford Hip Score 
 
PainDETECT  
 
Hospital Anxiety 
and Depression 
Score 
2 assessments: 4 
weeks prior to hip 
arthroplasty and 9 
months after the 
surgery 
 
Significant 
decreased in brain 
gray matter 
volume 
(i.e.thalamus) in 
subjects with 
painful hip OA 
compared to 
controls at 
baseline 
 
Reversal of 
reduced thalamic 
gray matter 
volume in OA 
subjects after 
surgery to normal 
levels seen in 
controls, which 
Inherent 
limitations of 
voxel-based 
morphometry 
analysis  
 
Cross-sectional 
study design 
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psychiatric 
conditions, regular 
medications (other 
than 
those for 
cardiovascular 
conditions), epilepsy,  
diabetes or lack of 
fulfillment criteria 
for safe MRI 
scanning 
was accompanied 
with a decrease on 
pain and increased 
function 
Hendiani et 
al. 2003 
Etiology Case-
control 
27 subjects with 
RA, 28 with knee 
OA and 27 
controls 
Knee ACR criteria Inclusion: history of 
arthritis, either RA or 
OA, according to 
ACR diagnostic 
criteria 
 
Exclusion: arthritic 
condition other than 
RA or OA, 
confounding acute or 
chronic comorbid 
condition, including 
fibromyalgia, gout, 
diabetes mellitus, 
history of cerebral 
vascular accident, or 
peripheral 
neuropathy, cancer 
survivors treated with 
chemotherapeutic 
protocols for cancer, 
history of trauma to 
lower extremities, 
hips or back, 
including prior 
surgery or 
arthroscopy, reported 
or documented use of 
recreational drugs 
within a year of the 
study, or RA or OA 
reported disease 
duration of less than 
3 months 
VAS: pain 
intensity at the 
time of testing 
 
Cutaneous joint 
temperature  
 
Joint 
circumference 
 
Cold allodynia 
(alcohol swab 
application), 
cutaneous 
mechanical 
thresholds and 
cutaneous pain 
threshold 
(allodynia), at the 
cutaneous field 
overlying the knee 
joint 
1 assessment, no 
follow-up 
 
Simultaneous 
cutaneous 
hypoesthesia 
(increased 
cutaneous 
mechanical 
thresholds) 
and mechanical 
allodynia 
(decreased 
thresholds for 
cutaneous 
mechanical 
pain) adjacent to 
the involved joint 
was observed both 
in RA and OA 
subjects*  
 
*These 
paradoxical 
responses were 
interpreted as the 
result of activation 
of a descending 
inhibitory system. 
 
 
All patients and 
controls reported 
non-painful, intact 
cold sensation to 
alcohol swab 
application 
 
Limited sample 
size  
 
Surface 
temperature only 
measured in the 
lateral inferior 
quadrant 
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Mechanical 
allodynia and 
increased joint 
surface 
temperature 
and circumference 
in RA patients 
(but not OA) were 
correlated 
Hochman 
et al. 2010 
  
Prevalence Cross-
sectional 
80 subjects with 
knee OA 
Knee Radiographic 
criteria 
Inclusion: English-
speaking adults ages 
≥40 years with knee 
OA (confirmed on 
radiographs), with 
aching, discomfort, 
pain and/or stiffness 
in or around a knee 
on most days of at 
least one month 
during the past year 
 
Exclusion: not 
specified 
Analysis of 
transcripts for 
unprompted use of 
pain descriptors 
that 
suggested 
neuropathic pain 
(items from 
validated 
neuropathic pain 
symptom-based 
questionnaires 
were used to guide 
the analysis) 
 
Duration of knee 
symptoms 
 
WOMAC 
 
NRS 
1 assessment, no 
follow-up 
 
34% of knee OA 
subjects  used pain 
quality 
descriptions 
suggestive of 
neuropathic pain  
 
Those who used 
neuropathic pain 
descriptors were 
younger and, 
although not 
statistically 
different, more 
likely to be 
women, with 
higher pain 
intensity and OA 
severity and 
longer OA 
duration, than 
those who did not 
use neuropathic 
pain descriptors 
Qualitative 
assessment of the 
OA pain 
experience 
 
Lack of 
information on 
comorbid 
medical or 
neurologic 
conditions 
contributing to 
neuropathic pain 
symptoms 
(although people 
with other 
chronic pain 
conditions were 
excluded) 
 
Small sample 
size 
Hochman 
et al. 2011 
Prevalence Cross-
sectional 
171 subjects with 
knee OA 
Knee Joint 
examination 
and 
radiographic 
criteria 
Inclusion: 
discomfort in at least 
one non-replaced 
knee on most days 
(≥15) over the past 
month 
 
Exclusion: self-
reported physician 
diagnosed 
inflammatory 
arthritis, bilateral 
Modified 
painDETECT  
 
WOMAC  
 
Von Korff Chronic 
Pain Grade pain 
intensity subscale 
 
Centre for 
Epidemiologic 
Studies Depression 
1 assessment, no 
follow-up 
 
28% of the 171 
subjects who 
completed the 
Modified 
painDETECT  
(19% after 
excluding 
participants with 
self-reported 
neurological 
conditions), had 
neuropathic pain 
Insufficient 
power (limited 
sample size) to 
evaluate, 
conclusively, the 
independent 
effects of 
postulated 
correlates of 
neuropathic pain 
symptoms 
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knee surgery, or 
factors that could 
interfered with 
questionnaire self-
completion (e.g. 
reduced 
cognition) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Scale  
 
Pain 
Catastrophizing 
Scale 
symptoms 
(Modified 
painDETECT 
score ≥19 in either 
knee) 
 
Excluding 
participants with 
self-reported 
neurological 
conditions, OA 
pain intensity, 
number of painful 
joints, and the 
presence of 
concomitant back 
or hip pain 
referred to the 
upper leg had high 
discriminative 
validity for 
distinguishing 
those with and 
without 
neuropathic pain 
range symptoms 
Participants had 
lower scores for 
psychological 
factors that have 
been associated 
with the presence 
and severity of 
neuropathic pain. 
Underestimation 
of 
the prevalence of 
neuropathic pain 
symptoms in the 
cohort could then 
have occurred.  
 
Only older adults 
with 
longstanding OA 
included in the 
sample 
Howard et 
al. 2012 
Etiology Case-
control 
16 subjects with 
1st 
CMC joint OA 
and 17 controls 
1st CMC joint ACR criteria Inclusion: 1st CMC 
joint OA 
 
Exclusion: 
claustrophobia, 
image artifacts, 
development 
of pain in other body 
sites, or use of 
analgesic medication 
other than the stable 
drug regimen 
required 
Pulsed continuous 
arterial spin 
labeling 
 
NRS 
 
2 assessments 
distributed in 2 
identical sessions, 
separated by a 
minimum of 7 days 
and a maximum of 
21 days 
Subjects with 1st 
CMC joint OA 
showed  increases 
in regional 
cerebral blood 
flow in a 
distributed 
network, including 
the 
somatosensory, 
insula, and 
cingulate cortices, 
thalamus, 
and 
midbrain/pontine 
tegmentum, 
compared to 
controls* 
 
Variability in 
Not specified 
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regional cerebral 
blood flow 
measures in 
subjects with 1st 
CMC joint OA 
pain was related to 
changes in their 
perceived ongoing 
pain; regional 
cerebral blood 
flow measures 
were stable 
between sessions 
in controls 
 
*The observed 
pattern of regional 
cerebral blood 
flow changes 
observed in OA 
subjects suggests 
dysregulation of 
systems that 
include evaluation 
of threat to the 
body from 
ongoing pain and 
the ability of the 
brain to modulate 
pain via 
descending 
modulatory 
mechanisms 
Imamura 
et al. 2008 
Etiology Case-
control 
62 female 
scheduled for a 
total knee 
replacement and 
22 female controls  
 
 
 
Knee ACR criteria 
and 
radiographic 
criteria  
 
Inclusion for 
patients: pain score 
≥ 4 on a VAS during 
the week preceding 
the clinical 
evaluation 
 
Inclusion for 
controls: lack of pain 
reported in the lower 
back or in the lower 
extremities for the 
previous year 
PPT measurements 
at subcutaneous, 
myotomal, and 
sclerotomal 
structures* 
 
-Subcutaneous: 
PPT during the 
pinch and roll 
maneuver at the 
L1, L2, L3, L4, L5, 
S1, and S2 
dermatome levels  
1 assessment, no 
follow-up 
Knee OA subjects 
had significantly 
lower PPT versus 
controls 
throughout sites of 
assessment at the 
dermatomal, 
myotomal, and 
sclerotomal 
structures 
 
Even when OA 
was unilateral, 
Lack of PPT 
measurement 
over other areas 
(i.e. thoracic and 
cervical 
innervated areas) 
 
Lack of 
evaluation of 
sensitization 
changes in 
central structures 
such as cortical 
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Exclusion: clinical 
manifestations of OA 
in other joints, 
clinical diagnosis of 
associated 
fibromyalgia, 
neurologic condition 
such as stroke or 
Parkinson’s disease, 
any systemic 
inflammatory 
disease, or 
impossibility to come 
to the hospital for 
evaluations 
 
-Myotomal: PPT at 
the vastus medialis, 
adductor longus, 
rectus femoris, 
vastus lateralis, 
tibialis anterior, 
peroneus longus, 
iliacus, quadratus 
lumborum, and 
popliteus muscles 
at classically 
described painful 
areas 
 
-Sclerotomal: PPT 
at the L1–L2, L2–
L3, L3–L4, L4–L5 
supraspinous 
ligaments, over the 
L5–S1 and S1–S2 
sacral areas, pes 
anserinus bursae, 
and at the patellar 
tendon  
 
*Except for 
supraspinous 
ligaments and the 
L5–S1 and S1–S2 
sacral areas (6 
sites), all 
measurements 
were done 
bilaterally 
 
VAS 
 
WOMAC   
 
Short-Form 36  
both extremities 
were equally 
affected in terms 
of hiperalgesia 
 
Lower PPT values 
were correlated 
with higher pain 
intensity (VAS), 
higher 
disability scores 
(WOMAC) and 
poorer quality of 
life (Short-Form 
36) 
brain areas  
Kavchak et 
al. 2012 
Etiology Case-
control 
16 subjects with 
knee OA and 16 
controls 
Knee Radiographic 
criteria 
Inclusion: Knee OA 
confirmed 
radiographically 
 
Exclusion: previous 
Mechanical 
detection threshold, 
allodynia, vibration 
perception 
threshold local at 
1 assessment, no 
follow-up 
Concurrent 
findings of local 
allodynia and 
hypoesthesia ,and 
local and 
Significant BMI 
differences 
between patients 
and controls 
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total knee 
arthroplasty in either 
knee, history of any 
diagnosed 
neurological 
conditions including 
depression or a 
chronic pain 
syndrome, 
rheumatoid condition 
or history of knee 
joint trauma, or 
ligamentous 
deficiency 
affected knee 
 
PPT local at 
affected knee and 
distally on the 
medial aspect of 
the lower limb 
 
Pain intensity 
ratings (VAS) and 
subjective reports 
of 
instability/buckling
, at rest and while 
performing a step-
up task 
 
 
widespread 
hiperalgesia, in 
subjects with knee 
OA 
 
Significant 
differences in 
local but not 
widespread  
hyperalgesia 
between subjects  
with OA having 
severe versus mild 
radiographic 
changes 
 
A moderate 
correlation 
between greater 
self-reported 
instability and 
increased 
vibratory 
hypoesthesia at the 
knee was 
demonstrated in 
OA subjects 
 
Possible 
contribution of 
muscle weakness 
to the subjective 
report of 
instability 
 
Lack of direct 
proprioception 
assessment  
Kosek et al. 
2000a 
Etiology-
treatment 
Case-
control 
14 subjects with 
hip OA and 14 
controls  
 
 
 
Hip Radiographic 
criteria 
Inclusion: 
radiological OA and 
severe pain for more 
than one year, 
candidate for 
surgery, healthy apart 
from their OA, and 
no pain contralateral 
to 
the affected side 
 
Exclusion: not 
specified 
 
 
VAS at the site of 
maximal pain on 
the affected side 
and the 
homologous 
contralateral site 
 
QST  at the 
maximal pain site 
and the 
homologous 
contralateral site: 
 
-PPT 
-Perception 
threshold to light-
touch 
-Perception 
1 assessment (pre-
surgery), no 
follow-up 
 
2 assessments (pre-
surgery and 10 
months after 
surgery on 
average), in 12 
subjects with hip 
OA and 12 controls  
 
Before surgery, 
subjects with hip 
OA demonstrated  
lower PPT (only 
on the maximally 
painful side, and 
increased 
sensitivity to 
innocuous 
warmth, cold pain 
and a strong 
tendency toward 
increased heat 
pain sensitivity 
(all bilateral), 
compared to 
controls 
 
Presence of a 
sensory deficit 
prior to pain 
relief was not 
assessed  
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thresholds to 
innocuous cold 
-Perception 
thresholds to 
innocuous 
warmth 
-Heat pain 
threshold 
-Cold pain 
threshold 
 
Following surgery 
sensitivity to light 
touch increased 
and PPT decreased 
on the affected 
side in subjects 
with hip OA, 
compared to their 
initial values 
 
Following surgery, 
neither statistically 
significant 
differences, nor 
trends towards 
statistically 
significant 
differences, in the 
sensitivity to any 
somato-sensory 
modality were 
found between 
patients and 
controls* 
 
*This finding 
indicated that the 
sensory 
aberrations were 
reversible after 
surgery and had 
been maintained 
by nociceptive 
inflow from the 
affected 
Hip 
Kosek et al. 
2000b 
 
 
 
 
 
 
 
 
Etiology-
treatment 
Case-
control 
15 subjects with 
hip OA and 15 
controls 
 
 
 
 
 
Hip Radiographic 
criteria 
Inclusion: 
radiological OA and 
severe pain for more 
than 1 year and 
waiting for surgery 
 
Exclusion: not 
specified 
Perception 
thresholds to light 
touch 
 
PPT 
 
Perception 
thresholds to non-
painful and painful 
warmth and cold 
1 assessment (pre-
surgery), no 
follow-up 
 
2 assessments (pre-
surgery and 6±14 
months after 
surgery), in 13 
subjects with hip 
OA and 13 controls 
Before surgery, no 
statistically 
significant 
increase in PPTs 
was seen during 
the tourniquet test 
in subjects with 
hip OA, as 
opposed to healthy 
controls* 
Not specified 
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*All these 
measures were 
assessed before, 
during and 45 min 
following the 
tourniquet test  
  
*This finding was 
interpreted as a 
sign of DNIC 
dysfunction 
 
Normal 
modulation of 
PPTs in subjects 
with hip OA  was 
seen during the 
tourniquet test in a 
pain-free state 
after surgery: 
dysfunction of 
DNIC was 
therefore 
maintained by 
ongoing 
nociceptive 
activity 
Kulkarni  
et al. 2007 
Etiology Cross-
sectional 
12 subjects with 
knee OA  
Knee ACR criteria Inclusion: knee OA 
following ACR 
criteria 
 
Exclusion: any 
psychiatric condition 
or other medical 
condition, or to have 
received opiates or 
antidepressants for at 
least 1 year prior to 
the study 
Positron emission 
tomography of the 
brain in 3 different 
pain states: arthritic 
knee pain, 
experimental knee 
pain, and pain-free 
1 assessment, no 
follow-up 
Both pain 
conditions 
(arthritis and 
experimental) 
activated the pain 
matrix, but 
arthritic pain was 
associated with 
increased 
activity in the 
medial pain 
system of the 
brain, including 
most of the 
cingulate cortex, 
the thalamus, and 
the amygdale* 
 
*All these areas 
are involved in the 
processing of fear, 
emotions, aversive 
conditioning and 
motivational 
responses 
Small sample 
size 
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Lee et al. 
2011 
Etiology Case-
control 
26 subjects with 
knee OA and 33 
controls 
Knee Clinical OA 
diagnosis 
(radiographs 
were not 
required to 
confirm/reject 
OA 
diagnosis) 
Inclusion for 
patients: clinically 
diagnosed with knee 
OA (documented by 
a physician in the 
medical record), pain 
attributed to knee OA 
(documented in the 
medical record) 
  
Inclusion for 
controls: lack of a 
diagnosis of OA and 
a history of joint pain  
 
Exclusion: current 
mood or anxiety 
disorder, current 
infection, current 
pregnancy, history of 
autoimmune 
disorders, 
cardiovascular 
disease, peripheral 
neuropathy, 
Raynaud’s syndrome, 
or peripheral vascular 
disease, recent 
history  of substance 
abuse or to use of 
opioids, 
antidepressants, or 
corticosteroids 
PPT  bilaterally at 
the trapezius 
muscle, the 
1stmetacarpophalan
geal joint, and the 
quadriceps muscle 
 
Heat pain 
thresholds and 
suprathreshold heat 
pain ratings 
 
Cold pain ratings 
and cold pain 
tolerance 
 
Serum levels of 
pro-inflammatory 
cytokines: C-
reactive protein, 
IL-6, IL-1β and 
TNF-α 
 
*Cytokine levels 
were taken at 
baseline and at 4 
points in time: 
immediately after 
testing and 15, 30 
and 60 minutes 
after testing 
1 assessment, no 
follow-up 
 
 
Subjects with knee 
OA had lower 
PPT and higher 
suprathreshold 
heat pain ratings 
across multiple 
body sites than 
controls  
 
Among subjects 
with knee OA 
heightened pain 
sensitivity (i.e. 
low PPTs and high 
suprathreshold 
heat pain ratings), 
was associated 
with elevated C-
reactive protein 
and IL-6 levels 
during the course 
of the study, 
respectively 
 
 
 
Not radiographic 
criteria for OA 
diagnosis 
 
  
Small sample 
size 
 
Cross-sectional 
design 
Lundbland 
et al. 2008 
Etiology-
treatment 
Case-
control 
69 subjects with 
knee OA and 24 
controls  
 
Knee Not specified Inclusion: knee OA 
 
Exclusion: clinical 
history of drug abuse 
or use of opioid 
drugs before surgery 
VAS (pain at rest 
and with 
movement) 
 
Matched pain (i.e. 
pain corresponding 
to the knee pain 
with movement) 
and  sensory and 
pain threshold, all 
taken with the aid 
of the Pain 
Matcher, which is 
2 assessments*: 
pre-surgery and at 
18 months after 
surgery 
 
*No measurements 
with the Pain 
Matcher were 
made at follow-up 
Before surgery, 
subjects with knee 
OA exhibited a 
significantly 
higher sensation 
threshold and 
lower pain 
threshold 
compared to 
controls 
 
Subjects with knee 
OA who reported 
Not specified 
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an electrical 
stimulation device.  
 
 
a high pre-
operative score for 
knee pain at rest 
(VAS) and low 
pre-operative pain 
threshold (Pain 
Matcher) were at 
increased risk of 
persistent pain 
after total knee 
replacement* 
 
*These latter 
finding was 
interpreted as a 
reflection of a 
central 
sensitization 
mechanism 
Lundborg 
et al. 2010 
Etiology Case-
control 
20 subjects with 
hip or knee OA 
and 20 controls 
 
 
 
Knee/Hip Not specified Inclusion: age above 
18 years and a 
history of at least six 
months of moderate 
to severe pain 
(VAS>5) 
 
Exclusion: acute 
illness, malignancy 
and/or current 
immune modulating 
therapy such as 
chemotherapy or 
corticosteroids 
 
VAS 
 
Short Form-36 
 
Intrathecally and 
blood 
concentrations of 
GDNF, IL-1β, 
TNF-α, IL-6, IL-10 
and IL-8  
 
1 assessment: no 
follow-up 
Subjects with OA 
presented 
increased levels in 
the central nervous 
system of GDNF, 
but decreased in 
peripheral blood  
 
IL-8 was 
uniformly higher 
in OA patients,  
both peripherally 
and centrally, 
compared to 
controls 
 
Pain level in 
subjects with OA 
was associated 
with high and low 
levels of GDNF 
intrathecally and 
in blood, 
respectively  
 
 
 
Small sample 
size 
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Moss et al. 
2007 
Treatment RCT 38 subjects with 
knee OA 
 
 
Knee ACR criteria Inclusion: mild to 
moderate pain from 
knee OA, knee OA 
following ACR 
classification and 
able to walk short 
distances, with or 
without an aid 
 
Exclusion: recent 
lower limb surgery, 
co-existing 
inflammatory or 
neurological 
conditions, altered 
sensation around 
their knee, or 
cognitive difficulties 
PPT at local (i.e. 
most tender point 
on the medial 
aspect of the 
affected knee) and 
remote site (i.e. 
medial ipsilateral 
heel) 
 
Timed “Up & Go” 
test 
 
WOMAC  
2 assessments: at 
baseline and 
following 
intervention*  
 
*3 interventions 
were applied to 
each subject in 
random order over 
three sessions: 
 
-Knee joint 
mobilization 
-Manual contact 
intervention 
-No-contact 
intervention 
Significantly 
greater increase in 
PPT at knee and 
remote sites was 
observed 
following knee 
joint 
mobilization, 
compared to 
manual contact 
and no-contact 
interventions 
 
Knee joint 
mobilization 
reduced ‘up and 
go’ time 
significantly more 
than manual 
contact and no-
contact 
interventions 
 
Possible ceiling 
effect of 
treatment due to 
low baseline 
values in pain  
 
Murphy et 
al. 2011a 
Etiology Cross-
sectional 
55 women with 
knee OA 
Knee Radiographic 
criteria 
Inclusion: 
radiographic 
evidence of knee or 
hip OA(Kellgren/ 
Lawrence score ≥2), 
joint pain for at least 
3 months in duration, 
and mild to moderate 
joint pain on the 
WOMAC pain scale 
 
Exclusion: non 
ambulatory patients, 
medical conditions 
other than OA that 
interfered with 
activity 
performance or 
caused pain and 
fatigue, joint 
replacement or 
surgery of the knee 
OA radiographic 
severity 
(Kellgren/Lawrenc
e grade, minimum 
joint space width) 
 
Age 
 
Pain severity over 
a 5-day home 
monitoring 
period 
 
Composite 
measure 
representing 
centrally-mediated 
symptoms* 
 
* It included 
fatigue severity, 
sleep efficiency 
Repeated 
assessments of 
pain severity and 
centrally mediated 
symptoms during a 
5-day home 
monitoring period 
27% of the 
variance in pain 
severity was 
explained by age, 
radiographic 
severity, and 
centrally mediated 
symptoms 
 
Centrally-
mediated 
symptoms 
explained an 
additional 10% of 
the variance in 
pain severity after 
the 
other 2 variables 
(age and 
radiographic 
severity), were 
entered 
Highly selected 
sample which 
could have led to 
an 
underestimation 
of the association 
between 
centrally-
mediated 
symptoms and 
pain severity 
 
Cross-sectional 
study design 
 
Small sample 
size and all 
subjects women 
 
Lack of QST   
Effect of neuroscience education on subjects with chronic knee pain related to osteoarthritis 
 
 
 Enrique Lluch Girbés  
94 
or hip in the previous 
6 months, inadequate 
cognition (by Mini-
Mental State 
Examination or 6-
Item Screener), 
inability to operate a 
wrist-worn 
accelerometer to 
measure sleep 
efficiency, or current 
non-pharmacologic 
treatment for OA 
(e.g. rehabilitation, 
injections) 
and depressive 
symptoms 
 
 
Murphy et 
al. 2011b 
Diagnosis Cross-
sectional 
129 community 
living older adults 
with knee and hip 
OA  
Knee/Hip ACR criteria Inclusion: pain in a 
joint with OA on the 
WOMAC scale of ≥ 
4 with at least two of 
the five items on the 
scale rated as 
moderate pain or 
more, fatigue 
symptoms at least a 
moderate amount of 
the time (that is, 
three to four of the 
past seven days), 
adequate cognition, 
and able to see, hear 
and operate the 
accelerometer used 
for pain reporting in 
the study 
 
Exclusion: other 
medical conditions 
that are capable of 
causing fatigue 
(acute illnesses or 
exacerbations 
of chronic illnesses, 
including common 
viral or bacterial 
infections, 
autoimmune 
Pain severity over 
a 5-day home 
monitoring 
period 
 
Center 
of Epidemiologic 
Studies Depression 
Scale 
 
Brief Fatigue 
Inventory  
 
Self-reported 
Illness burden*  
 
Pittsburgh Sleep 
Quality Index 
 
*It reflected the 
self-reported 
symptom load 
experienced by an 
individual and was 
calculated as the 
sum of 41 possible 
different somatic 
symptoms 
 
 
1 assessment*: no 
follow-up 
 
*A hierarchical 
agglomerative 
cluster analysis 
was conducted  
Three statistically 
differentiated 
subgroups/clusters 
of patients were 
characterized by 
differing symptom 
presentations, 
which may 
potentially 
be due to different 
pain mechanisms 
 
One group (36% 
of the sample) had 
the highest ratings 
on both pain and 
fatigue, the worst 
ratings on 
depressive 
symptoms and 
sleep and the 
highest illness 
burden, supporting 
a potential central 
nervous system 
contribution to 
symptoms 
Unknown 
structural 
severity of knee 
and hip OA  
 
Results only 
applicable to  
people with 
symptomatic 
knee or hip OA  
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diseases, 
fibromyalgia, chronic 
fatigue syndrome, 
and any uncontrolled 
illness),  
current treatment for 
cancer or treatment 
received for cancer in 
the previous 12 
months, reported  
doctor-diagnosed 
obstructive sleep 
apnea, untreated 
anemia or thyroid 
disorders per blood 
work, or to be non-
ambulatory 
O'Driscoll 
et al. 1974 
Etiology Case-
control 
21 subjects with 
hip OA awaiting 
total hip 
replacement, 12 
subjects with hip 
OA but with 
insufficient 
symptoms to 
merit surgery, 22 
subjects with hip 
OA after 
successful total 
hip replacement, 
and 21 controls 
 
 
Hip Radiographic 
criteria 
Inclusion: 
radiographic changes 
in the joints of grades 
III or IV measured by 
reference to the Atlas 
of Standard 
Radiographs of 
Arthritis (Council for 
International 
Organizations of 
Medical Sciences, 
1963) 
 
Exclusion: not 
specified 
PPT at the centre 
of the forehead 
2  assessment, 
before and after 
surgery 
 
PPT at the centre 
of the forehead 
was significantly 
lower in subjects 
who required 
surgery than in 
controls.  
 
After successful 
surgery, the PPT 
rose to normal 
levels  
 
In subjects with 
few or no 
symptoms from 
their OA hips the 
PPT was high 
Not specified 
Parks et al. 
2011 
Etiology Case-
control 
14 subjects with 
knee OA and 9 
controls 
Knee ACR criteria Inclusion: ACR 
criteria for OA, no 
history of other pain 
conditions, and OA 
pain for a duration 
longer than 3 months 
with a pain 
magnitude of at least 
30/100 on VAS 
 
Exclusion: not 
Ratings of 
spontaneous and 
evoked pain with 
application of 
mechanical painful 
pressure stimuli 
 
Brain activity with 
fMRI for 
spontaneous and 
stimulus-evoked 
1 assessment, no 
follow-up for brain 
activity for 
spontaneous and 
stimulus-evoked 
pain 
 
3 assessments for 
effect of treatment 
with COX2 
selective inhibitor 
Brain activity for 
pressure-evoked 
pain was 
minimally 
different between 
subjects with knee 
OA and healthy 
subjects and 
between knees 
with more or less 
pain among 
Not specified 
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specified pain (i.e. pressure-
evoked pain) 
 
Clinical 
characteristics of 
OA pain with Mc-
Gill Pain 
Questionnaire and 
WOMAC 
 
Brain activity 
changes modulated 
by treatment with a 
COX2 selective 
inhibitor (COX2i, 
valdecoxib) 
 
 
 
on brain activity: 
 
-Session 1: prior to 
the start of drug 
-Session 2: 24 
hours after start of 
drug  
-Session 3: 2 
weeks after 
continued use of 
drug  
subjects with OA 
 
Brain activity 
associated with 
spontaneous pain 
in subjects with 
knee OA had a 
brain 
representation 
(prefrontal-limbic 
regions including 
the amygdala and 
nucleus 
accumbens), 
similar to that seen 
for spontaneous 
pain in other 
clinical chronic 
pain conditions 
(i.e. chronic low 
back pain)* 
 
* The latter 
engaging brain 
regions are 
involved in 
emotional 
assessment of the 
self so it was 
concluded that OA 
pain it’s more of 
an emotional state 
Treatment with a 
COX2 selective 
inhibitor in 
subjects with knee 
OA decreased 
spontaneous pain 
for the worse knee 
and clinical 
characteristics of 
OA,  which 
correlated 
positively with 
prefrontal-limbic 
brain activity 
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Quante et 
al. 2008 
Etiology Cross-
sectional 
12 subjects with 
knee 
OA 
Knee Radiographic 
criteria 
Inclusion: unilateral 
OA of the knee, 
radiological 
grade IV OA based 
on X-ray, pain for a 
minimum of 6 
months limiting 
walking distance, 
presence of pain 
phases at rest, 
scheduled for an 
intraarticular 
infiltration,  and 
instantaneous relief 
from OA pain 
obtained by a  
comfortable, slightly 
flexed knee position  
 
Exclusion: any 
previous spine 
surgery, any surgery 
or diseases of the 
peripheral and central 
nervous system, 
infectious, 
inflammatory or 
neoplastic diseases, 
epidural injections 
within one week 
prior to investigation, 
bilateral OA, or pain 
from other causes 
(i.e. migraine, 
neuropathy, etc) 
DNIC function* 
 
*It was assessed by 
provoking OA pain 
by a slightly 
hyperextended 
joint position 
(counterirritation 
stimulus) while 
applying short 
electrical pain 
stimuli at the 
fingertip (middle 
finger) 
contralateral to the 
OA side 
 
DNIC effect on 
evoked brain 
activity with EEG 
and MEG 
1 assessment, no 
follow-up 
 
Dysfunction in 
DNIC  
 
Although the 
patients did not 
report a reduction 
of electrical pain 
perception, the 
cingulate gyrus 
showed a decrease 
of activation 
during provoked 
OA pain, while 
activity in the 
secondary 
somatosensory 
cortex didn’t 
change 
Small sample 
size  
 
Vance et al. 
2012 
 
Treatment RCT 75 subjects with 
knee OA  
 
 
Knee Radiographic 
criteria 
Inclusion: diagnosis 
of medial 
compartment 
knee OA 
(radiographically 
and symptomatically 
diagnosed by an 
orthopedic surgeon), 
18 to 95 years of age, 
able to ambulate to 
mailbox and back, 
Cutaneous 
mechanical pain 
threshold 
 
PPT at knee and 
tibialis anterior 
bilaterally 
 
Heat pain threshold 
 
Heat temporal 
1 assessment*, no 
follow-up 
 
Outcome 
measurements 
were obtained 
before and during a 
single TENS 
treatment. 
Participants were 
randomly assigned 
Compared with 
placebo TENS, 
HF-TENS and LF-
TENS increased 
PPT at the 
affected knee  
 
HF-TENS also 
increased PPT 
over the tibialis 
anterior muscle of 
Only a single 
TENS treatment 
 
Possible 
influence of 
caffeine on the 
results 
 
Effect of neuroscience education on subjects with chronic knee pain related to osteoarthritis 
 
 
 Enrique Lluch Girbés  
98 
stable medication 
schedule for 3 weeks 
before testing, and 
pain rating >3 during 
weight bearing on a 
verbal rating scale 
 
Exclusion: Lateral 
compartment knee 
OA, loss of 
sensation, 
uncontrolled diabetes 
mellitus or 
hypertension, 
dementia or cognitive 
Impairment, 
neurological 
disorder, permanent 
lower-extremity 
sensory 
loss, earlier TENS 
use, knee surgery in 
last 6 months, or 
knee injection in last 
4 weeks 
summation 
 
Timed “Up & Go” 
Test  
 
 
to receive high-
frequency(HF) 
TENS (100 Hz) 
(n=25), low 
frequency (LF) 
TENS (4 Hz) 
(n=25), or placebo 
TENS (n=25) 
 
 
the affected knee  
 
There was no 
effect with any 
application of 
TENS on the 
cutaneous 
mechanical pain 
threshold, heat 
pain threshold, or 
heat 
temporal 
summation 
 
Pain at rest and 
during the Timed 
“Up & Go” Test  
was significantly 
reduced by HF-
TENS, LF-TENS, 
and placebo TENS 
Wilder-
Smith et al. 
2001 
Treatment RCT 60 hip/knee OA 
subjects awaiting 
hip or knee 
replacement 
surgery 
randomized in 
two groups (30 
receiving 
tramadol and 30 
receiving 
dihydrocodeine) 
and 
30 controls, with 
pain controlled by 
NSAID's alone*  
 
*Data were not 
evaluated in 1 and 
2 subjects of the  
dihydrocodeine 
and  tramadol 
Hip/Knee Not described Inclusion: mean pain 
score of 3 or more 
during normal 
activity on a verbal 
rating scale of 
0=none to 
4=unbearable, in a 1 
week run-in period 
despite current 
NSAID medication 
 
Exclusion: clinically 
relevant 
cardiopulmonary, 
hepatic, renal and 
mental compromise, 
known allergies 
against the study 
drugs, or drug abuse 
Electrical 1st 
sensation and pain 
tolerance 
thresholds in the 
dermatome of the 
OA joint and mid-
clavicle* 
 
Suprathreshold 
pain stimulation at 
affected OA joint 
and mid-clavicle* 
 
*Both measured on 
the 4th treatment 
day 
 
2 assessments: 
during the run-in 
period before the 
start of study drug 
dosing and at the 
end of the 1st 
month of the 
treatment 
In the treatment 
groups pain 
tolerance 
thresholds were 
lower before 
treatment and 
increased to values 
similar to controls 
during treatment. 
This 
antinociceptive 
effect was more 
pronounced with 
tramadol and mid-
clavicularly and 
was significant 
after 1 month's 
treatment 
 
A significant 
inverse correlation 
The potency 
estimation of the 
slow-release 
formulations 
may have been 
slightly biased 
by the 
availability of 
only fixed dose 
of each drug 
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group, 
respectively  
between baseline 
pain intensity and 
sensation and pain 
thresholds over the 
clavicle was found 
demonstrating a 
relationship 
between greater 
pain and 
generalized 
sensory 
sensitization 
Wood et al. 
2007 
Diagnosis Cross-
sectional 
697 subjects 
divided in two 
groups: no 
symptomatic 
radiographic 
knee OA (n= 497) 
and 
symptomatic knee 
OA (n= 230)* 
 
*Symptomatic 
radiographic OA 
of the knee was 
defined as 
symptoms on 
most days in the 
previous month 
and definite 
osteophyte in 
index knee with 
current pain 
intensity of ≥ 2 on 
a NRS 
Knee Radiographic 
criteria 
Inclusion: OA of the 
knee with some pain 
in the last year 
 
Exclusion: red flags’ 
(recent trauma likely 
to be associated with 
significant tissue 
damage: acute, hot, 
swollen joint), not 
experienced knee 
pain within the 6 
months prior to clinic 
attendance, pre-
existing diagnosis of 
inflammatory 
arthropathy in 
the medical records, 
total knee 
replacement in their 
most affected knee, 
or incomplete X-ray 
data 
Knee pain 
locations coded on 
a body chart 
 
Socio-
demographic, 
radiographic and 
clinical features 
(WOMAC, 
Chronic Pain 
Grade, Hospital 
Anxiety and 
Depression scale) 
1 assessment, no 
follow-up 
Generalized knee 
pain and medial 
knee pain were the 
most common 
patterns among all 
the subjects 
 
Medial knee pain 
and generalized 
knee pain with 
distal radiation 
occurred more 
frequently in those 
with symptomatic 
knee OA  
 
Individuals with 
generalized knee 
pain with radiation 
had more 
persistent and 
severe pain, 
anxiety levels, and 
a relatively high 
proportion had 
moderate or severe 
radiographic 
disease* 
 
*This results were 
considered 
consistent with 
central 
sensitization 
Heterogeneous 
sample 
 
Misclassification 
probability: 
definition of 
symptomatic 
knee OA didn’t 
preclude other 
concomitant 
causes of knee 
pain 
 
Reliability of 
pain 
location data was 
not formally 
investigated 
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ACR: American College of Rheumatology; BMI: Body Mass Index; CMC: Carpo-metacarpal; CPM: Conditioned Pain Modulation; DNIC: Diffuse Noxious Inhibitory Control; EEG: 
electroencephalogram; fMRI: functional Magnetic Resonance Imaging; GDNF: Glial cell line-derived neurotrophic factor; MCP: Metacarpophalangeal; MEG: magnetoencephalogram; NFR: 
Nociceptive Flexion Reflex; NRS: Numerical Rating Scale; OA: Osteoarthritis; PPT: Pressure Pain Threshold; QST: Quantitative Sensory testing; RA: Rheumatoid Arthritis; VAS: Visual 
Analogue Scale; WOMAC: Western Ontario and McMaster Universities Osteoarthritis Index 
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Evidence for Central Sensitization in OA 
Besides listing the search results and characteristics of included studies, the aim of this 
systematic review was to summarize the present knowledge on CS in OA. In the 
following section, the results of this review will be structured according to the different 
aspects of sensitization which have been identified in patients with OA. 
Clinical manifestations of CS in OA 
Three studies inferred CS based on neuropathic pain descriptors of symptoms (Gwilym 
et al., 2009; Hochman et al., 2010, 2011). Hochman et al. (2010) qualitatively assessed 
the OA pain experienced by 80 subjects with knee OA. A small subgroup of patients 
(i.e. 34% from the total), who used neuropathic pain descriptors was identified. Those 
who used neuropathic pain descriptors were mainly young women with high pain 
intensity, high OA severity and long OA duration. In a later study, a similar percentage 
of patients reporting neuropathic pain symptoms (i.e. 28% from a total of 171 subjects 
with knee OA) was found (Hochman et al., 2011). Gwilym et al. (2009) determined that 
the magnitude of activation in the periaqueductal grey matter of subjects with hip OA 
after punctuate stimulation of their referred pain areas was correlated with the extent of 
neuropathic pain symptoms.  
 
Based on the location of the symptoms (Wood et al., 2007) and a positive correlation 
between OA pain severity and centrally-mediated symptoms (Murphy et al., 2011a, 
2011b), some studies indicated a potential contribution of the central nervous system in 
subjects with OA. Wood et al. (2007) found that subjects with knee OA reporting 
generalized knee pain with radiation had more persistent and severe pain, and higher 
anxiety levels. Murphy et al. (2011a) measured pain severity and centrally mediated 
symptoms in women with knee OA. Age, radiographic severity, and centrally mediated 
symptoms explained 27% of the variance in pain severity reported by the patients. After 
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entering age and radiographic severity as variables, centrally-mediated symptoms 
explained an additional 10% of the variance in pain. 
 
Arendt-Nielsen et al. (2010) showed how the degree of local (i.e. knee) and spreading 
(i.e. leg, arm) sensitization correlated with pain severity. However, no correlation was 
found between radiological findings and experimental or clinical pain parameters. 
Accordingly, Lundblad et al. (2008)
 
demonstrated that elimination of the nociceptive 
input from the damaged joint (i.e. prosthetic substitution) was not always followed by a 
complete resolution of symptoms. Interestingly, subjects who reported a high pre-
operative score for knee pain and low pre-operative pain thresholds were at increased 
risk of persistent pain after surgery.  
 
Quantitative Sensory Testing results in OA 
Seventeen studies in total performed quantitative sensory testing (QST) analysis as part 
of their outcome measures (O’Driscoll and Jayson, 1974; Farrell et al., 2000a, 2000b; 
Kosek and Ordeberg, 2000b; Wilder-Smith et al., 2001; Hendiani et al., 2003; France et 
al., 2004; Moss et al., 2007; Imamura et al., 2008; Lundblad et al., 2008; Gwilym et al., 
2009; Arendt-Nielsen et al., 2010; Lee et al., 2011; Graven-Nielsen et al., 2012; 
Kavchak et al., 2012; Vance et al., 2012; Finan et al., 2013). Different QST modalities 
were used for evaluating sensory and pain perception, with the mechanical stimulus 
being the most common form of external stimulation used (14/17 studies) (Farrell et al., 
2000a, 2000b; Kosek and Ordeberg, 2000b; Hendiani et al., 2003; Moss et al., 2007; 
Imamura et al., 2008; Gwilym et al., 2009; Arendt-Nielsen et al., 2010; Lee et al., 2011; 
Graven-Nielsen et al., 2012; Kavchak et al., 2012; Vance et al., 2012; Finan et al., 
2013). Most of the studies performed QST at local (i.e. on or in close proximity to the 
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joint affected by OA), and distant sites (i.e. remote from the affected joint) (Kosek and 
Ordeberg, 2000b; Hendiani et al., 2003; France et al., 2004; Moss et al., 2007; Imamura 
et al., 2008; Arendt-Nielsen et al., 2010; Graven-Nielsen et al., 2012; Kavchak et al., 
2012; Vance et al., 2012; Finan et al., 2013).  
 
Several studies reported more local and widespread hyperalgesia in subjects with OA 
compared to controls (Farrell et al., 2000a, Kosek and Ordeberg, 2000b; Imamura et al., 
2008; Arendt-Nielsen et al., 2010; Lee et al., 2011; Graven-Nielsen et al., 2012; 
Kavchak et al., 2012). In addition, a higher degree of general sensitization was related to 
higher levels of pain perception (Farrell et al., 2000a; Wilder-Smith et al., 2001; 
Imamura et al., 2008; Arendt-Nielsen et al., 2010; Finan et al., 2013), disability and 
poorer quality of life (Imamura et al., 2008), poor prognosis after joint replacement 
(Lundblad et al., 2008), less radiographic evidence of OA (Finan et al., 2013), and high 
serum concentration of pro-inflammatory cytokines (Lee et al., 2011). Improvements of 
widespread hyperalgesia were reported after surgery (O’Driscoll and Jayson, 1974; 
Kosek and Ordeberg, 2000b, Graven-Nielsen et al., 2012), mobilization of the affected 
joint (Moss et al., 2007), TENS application (Vance et al., 2012), and medication 
(Wilder-Smith et al., 2001). 
 
Allodynia both locally (Hendiani et al., 2003; Kavchak et al., 2012) and extensively 
(Kosek et al., 2000b), was shown to be present in OA subjects as compared to controls. 
Hypoesthesia was also higher in patients with OA (Hendiani et al., 2003; Gwilym et al., 
2009; Kavchak et al., 2012), but only at the affected joint.  
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Induced Referred pain in OA  
Only one study examined the phenomenon of evoked referred pain in subjects with OA 
(Bajaj et al., 2001). Compared with controls, subjects with OA showed significant 
higher local pain duration and intensity, larger pain areas, and increased referred and 
radiating pain intensities after intramuscular hypertonic saline infusion.  
 
Altered Spinal Reflexes in OA 
Three studies used the Nociceptive Flexion Reflex (NFR) to investigate possible 
disturbances in nociceptive processes (Emery et al., 2006; Courtney et al., 2009, 2010). 
Increased excitability of NFR was found in subjects with chronic knee OA compared to 
controls (Courtney et al., 2009). In a later study, NFR responses markedly augmented 
after applying joint compression, whereas joint mobilization (but not sham intervention) 
reduced NFR excitability (Courtney et al., 2010). Emery et al. (2006) showed an 
increase in NFR thresholds and decrease on pain ratings following a 45-minute coping 
skills treatment session.  
 
Enhanced Temporal or Spatial Summation of pain in OA 
Two case-control studies reported enhanced TS in subjects with knee OA compared to 
healthy controls (Graven-Nielsen et al., 2012; Goodin et al., 2013). Goodin et al. (2013) 
assessed the relation of TS of heat pain with clinical measures like dispositional 
optimism, pain catastrophizing and depression. A greater dispositional optimism was 
found to be associated with less pain catastrophizing and less TS of heat pain.  
 
The only study which showed enhanced SS of pressure-pain in subjects with knee OA 
was conducted by Graven-Nielsen et al. (2012). It is worth emphasizing that they found 
restoration of SS ratios following knee joint replacement surgery.  
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Dysfunctional endogenous nociceptive inhibition in OA 
Descending modulation of pain has been evaluated through the conditioned pain 
modulation (CPM) paradigm which assesses the efficiency of descending pain 
inhibitory mechanisms. Five studies provided evidence for impaired CPM in subjects 
with OA (Kosek and Ordeberg, 2000a; Quante et al., 2008; Arendt-Nielsen et al., 2010; 
Graven-Nielsen et al., 2012). In addition, Kosek et al. (2000a) and Graven-Nielsen et al. 
(2012) demonstrated restoration of impaired CPM after surgery. Ischemic compression 
of the arm with a tourniquet cuff was used as conditioning stimuli in all (Kosek and 
Ordeberg, 2000a; Arendt-Nielsen et al., 2010; Graven-Nielsen et al., 2012), except for 
one study (Quante et al., 2008). Experimental stimuli (dependent variable) consisted of 
pressure pain (Arendt-Nielsen et al., 2010; Graven-Nielsen et al., 2012), electrical 
induced pain (Quante et al., 2008), or a combination of thermal and pressure pain 
(Kosek and Ordeberg, 2000a).  
 
Dysfunctional opioid and non-opioid mechanisms of pain control in OA 
In order to further unravel the role of CS in patients with OA, two randomized 
controlled trials evaluated the efficacy of centrally acting drugs (Chappell et al., 2009; 
Abou-Raya et al., 2012). Abou-Raya et al. (2012) and Chappell et al. (2009) found a 
significant reduction on pain after duloxetine administration compared to placebo 
supporting a role of CS in OA.  
 
Altered Cytokine and Neuropeptide concentrations in OA 
One study highlighted the relationship between central pain processing and the 
inflammatory response in OA by identifying associations between psychophysical pain 
measures (i.e. QST) and proinflammatory cytokine levels (Lee et al., 2011). Low PPTs 
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taken at remote sites from the affected joint and high suprathreshold heat pain ratings 
were associated with elevate C-reactive protein and IL-6 serum levels (Lee et al., 2011).
  
 
Intrathecal and blood concentrations of Glial cell line-derived neurotrophic factor 
(GDNF), IL-1B, TNFα, IL-6, IL-10 and IL-8 were compared between subjects with OA 
and controls by Lundborg et al. (2010). Subjects with OA presented higher central 
nervous system levels of GDNF and IL-8 than controls and pain level was associated 
with high levels of GDNF (Lundborg et al., 2010). 
 
Neuroimaging  
Five studies reported alterations in brain function in subjects with chronic OA pain 
(Kulkarni et al., 2007; Quante et al., 2008; Gwilym et al., 2009; Parks et al., 2011; 
Howard et al., 2012). Gwilyn et al. (2009) observed greater activation in periaqueductal 
grey matter in OA subjects in response to punctate stimulation of their referred pain 
areas. In another study, brain activity associated with spontaneous OA pain had a brain 
representation consisting of the prefrontal-limbic region, which is a brain region known 
to be involved in emotional self-assessment (Parks et al., 2011). Areas involved in the 
processing of fear, emotions, aversive conditioning and motivational responses (i.e. 
medial pain system of the brain), showed increased activity with positron emission 
tomography (Kulkarni et al., 2007). Quante et al. (2008) observed a decreased activation 
of the cingulated gyrus during provoked OA pain. Lastly, another study paid attention to 
patterns of regional cerebral blood flow changes in subjects with 1
st
 CMC joint OA 
(Howard et al., 2012). An increase in regional cerebral blood flow in brain areas related 
to evaluation of threat to the body from ongoing pain and descending modulatory 
mechanisms was observed. 
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Only one study conducted by Gwilyn et al. (2010) revealed changes in brain structure in 
subjects with hip OA. A significant decrease in gray matter volume (i.e. thalamus) was 
observed, which was reversible after surgery and was accompanied with improvements 
on pain and function. Although not detected within our search strategy, a recent study 
by Baliki et al (2011) reported specific changes in the cortical gray matter in subjects 
with knee OA using MRI. Brain reorganization in OA patients was unique to this 
condition, enabling to differentiate their “brain signature” from others (chronic back 
pain, complex regional pain syndrome) with high accuracy.  
 
Psychosocial influences in OA 
Three studies considered psychosocial factors related to OA pain (France et al., 2004; 
Emery et al., 2006; Goodin et al., 2013). Emery et al (2006) observed more reduction in 
anxiety levels in women with knee OA compared to men, immediately after a coping 
skills training intervention, accompanied by an increase of the NFR threshold and a 
decrease of pain ratings. 
Catastrophizing and emotional-focused coping strategies were associated with higher 
pain and lower pain threshold and tolerance levels locally, but not with NFR (France et 
al., 2004). Goodin et al. (2013) showed how greater dispositional optimism was 
associated with less catastrophizing and less TS of heat pain. 
 
DISCUSSION AND CONCLUSIONS 
The goal of this paper was to review and evaluate the existing scientific literature 
regarding the role of CS in chronic OA pain. Different assessment methodologies were 
utilized for evaluating the phenomenon of CS, aiming to understand the different 
changes in pain sensibility observed in this population. Overall results from our 
systematic review seem to support a key role of CS in chronic pain related to OA. 
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The term CS is not really “yes” or “no” but it occurs at different degrees over a 
continuum, from a little to a lot. For instance, in some patient populations, CS may be 
the characteristic feature of the disorder (e.g. fibromyalgia). In others, such in OA, not 
all patients have CS, but only a sub-group. Although peripheral mechanisms in OA pain 
are undeniable, our review disclosed a subgroup of subjects (around 30% of OA 
patients), with CS contributing to their clinical picture (Hochman et al., 2010, 2011; 
Murphy et al., 2011b). This was corroborated by means of different subjective (i.e. 
persistent pain complaints, presence of centrally mediated symptoms, neuropathic pain 
descriptors), and objective parameters (i.e. widespread hyperalgesia and allodynia, 
enlarged radiation of pain, altered spinal reflexes, abnormal spatial and temporal 
summation, impaired descending inhibition, enhanced descending facilitation, and brain 
changes). It should be acknowledged that some of these findings (i.e. enhanced 
temporal summation or reduced pain inhibition based on QST), provide direct evidence 
of CS in OA (Arendt-Nielsen and Graven-Nielsen, 2011). However, other findings (i.e. 
neuropathic pain descriptors, presence of symptoms such as sleep disturbance), are 
frequently seen but not exclusively in patients with CS so they only offer indirect 
evidence of hypersensitivity of the central nervous system in OA. Similar findings 
characteristic of CS have been previously reported in other chronic pain conditions such 
as whiplash (Van Oosterwijck et al., 2013) or rheumatoid arthritis (Meeus et al., 2012), 
suggesting these conditions are bound by the similar mechanism of altered central pain 
processing.   
 
Modulation of central hyperexcitability occurred after implementation of different 
locally treatment modalities like manual therapy (Moss et al., 2007; Courtney et al., 
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2010), TENS (Vance et al., 2012), joint replacement surgery (O’Driscoll and Jayson, 
1974; Kosek and Ordeberg, 2000b; Graven-Nielsen et al., 2012), or medication (Wilder-
Smith et al., 2001). This is in line with the acknowledged modulation of CS by 
peripheral nociceptive input observed in other chronic pain populations (Staud, 2010). 
Apart from one study (Emery et al., 2006), interventions specifically addressing 
descending facilitatory (e.g. cognitive-behavioral therapy), or descending inhibitory 
mechanisms (e.g. exercise therapy), were not identified in the OA literature. More 
research should examine the effect of treatment modalities and their influence on 
outcome measures related to CS in OA.  
 
Supraspinal descending facilitatory influences are able to modulate central 
hypersensibility and influence the results of QST (Zusman, 2002). Only Goodin et al. 
(2013) assessed the impact psychosocial factors could have on psychophysical measures 
of CS. More research is warranted to examine the precise influence of psychological 
factors on the processing of sensory input in patients with OA, and hence to study 
cognitive-emotional sensitization in these patients (Brosschot, 2002).  
 
Clinical and laboratory methods employed for diagnosing potential involvement of CS 
in musculoskeletal pain conditions are diverse (i.e. QST, brain imaging techniques, 
efficacy of centrally acting drugs). All of them assessed the same underlying biological 
concept (CS), but in its different manifestations related to the different aspects of 
sensitization (Graven-Nielsen and Arendt-Nielsen, 2010). For instance, widespread 
hyperalgesia, which is a manifestation of CS, can be assessed quantitatively in a 
standardized way using sensory tests, such as pressure algometry. The majority of the 
studies of the current review identified pain hypersensitivity within laboratory 
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conditions, using costly and unattainable equipment for clinicians. Therefore, evidence-
based clinical strategies to more readily and systematically identify CS in OA pain are 
needed (Lluch Girbés et al., 2013).  
 
Although the quality criteria used for assessing the risk of bias of the selected studies 
has proven to generate reliable data (Van Oosterwijck et al., 2013)  and has been used 
previously to examine the presence of central sensitization in another chronic pain 
population (Van Oosterwijck et al., 2013), some issues remain. For instance, a wash-out 
period could be considered a strength or a weakness: having patients wash-out could 
itself induce CS, depending on what medications they are using. On the other hand, 
enrolling only those patients who are able and willing to discontinue medication use can 
bias the study toward patients with less severe symptoms who are less likely to show 
CS. These are important considerations for future research in this area. 
 
Based on the methodological issues identified in the existing studies, future study 
designs should use a sufficient and justified sample size and report validity and 
reliability of outcome measures used. Prevention of bias by including a wash-out period 
before starting data collection is warranted. Finally, description of the blinding 
procedure is recommended, and a follow-up period should be included to evaluate the 
role of central alterations on the long-term.  
 
Some limitations need to be acknowledged in this review. First, the screening of the 
literature databases and selection of studies was carried out by only one assessor, which 
implies that some relevant studies may have been excluded. Still, the methodological 
screening of the selected studies was conducted by two blinded researchers. Studies 
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assessing the phenomenon of CS in animal models were excluded, based on the 
observation that animal models do not closely mirror the human condition (Arendt-
Nielsen et al., 2007). Finally, the majority of the selected studies addressed OA of the 
knee joint. Hence, care must be taken to extrapolate the results of this review to all OA 
patients. 
 
In conclusion, the majority of the literature reviewed suggests that the CNS becomes 
hypersensitized in subjects with chronic OA pain, and that the phenomenon of CS plays 
a crucial role in the pain complaints reported by these patients. However, both clinical 
identification and treatment of CS in OA is still in its infancy, and more human research 
with a good methodological quality is warranted. 
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ABSTRACT 
Osteoarthritis is one of the most frequent, disabling and costly pathologies of modern 
society. One of the main aims of osteoarthritis management is pain control and 
functional ability improvement. The exact cause of osteoarthritis pain remains unclear.  
In addition to the pathological changes in articular structures, changes in central pain 
processing or central sensitization appear to be involved in osteoarthritis pain. The latter 
calls for a broader approach to the management of patients with osteoarthritis. Yet the 
scientific literature offers few information addressing the treatment of central 
sensitization specifically in osteoarthritis patients. Interventions like cognitive- 
behavioral therapy and neuroscience education potentially target cognitive-emotional 
sensitization (and descending facilitation), while centrally acting drugs and exercise 
therapy can improve endogenous analgesia (descending inhibition) in patients with 
osteoarthritis. Future studies should assess these new treatment avenues.  
 
Key words: osteoarthritis, pain, central sensitization, neuroscience education, exercise 
therapy, graded activity. 
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INTRODUCTION 
Osteoarthritis (OA) is one of the most common rheumatologic conditions in our 
society
1,2
, which affects over 80% of the population beyond the age of 55
3
. Two of the 
most commonly affected joints are the knees and the hips, sharing a predominantly 
load-bearing function
4
. Individuals with OA often suffer from chronic pain, which 
causes a great deal of disabilities and significant healthcare costs
5
. Unfortunately, at 
present, both the causes of the pain as well as the most effective treatment have not yet 
been established
6,7
. 
 
Historically, OA pain has been considered a nociceptive pain related to the degree of 
structural damage to the affected joint. Since the cartilage, under normal physiological 
conditions, is an avascular and aneural tissue, the issue of whether pain could come 
from other joint structures was raised. Thus, OA pain has been attributed to deformation 
of the periarticular tissues
8 
and the subchondral bone
9
, increased intraosseous pressure
10
, 
synovial inflammation
11
 or injuries to the bone marrow
12
. OA pain has also been 
described as a chronic inflammatory response
13
, partly caused by an up-regulation of 
Na+ channels
14
 and local production of nitric oxide (NO), associated with the 
degeneration of the joint cartilage
15
.  
 
Recently, OA has been considered as a hypertrophic arthritis
6
 in order to differentiate it 
from the atrophic arthritis typical of rheumatoid arthritis. This is due to the fact that, 
apart from cell death of chondrocytes and loss of joint cartilage, the production of new 
tissue has been observed in OA, including fibrocartilage. Hence, in an attempt of the 
cartilage to regenerate, an increase in protein synthesis by the chondrocytes has become 
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evident, especially in the initial stages
16
. Moreover, the osteochondral angiogenesis 
derived from expression of growth factors (e.g. vascular endothelial growth factor and 
platelet-derived growth factor) has been proposed as a factor that could facilitate the 
chronicity of pain in OA
17,18
. Furthermore, literature has described cases of patients 
suffering from OA with satisfactory results after treating myofascial trigger points, 
which indicates that musculoskeletal tissues may also play a part in the pain related to 
OA
19
.  
 
Since OA is an incurable pathology, therapeutic objectives usually focus on maximizing 
patient´s function and quality of life, while keeping pain under control and minimizing 
the adverse effects derived from the use of medication
6,20,21
. Non-steroidal anti-
inflammatory drugs (NSAIDs) can be beneficial in initial stages but in time they 
become inefficient, being the administration of other medication such as amitriptyline 
or gabapentin more advisable
22
. This phenomenon might be related to the fact that 
chronic pain in OA is more related to neuroplastic changes in the nervous system than 
to an inflammatory condition of the joint
22
. Those who do not respond well to 
conservative treatment usually end up with a prosthetic restoration of the affected 
joint
20,21
. However, surgery does not always imply a complete resolution of 
symptoms
23
.  
 
OSTEOARTHRITIS PAIN 
The understanding of pain in OA, its modulation and treatment is central to physical 
therapists practice as they usually manage patients affected by this disease. Although 
pain is a very common complaint in OA, there is scarce knowledge on the etiology, 
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mechanisms and treatment of OA pain by healthcare professionals
24
. General trend is 
for healthcare professionals to consider OA pain as a reliable “informant” of what is 
happening at peripheral tissue level. Thus, greater joint degeneration is used to be 
associated with greater pain.  Nevertheless, there are different arguments that make it 
difficult to explain OA using exclusively a “peripheral model” of pain. It has been 
proven, for instance, that radiological changes identified in OA patients are not always 
consistent with pain
25-28
, although there are studies that do prove this correlation
29,30
. 
The great inter-individual variability on pain severity and the unclear relationship 
between pain and structural damage have raised the issue of the existence of other 
mechanisms responsible for the pain in OA. At present, peripheral sensitization and, 
especially, central sensitization, have been proposed as two of the mechanisms 
underlying pain in OA
24,31,32
, as in other chronic musculoskeletal pain conditions
33,34
. 
Indeed, there’s a growing body of research involving pain mechanisms in OA being 
central pain mechanism an issue discussed in several reviews during the last years 
6,24,31,32,34,35
. 
 
Mechanisms involved in central sensitization have been shown across several chronic 
conditions, which have been recently grouped together under the term central sensitivity 
syndromes (CSS)
36,37
. This novel unifying concept is now emerging as a single common 
set of central nervous system (CNS) processes
38
 and has been proposed to include 
chronic painful conditions that are based on central sensitization as fibromyalgia, 
irritable bowel syndrome or temporomandibular disorder. For the moment, OA pain has 
not been included on such list because the role of central sensitization in OA is still in 
his infancy. Yet here we advocate that increasing evidence supports the inclusion of OA 
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in the group of CSS. The hallmark of these 'centrally driven' pain conditions is a diffuse 
hyperalgesic state identifiable using experimental sensory testing (i.e. Quantitative 
sensory testing
39
) and corroborated by functional neuroimaging
40
. The characteristic 
symptoms of these central pain conditions include multifocal pain, fatigue, insomnia, 
memory difficulties and a higher rate of co-morbid mood disorders
36
.  
 
CSS is an important new concept that also embraces the biopsychosocial model of 
disease. In this sense, OA pain experience is multidimensional fitting well with the 
biopsychosocial model, which reflects the influence of biological (i.e. structural 
changes), psychological (i.e. mood and coping), and social factors (i.e.social support) in 
the individual symptoms and suffering. Several psychosocial variables (i.e. 
catastrophizing, high level of depression, cognition about pain, etc.) have been 
suggested as influencing OA pain and disability
41
. Psychosocial interventions as 
cognitive behavioral therapy (CBT) or activity pacing may decrease OA pain and 
disability
42-45
and studies addressing the effects of combined physical and 
physocological approaches in OA pain are being conducted
46,47
. 
 
OSTEOARTHRITIS AND CENTRAL SENSITIZATION 
In last decades, great progress has been made in the knowledge of pain. Nowadays, it is 
clear that the majority of chronic musculoskeletal pain conditions are characterized by 
an alteration in pain processing by the CNS
34
. More specifically, sensitivity of central 
neurons to inputs coming from the unimodal and polimodal receptors increase, which 
results in a physiopathological condition called central sensitization, characterized by a 
general or extended hypersensitivity. Central sensitization is defined as “an increased 
response of CNS neurons which inform of pain when faced with inputs coming from low 
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threshold mechanoreceptors”48. However, central sensitization not only refers to spinal 
cord sensitization or amplification of the afferent impulses coming from the periphery. 
It also includes an alteration of sensory processing in the brain
49
, loss of descending 
anti-nociceptive mechanisms
50
, enhanced facilitatory pain mechanisms, increased 
temporal summation or wind-up
51
 and long-term potentiation of neuronal synapsis in 
the anterior cingulate cortex
52
. Pathophysiological mechanisms underlying central 
sensitization are complex and numerous, but the net effect is an amplification of neural 
signaling within the CNS than elicits pain hypersensitivity
34.
  
 
Central sensitization is present in different chronic musculoskeletal conditions such as 
whiplash trauma
53
, chronic low back pain
54
, fibromyalgia
55
 or, more recently, in 
OA
6,24,31,32,35
 which concerns us here. One of the factors that favor the development of 
central sensitization in OA is the massive and repetitive nociceptive input coming from 
peripheral joint nociceptors arriving to dorsal horn neurons in the spinal cord. 
Therefore, intense and continued nociceptive input proceeding from an OA joint may 
cause central sensitization, as shown in different studies
56-58
. Presence of central 
sensitization entails greater complexity of the clinical picture
59
 and less possibilities of 
achieving positive results with physical therapy treatment
60.
 
 
Patients with OA quite often present referred pain and changes in skin sensitivity in 
remote areas with respect to the affected joint. There are various theories on referred 
pain, but they all include a higher centers misinterpretation of the peripheral origin of 
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nociception
61.
 Referred pain is a phenomenon attributed to central sensitization so its 
presence in OA is highly indicative of changes in pain processing in the CNS.  
 
Another phenomenon associated with central sensitization is secondary hyperalgesia. 
While primary hyperalgesia or peripheral sensitization involves an increased sensitivity 
of peripheral nociceptors in response to tissue damage, secondary hyperalgesia 
correspond to increased sensitivity of dorsal horn neurons, located in the spinal 
segments corresponding to the primary nociceptive source. Peripheral sensitization is a 
local phenomenon, while secondary hyperalgesia is a central process of the nervous 
system. Regarding OA, different studies have shown an increase in nociceptive 
transmission in dorsal horn neurons, typical of secondary hyperalgesia
62,63
. Im et al
7
 
provided key in vivo evidence that OA pain is caused by central sensitization through 
communication between peripheral OA nociceptors and the central sensory system. 
They observed that structural changes in components of the peripheral knee joint 
correlated with alterations in the central compartments (dorsal root ganglia and the 
spinal cord) and symptomatic pain assessed by behavioral hyperalgesia. 
 
Apart from referred pain and secondary hyperalgesia, there is further evidence in 
scientific literature that shows how pain in OA can be modulated through mechanisms 
related to the CNS. It has been found, for instance, that OA not only causes a decrease 
in pain thresholds in the affected joint, but also far from it in remote and over extended 
areas
64,65
. Loss of descending pain inhibitory mechanisms
64,66
, increase of temporal 
summation (increase of painful response to repetitive stimulation)
66
 as well as the 
presence of extended areas of hyperalgesia in patients with OA
66,67,68
, further support 
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the role of central sensitization in OA pain. Moreover, it is important to remember that 
patients with chronic musculoskeletal pain conditions usually present generalized 
hyperalgesia in deep tissues and an increased response to experimental painful 
stimulation
69,70
.  
 
Recent evidence of the role central sensitization plays in OA pain comes from a study 
by Arendt-Nielsen et al
71
 who conducted a protocol of pain assessment in subjects with 
knee OA. Widespread hyperesthesia, enhanced spatial summation and loss of 
conditioned pain modulation (CPM) were observed which imply sensitized central pain 
mechanisms in these patients. Moreover, all these measurements were normalized 
following joint replacement which implies that these central pain processes were 
maintained by peripheral input. 
 
Various animal studies have shown the contribution of the spinal glial cells to central 
sensitization associated with OA
72
. Glial cells are crucial in the onset and maintenance 
of central sensitization, especially in relation to neuropathic pain. Activated glial cells 
(microglia and astrocytes) in the spinal cord can contribute to central sensitization by 
producing pro-inflammatory cytokines, complement factors and cyclo-oxygenase 
(COX) type 1 and 2 inside the CNS. Their participation in OA pain indicates that 
mechanisms underlying neuropathic and osteoarthritis pain might be similar
22.
 Still, 
these animal observations require confirmation in human studies.  
 
Chapter 2 
 
 Enrique Lluch Girbés  129 
One of the characteristics of central sensitization is that, once installed, it can persist in 
time despite the lack of new painful stimuli from the periphery. In clinical practice, it is 
not uncommon to find patients with OA who show symptoms even after prosthetic 
substitution. It has been noted that patients suffering from OA with a high degree of 
pain and low pain thresholds before surgery run a greater risk of continued pain after 
getting a prosthetic knee, which has been interpreted as an accurate reflection of central 
sensitization
23
. 
 
The effect of certain centrally acting drugs like duloxetine on OA pain
73,74
 and the result 
of various studies carried out with functional Magnetic Resonance Imaging (fMRI) have 
further consolidated the role of central sensitization in this pathology. Duloxetine is a 
serotonin and norepinephrine reuptake inhibitor drug activating descending 
noradrenergic descending pathways together with serotonergic pathways
75
. fMRI is a 
valid test that identifies how and where the pain is processed in the brain and how this 
process varies for different patients
76,77
. Studies using fMRI have shown an increased 
activity of the periaqueductal gray in patients with OA, in comparison with healthy 
subjects
78
. This has been interpreted as increased activity of descending facilitatory pain 
mechanisms (a mechanism with the same net effect as decreased descending analgesia). 
Pain of knee OA is processed in areas related with emotions and fears
79
 and activates 
pain areas of the prefrontal limbic region
80
, which is also typical of other chronic 
musculoskeletal conditions such as low back pain
81.
 These areas are involved in the 
emotional evaluation of one´s surroundings
82,
 thus confirming that chronic pain is an 
emotional state. This view applies to OA pain, as already noted by Kulkarni et al
79
. 
Table 1 summarizes the currently available evidence regarding central sensitization in 
OA pain.  
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With regard to central sensitization in patients with OA pain, there is still much to 
discover. Notably, we need to determine which contributing genetic and environmental 
factors increase the risk of developing central sensitization, precisely what triggers and 
maintains this phenomenon and what is the responsible factor of its persistence in some 
individuals
34
. However, identifying the contribution of central sensitization to many 
painful clinical conditions, “inexplicable” until some time ago, has marked an important 
shift in clinicians’ thinking model and has favored the development of new therapeutic 
strategies
83
.  
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Table 1.  Summary of current evidence regarding central sensitization in osteoarthritis pain. fMRI (functional Magnetic Resonance Imaging). 
 Year of 
publication 
Experimental model Joint  under study Evidence of central sensitization 
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Neugebauer et al57 
 
Kosek et al64 
 
 
Bajaj et al67 
 
Sharif et al63 
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Kulkarni et al79 
 
Martindale et al56 
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Imamura et al68 
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Arendt-Nielsen et al66 
 
Im et al7  
 
Hochman et al97 
 
1974 
 
1993 
 
2000 
 
 
2001 
 
2005 
 
2007 
 
2007 
 
2007 
 
2007 
 
2008 
 
2008 
 
2009 
 
2009 
 
2010 
 
2010 
 
2010 
 
Human 
 
Animal 
 
Human 
 
 
Human 
 
Animal 
 
Animal 
 
Human 
 
Animal 
 
Animal 
 
Human 
 
Human 
 
Human 
 
Human 
 
Human 
 
Animal 
 
Human 
 
Hip 
 
Knee 
 
Hip 
 
 
Lower extremitity 
 
Ankle 
 
Knee 
 
Knee 
 
Knee 
 
Ankle 
 
Knee 
 
Knee 
 
Knee 
 
Hip 
 
Knee 
 
Knee 
 
Knee 
 
Extended and remoted areas of hyperalgesia from affected joint. 
 
Dorsal horn sensitization (secondary hyperalgesia) 
 
Extended and remoted areas of hyperalgesia from affected joint 
Loss of descending pain inhibitory mechanisms 
 
Extended and remoted areas of hyperalgesia from affected joint 
 
Dorsal horn sensitization (secondary hyperalgesia) 
 
Contribution of spinal glial cells to pain 
 
fMRI 
 
Dorsal horn sensitization (secondary hyperalgesia) 
 
Dorsal horn sensitization (secondary hyperalgesia) 
 
Extended and remoted areas of hyperalgesia from affected joint 
 
Persistence of pain after prosthetic substitution 
 
Positive effects of centrally acting drugs 
 
fMRI 
 
Extended and remoted areas of hyperalgesia from affected joint 
Loss of descending pain inhibitory mechanisms 
Communication between peripheral OA nociceptors and the central sensory system 
 
Neuropathic pain descriptors of symptoms 
Effect of neuroscience education on subjects with chronic knee pain related to osteoarthritis 
 
 
 Enrique Lluch Girbés  
132 
 
Abou-Raya et al74 
 
Parks et al80 
 
Murphy et al85 
 
 
Murphy et al86 
 
Sagar et al72 
 
Hochman et al98 
 
Arendt-Nielsen et al71 
 
2011 
 
2011 
 
2011 
 
 
2011 
 
2011 
 
2011 
 
2012 
 
Human 
 
Human 
 
Human 
 
 
Human 
 
Animal 
 
Human 
 
Human 
 
 
Knee 
 
Knee 
 
Knee/Hip 
 
 
Knee 
 
Ankle 
 
Knee 
 
Knee 
 
Positive effects of centrally acting drugs 
 
fMRI 
 
Identification of subgroup of patients with symptoms suggesting central sensitization  
 
Identification of subgroup of patients with symptoms suggesting central sensitization  
 
 
Contribution of spinal glial cells to pain 
 
Neuropathic pain descriptors of symptoms 
 
Widespread hyperesthesia, enhanced spatial summation and loss of conditioned pain modulation 
 
 
 
 
 
 
 
 
 
Chapter 2 
 
 Enrique Lluch Girbés  133 
IDENTIFICATION OF CENTRAL SENSITIZATION IN PATIENTS WITH 
OSTEOARTHRITIS 
For some physical therapists, central sensitization is a theoretical concept, difficult to 
apply in daily clinical practice. Some have even come to believe that it is a phenomenon 
that can rarely occur in their patients, which contradicts reality. Unfortunately, there is 
currently neither an international consensus definition nor a set of valid clinical criteria 
for the diagnosis of central sensitization. In other words, the diagnosis of central 
sensitization in patients with chronic musculoskeletal pain cannot be given directly and 
clinicians should rely on symptoms and signs suggestive of central sensitization pain. 
 
A recent study has shown how physical therapists can use information obtained from 
the medical diagnosis, patient´s medical record, physical examination and treatment 
response, in order to clinically identify central sensitization in patients with 
musculoskeletal pain
84
. Not all OA patients are characterized by central sensitization 
thus probably constituting a subgroup within this pathology
85
. Murphy et al
85
 identified, 
in a heterogeneous sample of patients suffering from hip and knee OA, a small 
subgroup (36%) with symptoms suggesting central sensitization (widespread pain, 
fatigue, sleep disturbance and cognitive difficulties). However, no attempt was made to 
see if those symptoms were manifestations of OA or other comorbid conditions such as 
fibromyalgia. In a recent study Murphy et al
86
 showed how 27% of the variance in pain 
severity in women with knee OA was explained by age, radiographic severity, and 
centrally-mediated symptoms. Centrally-mediated symptoms explained an additional 
10% of the variance in pain severity after the other 2 variables were entered. Both 
radiographic severity and centrally-mediated symptoms were independently and 
significantly associated with pain severity. In addition to more severe radiographic 
features, women with higher centrally-mediated symptoms had greater pain severity. 
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Although studies by Murphy et colleagues have provided some evidence that patients 
with greater central pain contributions can be identified in routine clinical practice, the 
implications of this involvement in OA are just starting to be realized and larger 
longitudinal studies are needed. Evidence-based strategies are still needed to more 
readily and systematically identify these patients. Guidelines for the recognition of CS 
in patients with musculoskeletal pain like OA have been presented
84
, and are currently 
being updated and upgraded towards the first international diagnostic criteria for CS in 
patients with musculoskeletal pain. Development of these diagnostic criteria should 
represent an improvement in the field and constitute an important step toward 
facilitating the acknowledgement and recognition of CS as a disease. 
 
There are some classification systems based on pain mechanisms described in scientific 
literature
87-91
. In them, a classification of the patient´s pain is attempted according to the 
neurophysiological mechanism responsible for the generation or maintenance of pain90-
93
. Therefore, starting with a set of signs and symptoms, patients are classified in three 
groups: nociceptive pain, peripheral neuropathic pain and pain due to central 
sensitization. This, in theory, allows us to establish the most adequate treatment strategy 
and improve outcomes
87
. One of the advantages of such classifications is that they offer 
a better explanation of variations observed in the nature and severity of many clinical 
presentations of musculoskeletal pain disorders like OA, where pain can be present 
without pathology, pathology without pain or persistent pain despite resolution of 
pathology. Reliability and discriminating validity of these classification systems have 
been documented recently in relation to lower back and lower limb pain
94-96
. However, 
whether or not these results can be extrapolated to a population with OA is unknown.  
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Central sensitization has also been inferred from OA in humans in terms of neuropathic 
pain descriptors of symptoms. Hochman et al. recently identified in a sample of subjects 
with chronic pain due to knee OA, a small subgroup who used subjective descriptors of 
pain suggesting neuropathic pain
97
. The neuropathic pain subgroup mainly comprised of 
young women with greater pain intensity and severity, and longer duration of pain
97
. 
Using specific questionnaires also allowed identification of a neuropathic pain 
component in patients with OA
98
.  
 
In order to understand exactly the role central sensitization plays in patients with OA, it 
could prove useful to evaluate the response to interventions specifically addressing 
alterations in central pain processing. Moreover, OA patients having clear signs and 
symptoms of central sensitization (.i.e. a patient with hip OA with widespread pain, 
hypersensitivity to bright light and intolerance to stress) can be treated differently. Once 
the physical therapist concludes that central sensitization rather than the local joint 
destruction dominates the clinical picture of the patient with OA, then the treatment 
focus should be reset on the CNS (i.e. diminishing the hypersensitivity of the CNS ). 
Apart from pharmacological treatments mentioned above (i.e. centrally-acting drugs), 
other treatments addressing cognitive-emotional sensitization such as CBT or 
neuroscience education should be taken into consideration
99
. However, until now, these 
types of interventions have been underestimated in patients with OA
100
. Finally, 
education can be combined with graded exercise therapy/graded activity and stress 
management to design a comprehensive rehabilitation program targeting central 
sensitization in patients with OA. These interventions will be explained below.  
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NEUROSCIENCE EDUCATION: A FUTURE TOOL IN OSTEOARTHRITIS? 
Traditional rehabilitation treatments for OA are typically directed to the periphery (i.e. 
joint and surrounding structures) through interventions such as joint injections, joint 
protection, analgesic medication, manual therapy, exercise or TENS. Techniques used 
to manage pain as manual therapy
101,102
, exercise or Transcutaneous Electrical Nerve 
Stimulation
103
 can potentially target central sensitization by modulating pain and 
desensitizing the CNS
35,99
, although its effects on central sensitization are unclear 
.Moreover, therapeutic strategies addressing symptom experience that accompanies OA 
pain (i.e. sleep disturbance, depression, fatigue) as CBT or CBT-guided and activity 
pacing, could also act on central factors contributing to pain in OA. 
 
One recently intervention used to desensitize CNS is Neuroscience Education (NE). NE 
is an educational intervention aiming to reduce pain and disability, by explaining patient 
the biological processes underlying their pain condition. Its use is recommended in 
central sensitization conditions, where the patient presents mal-adaptive cognitions, 
behavior or coping strategies in response to pain
104
. In contrast to educational programs 
commonly used in rehabilitation that apply pathoanatomical and biomechanical models 
to explain the pain (focusing on the tissues and tissue damage), NE describes how the 
nervous system interprets information coming from the tissues through peripheral 
sensitization, central sensitization, synaptic activity and cortical processing. 
Conventional biomedical models not only have a limited efficiency in decreasing pain 
and disability
105,106
, but they can also prove counterproductive since they increase 
patient´s fear, anxiety and stress, which can also increase the pain
107-109
.  
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From a clinical perspective, it is a challenge to put into practice scientific knowledge 
related to central sensitization and chronic pain. Clinical guides are now available that 
provide information for explaining central sensitization, describing how to perfom a NE 
session/s with patients suffering from chronic musculoskeletal pain
104
. A systematic 
review of the effect of NE on pain, disability and stress in patients with chronic 
musculoskeletal pain has recently been published
110
. In this review it was concluded 
that there is convincing evidence that NE has positive effects on pain, disability, 
catastrophizing and physical performance in patients with chronic musculoskeletal pain. 
Moreover, structure, content and evidence of treatment with NE for different chronic 
conditions are detailed elsewhere
104,110
. Nonetheless, one of the limitations of this 
review is that evidence only exists for very specific pathologies such as chronic low 
back pain, chronic fatigue syndrome, fibromyalgia or chronic whiplash trauma. It 
remains to be established whether these findings can be extrapolated to other 
musculoskeletal pain conditions like OA. Hence, future studies should specifically 
evaluate efficacy of interventions addressing psychosocial aspects in OA like NE as has 
already been done with CBT or activity pacing. Moreover, one of the challenges 
clinicians are faced with is to find the perfect balance, for each OA patient, between 
interventions directed at musculoskeletal tissues and “hands off” approaches111.   
 
It should be emphasized that NE is not a treatment, but rather a strategy targeting 
cognitive barriers for behavioral change and hence effective physical therapy. NE aims 
at reconceptualizing chronic pain in way that pain is no longer regarded as threatening 
(i.e. the patient should understand that pain in case of central sensitization no longer 
reflect tissue damage, but rather reflects ‘noise’ in the sensory system). This opens the 
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avenue for a time contingent approach to exercise therapy and activity management, 
which will be explained below. 
 
EXERCISE THERAPY AND GRADED ACTIVITY 
Exercise is frequently encountered as a central component of the treatment of OA pain. 
Although the clinical benefits of exercise therapy in OA are well established (i.e. 
evidence based)
112
, it is currently unclear whether exercise therapy has positive effects 
on the processes involved in central sensitization. From a theoretical perspective, 
exercise has the potential to ‘treat’ the process of central sensitization: exercise activates 
brain-orchestrated endogenous analgesia [reviewed in
113
]. From a clinical perspective, 
clinicians are advocated to use a time-contingent approach when exercises patients with 
OA and central sensitization. This implies that the patient does not cease exercise bouts 
once (local) pain severity increases. Instead, the patient complies with the 
predetermined exercise modalities (including exercise duration, cfr. time-contingent) 
and interprets pain increases as non-threatening. Such a time-contingent approach is 
unlikely to be effective unless the patient applies this time-contingent approach in daily 
life as well. Indeed, graded activity is a behavioral therapy applying such a time-
contingent approach into the daily life of patients with OA. Physical activity increases 
are effective for treating pain in OA patients with overweight
114
 and graded activity 
therapy is effective for patients with OA in general
115,116
. Moreover, graded activity 
results in better exercise adherence and more physical activity than usual care in 
patients with hip or knee OA, both in the short- and long term
117
.  
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CONCLUSION 
OA is a frequent chronic musculoskeletal pathology that usually causes great disability 
and significant healthcare costs. Even though patients with OA present structural 
anomalies, the severity of these changes is not always proportional with the degree of 
pain or disability. A significant proportion of these patients with OA show signs of 
central sensitization, with pain modulation and processing altered at the CNS level. 
Substantial scientific evidence indicates a role for central sensitization in OA pain, yet it 
is necessary to develop strategies to allow reliable and systematic recognition of 
patients with OA whose pain has a central sensitization component. Central 
sensitization management is an area of great interest at least in the subgroup of patients 
with OA pain having central sensitization. Interventions like CBT and NE potentially 
target cognitive-emotional sensitization (and descending facilitation), while centrally 
acting drugs and exercise therapy can improve endogenous analgesia (descending 
inhibition) in patients with OA. However, to date, evidence both on identification and 
treatment of central sensitization in osteoarthritis is still scarce and more human 
research is needed. Optimum treatment for people with OA pain requires a 
multidisciplinary approach and determination of how peripheral and central factors are 
contributing to pain in each patient, to enable individualization of treatment strategies. 
Physical therapists are in a good position to deliver an individualized intervention 
because they are cognizant of the need for a biopsychosocial approach to management. 
In addition, they can perform systematic assessment and choose to utilize a more 
peripheral or central based therapy. 
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Are measures of central sensitization associated with the area of 
pain and clinical symptoms in subjects with knee osteoarthritis? 
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ABSTRACT 
Background: Expanded distribution of pain is considered a sign of central sensitization 
(CS). The relationship between recording of symptoms and CS in people with knee 
osteoarthritis (OA) has been poorly investigated. 
Objective: To examine whether the area of pain assessed using pain drawings relates to 
CS and clinical symptoms in people with knee OA. 
Design: Cross-sectional study. 
Methods: Fifty-three subjects with knee OA scheduled to undergo primary total knee 
arthroplasty were studied. All participants completed pain drawings using a novel 
digital device, self-administration questionnaires and were assessed by quantitative 
sensory testing. Pain frequency maps were generated separately for women and men. 
Spearman’s correlation coefficients were computed to reveal possible correlations 
between the area of pain and quantitative sensory testing and clinical symptoms. 
Results: Pain frequency maps revealed enlarged areas of pain, especially in women. 
Enlarged areas of pain were associated with higher knee pain severity (rs= .325, P < 
0.05) and stiffness (rs=.341, P < 0.05), lower pressure pain thresholds at the knee (rs=-
.306, P < 0.05) and epicondyle (rs=-.308, P < 0.05) and higher scores with the Central 
Sensitization Inventory (rs=.456, P < 0.01). No significant associations were observed 
between the area of pain and the remaining clinical symptoms and measures of CS.  
Limitations: Firm conclusions about the predictive role of pain drawings cannot be 
drawn. Further evaluation of the reliability and validity of pain area extracted from pain 
drawings in people with knee OA is required. 
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Conclusion: Expanded distribution of pain was correlated with some measures of CS in 
individuals with knee OA. Pain drawings may constitute an easy way for the early 
identification of CS in people with knee OA, but further research is required. 
Key words: Knee osteoarthritis, chronic pain, pain location, central nervous system 
sensitization. 
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INTRODUCTION 
There is compelling evidence that central sensitization (CS) is present in a subgroup of 
people with knee osteoarthritis (OA) pain, especially in those with more advanced knee 
OA, and may be associated with knee OA symptom severity.
1,2
 According to Woolf, CS 
is “operationally defined as an amplification of neural signaling within the central 
nervous system that elicits pain hypersensitivity”.3 CS is a broad concept encompassing 
numerous and complex pathophysiological mechanisms such as spinal cord 
sensitization, impaired functioning of brain-orchestrated descending anti-nociceptive 
(inhibitory) mechanisms, (over)activation of descending pain facilitatory pathways, 
increased temporal summation (TS) or wind-up and alteration of sensory processing in 
the brain.
3
  
 
If present in people with knee OA pain, CS may mediate treatment responses. For 
instance, the presence of pre-operative CS [e.g. widespread pain sensitization, enhanced 
TS of pain] was associated with poor outcomes after total knee replacement.
4,5
 
Therefore, it may be important for clinicians to identify CS in people with knee OA 
pain. In such patients, a broader therapeutic approach aiming to desensitize the central 
nervous system seems warranted.
6
 
 
Several methods for assessing CS in people with knee OA pain are available. However, 
they are typically performed within laboratory conditions including brain imaging 
techniques,
7,8
 psychophysical testing with various stimuli [e.g. quantitative sensory 
testing (QST)
9,10
] and cerebral metabolism studies.
11
 Currently, there is a lack of 
established criteria for the clinical diagnosis of CS in knee OA.
12
 Laboratory-based 
measures like the nociceptive flexor reflex
13
 or laser-evoked potentials provide more 
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objective evidence for hyperexcitability of central nervous system neurons, but no 
single measurement can be regarded as gold standard for establishing CS in knee OA. 
The lack of gold standard may be due to the complexity and diversity of the underlying 
mechanisms. 
 
Recently, a set of criteria to assist clinicians on the classification of CS pain have been 
published,
14
 but the suitability of this classification algorithm to the OA knee pain 
population is unknown. One criterion included for the classification of CS pain is 
diffuse pain distribution (i.e. large pain areas with a neuroanatomically illogical 
distribution) as identified from the clinical history and/or a body chart.
14
 Expanded 
distribution of pain is a well-recognized sign of CS
12,15,16
 and, in this regard, pain 
drawings might be useful to identify extended areas of pain distribution in people with 
knee OA.  
 
Pain drawings have been used to obtain a graphic representation of pain distribution and 
location in people with knee OA pain.
17-23
 In pain drawing, the patient or clinician 
indicates the location of pain by shading the painful area.
24
 Several methods and 
instruments have been described to record the pain location and classify the pattern of 
knee OA pain, and the most common method is asking people to draw where they feel 
pain on a body chart.
17,19,20
 Based on studies investigating pain drawings in individuals 
with knee OA pain, the medial knee region seems to be the most frequently reported 
pain location amongst people with knee OA pain,
19,20,25,26
 though generalized or diffuse  
 
knee pain is also commonly reported.
17,19
 However, the location of pain is 
heterogeneous with no single pattern of pain location being pathognomonic for knee 
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OA.
19
 This might be due to the multiple sources of pain (e.g. ligaments stretch, 
subchondral bone damage, bone marrow lesions) in knee OA.
20
 
Recently, the presence of widespread pain as recorded on pain drawings, was most 
frequently reported by a subgroup of individuals with high levels of (in particular 
bilateral) knee OA pain and low level of structural damage on radiography (e.g. grade I 
and II on the Kellgren-Lawrence grading system for OA).
27
 Enlarged areas of pain in 
this subgroup was attributed to a variety of etiological factors, including abnormal 
central pain processing mechanisms.  Wood and colleagues
 
found that subjects with 
knee OA reporting enlarged areas of pain had more persistent and severe pain and 
higher anxiety levels, which was also interpreted as reflecting altered central pain 
processing mechanisms.
19
 However, it must be emphasized that in the above mentioned 
studies
 
CS was only hypothesized as the explanation of the study findings, and no 
attempts were made to directly measure CS. 
 
To our knowledge, only the two above mentioned studies
19, 27 
related central pain 
mechanisms to individuals’ recording of symptom location and distribution in people 
with knee OA pain. If CS was the dominant pain mechanism in an individual with knee 
OA pain, this should be reflected in more extended areas of pain mapped in pain 
drawings as compared to people with a lesser degree of pain sensitization.
22
  
 
Therefore the primary aim of this study was to examine whether the area of pain 
assessed using pain drawings relates to direct (QST) and indirect (self-reported 
questionnaires, neuropathic pain) measures of CS in people with different degrees of 
chronic knee OA pain. As opposed to quantitative pain assessment tools which provide 
direct evidence of CS in chronic joint pain,
9,10,12
 indirect measures of CS (e.g. self-
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report questionnaires designed to determine presence of neuropathic pain) only offer 
indirect evidence of hypersensitivity of the central nervous system in people with knee 
OA pain.
1,14,28
 As a secondary aim, the association between the area of pain and clinical 
symptoms (including the level of knee pain, disability and psychosocial variables) was 
also investigated. Psychosocial factors (e.g. cognitions and beliefs about pain), may 
explain some of the variation in pain reporting among individuals with knee OA.
29
 For 
instance, catastrophic thinking and poor coping strategies in people with knee OA pain 
can predict the presence of more pain after total knee replacement surgery.
4
  
 
METHODS 
Subjects 
A convenience sample of fifty-three subjects with chronic knee OA pain of more than 3 
months duration who were scheduled to undergo primary total knee arthroplasty 
participated in the study. Subjects with knee OA affecting the tibiofemoral and 
patellofemoral compartments were included. These subjects participated in a 
randomized controlled trial investigating the effects of pain neuroscience education on 
pain and function in subjects with chronic knee OA pain (Clinical Trials database 
NCT02246088). Baseline data from the entire cohort were used for this study. All 
participants were recruited from the Orthopedic Surgery Service of the Hospital 
Universitario de La Ribera (Alzira, Spain) between January 2014 and February 2015. 
 
All participants underwent weight bearing, fixed flexion posteroanterior and lateral X-
rays of their affected knee. Radiographic disease severity of both the tibiofemoral 
(Kellgren–Lawrence 0–4 grading scale30) and patellofemoral (Ahlbäck 0-5 grading 
scale
31
) compartments was evaluated for each participant. Knee OA was diagnosed by a 
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surgeon according to the American College of Rheumatology classification,
32
 including 
the regular experience of knee pain, plus either osteophytes on radiography or a 
combination of morning stiffness, crepitus and age 50 years or above. These criteria 
were found to be 89% sensitive and 88% specific for diagnosing knee OA.
32
  
Subjects were excluded from study participation if they had previously undergone knee 
joint replacement surgery of the affected joint or any other lower limb surgery within 
the past six months, had co-existing inflammatory, metabolic, neurological or severe 
medical conditions hindering the ability of the patient to participate in the study or 
cognitive disturbances that could influence completion of the pain drawings.  
 
This study was approved by the Ethics Committee of the Hospital Universitario de La 
Ribera (Alzira, Spain) and conducted in accordance with the Declaration of Helsinki. 
Before study participation, all the subjects carefully read an information leaflet and 
signed informed consent forms.  
 
Procedure 
Demographic information including age, sex, body mass index and pain duration were 
collected by self-report. Participants additionally completed a 11-point numeric rating 
scale to quantify their current pain intensity and were asked to complete a pain drawing 
to illustrate their area of pain.  
 
Subjects then completed the following self-administration questionnaires in a 
standardized order: the Western Ontario and McMaster Universities Arthritis Index 
(WOMAC) scale, Pain Catastrophizing Scale (PCS), Central Sensitization Inventory 
(CSI), painDETECT (PD-Q), Tampa Scale for Kinesiophobia (TSK), Pain Vigilance 
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and Awareness Questionnaire (PVAQ) and the Chronic Pain Acceptance Questionnaire 
(CPAQ).  
 
Afterwards, a standardized physical examination including physical performance tests 
was performed on each participant. Finally, all subjects were assessed by QST to 
examine pressure pain thresholds (PPT), TS and conditioned pain modulation (CPM). 
All QST was carried out by the same researcher in one individual session in the 
laboratories of the Hospital Universitario de La Ribera (Alzira, Spain). The participants 
were requested not to take analgesic medication 24h before the experiment. At the time 
of examination, the assessor was blinded to the questionnaire data including analysis of 
the scores obtained with pain drawings. Statistical analysis of the pain drawings data 
was performed by a researcher who was blinded from the QST data. 
 
Measurements 
Area of pain  
A novel method for obtaining and quantifying the area of pain using a digital tablet was 
used.
33
 Test-retest reliability of this method for acquisition of pain drawings was 
recently demonstrated in people with chronic neck and low back pain.
33
 Pain drawings 
were completed on a digital tablet (iPad 2, Apple Computer, Cupertino, CA, USA) 
using a stylus pen for digital tablets (CS100B, Wacom, Vancouver, WA, USA) and a 
commercially available sketching software (SketchBook Pro). Depending on the gender  
of the subject, a male or female body chart with different views of the knee region 
(frontal, dorsal) was chosen and opened in the sketching software (Figure 1A). The 
type, size and colour of the pen stroke were standardized across all participants.  
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An operator, who trained with the device in clinical practice one month prior to the start 
of the study, gave each subject a standardized verbal explanation on what the pain 
drawing was and how to complete it using the digital tablet. The pain drawing was 
presented to participants as a tool where they should illustrate precisely where they had 
felt pain during the previous week. The assessor highlighted the importance of fully 
illustrating all pain sites. After a demonstration and brief training to familiarize the 
subjects with the device, they were asked to complete their pain drawings. Participants 
were instructed as follows: ‘Please shade the areas where you felt your usual pain 
during the last week on this body chart and try to be as precise as possible’. They were 
instructed to colour every part of the body where they perceived pain in the previous 
week, independently from the type and the severity of pain. Before saving and storing 
the pain drawing, participants were asked if the pain drawing corresponded to their real 
pain distribution. If not, they were given the possibility to correct the drawing using the 
“eraser” tool.  
 
A custom software was used to compute the total area of pain for each subject, and to 
generate two pain frequency maps (i.e. frontal and dorsal body chart) separately for men 
and women.
33
 The area of pain was expressed as the total number of pixels coloured 
inside the frontal and dorsal body chart perimeter. Thus the area of pain extracted from 
the dorsal view and frontal view were combined to generate a single value of area of 
pain. Pain frequency maps were obtained by superimposing the pain drawings from all 
subjects to illustrate the most frequently reported location of pain across the entire 
sample. This was done for women and men separately. A colour grid was used to 
indicate the percentage of individuals that reported pain in that specific area. 
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Figure 1. a) Example of the available templates; b) Pain frequency maps generated 
separately for men and women by superimposing the pain drawings of all individuals 
with knee OA pain. The colour grid indicates both the number and the percentage of 
individuals that reported pain in that specific area. Dark red represents the most 
frequently reported area of pain. 
Direct measures of CS 
Pressure pain threshold (PPT)  
A standardized protocol for evaluating PPT was used.
34
 Two test sites in the peripatellar 
region (3 cm medial and lateral to the midpoint of the medial and lateral edge of patella, 
respectively) and one control distant site on the ipsilateral extensor carpi radialis longus 
(5 cm distal to lateral epicondyle of humerus) were selected for PPT measurement.
21
 
The PPT was measured using an analogue Fisher algometer (Force Dial model FDK 40 
Push Pull Force Gage, Wagner Instruments, P.O.B. 1217, Greenwich CT 06836) with a 
surface area at the round tip of 1cm
2
. The algometer probe tip was applied perpendicular 
to the skin at a rate of 1kg/cm
2
/s until the first onset of pain. PPT was measured three 
times on each site with a 30 s interstimulus interval between each measurement. The 
mean of the three measurements was used in the statistical analysis. 
 
 
Temporal summation of pain and Conditioned pain modulation (CPM) 
For measuring excitability of nociceptive pathways and efficacy of endogenous pain 
inhibition, the TS and CPM paradigms were used. TS and CPM are established ways of 
measuring excitability of nociceptive pathways and pain inhibition, respectively.
35,36
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First, PPTs were measured at the peripatellar region and the ipsilateral extensor carpi 
radialis longus as described above. Second, TS was provoked by means of 10 
consecutive pulses at previously determined PPT at each location. TS started 2 min after 
PPT measurement. For each pulse, pressure was gradually increased at a rate of 2 kg/s 
to the determined PPT and maintained for 1 s before being released (1 s interstimulus 
interval). Pain intensity of the first, fifth, and tenth pulse was rated on a numerical rating 
scale (0: no pain to 10: worst possible pain). Afterwards, a rest period of 5 min was 
given.  
 
Third, CPM was induced by combining the TS procedure namely the test stimulus and 
an inflated occlusion cuff around the subject’s arm, contralateral to the side of the 
affected knee, to a painful intensity (conditioning stimulus). The occlusion cuff was 
inflated at a rate of 20 mm Hg/s until ‘the first sensation of pain’ and maintained for 30 
s. Afterwards, pain intensity, as a result of cuff inflation, was rated on a numerical 
rating scale. Next, cuff inflation was increased or decreased until the pain intensity was 
rated as 3/10. The length of time to reach 3/10 pain was recorded. TS assessment was 
then repeated during maintenance of the cuff inflation.
37
 
 
The details and data supporting the test-retest reliability and validity of the protocol for 
examining TS and CPM are described elsewhere.
37
 
 
Indirect measures of CS 
Central Sensitization Inventory (CSI) 
The Central Sensitization Inventory is a self-report screening instrument to help identify 
people with central sensitivity syndromes for which CS may be a common etiology.
38
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The part A of the CSI assesses symptoms common to CS and comprises of 25 items 
each ranged on a 5-point scale with the end points (0) “never” and (4) “always” (range: 
0-100). It has high reliability and validity
38
 and a cutoff score of 40 out of 100 was able 
to distinguish between individuals diagnosed with central sensitivity syndromes and a 
non-patient comparison sample (sensitivity = 81%, specificity = 75%).
39
 The Spanish 
version of the CSI was used in this study. 
 
Neuropathic pain 
The Spanish version of the PainDETECT questionnaire (PD-Q) was used to facilitate 
the identification of neuropathic pain related to knee OA.
40
 Although developed as a 
screening questionnaire for neuropathic pain, the PD-Q may also function as a measure 
of characteristics that indicate augmented central pain processing in people with knee 
OA pain.
41
 
The PD-Q is a self-administered questionnaire comprised of 9 items: seven evaluating 
pain quality, one pain pattern and one pain radiation, which all contribute to an 
aggregate score (range: -1 to 38). Sensitivity, specificity, and positive predictive values 
for neuropathic pain symptoms in people with back pain using the cut-off score of 19 
were 85%, 80%, and 83%, respectively.
42
 The relationship between PD-Q scores and 
signs of central sensitization in people with hip OA has been previously demonstrated.
43
 
 
Clinical symptoms 
Self-reported knee pain 
Participants were asked to indicate the intensity of their pain in the last week on a 
numeric rating pain scale ranging from 0 (no pain) to 10 (worst pain imaginable). The 
patient-reported numeric rating scale has demonstrated good construct validity and 
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moderate to large responsiveness [(standardized response mean and effect size ranging 
from 0.6 (hip OA) to 0.9 (knee OA)], for evaluating functional disability in people with 
hip and knee osteoarthritis.
44 
 
Physical performance tests 
Range of motion measurement for both active knee flexion and extension and the Timed 
Up and Go test were performed in each participant. These objective measures were 
selected on the basis of their ability to reflect functional mobility impairments.  
 
High intra- and intertester reliability and criterion validity of goniometry to measure 
range of motion has been documented for knee flexion and extension in subjects with 
knee restrictions of different etiologies.
45
 The Timed Up and Go test is a reliable test 
with adequate minimum detectable change for clinical use in individuals with doubtful 
to moderate (grade 1-3) knee OA.
46,47 
Intra-rater and inter-rater reliability of the Timed 
Up and Go test were 0.97 (95% confidence interval [CI], 0.95 - 0.98) and 0.96 (95% 
confidence interval [CI], 0.94 - 0.97), respectively. Its minimum detectable change, 
based on measurements performed by a single rater and between raters, was 1.10 and 
1.14 seconds, respectively.
47
 
 
Western Ontario and McMaster Universities (WOMAC) knee osteoarthritis index  
The Spanish version of the self-administered Western Ontario and McMaster 
Universities (WOMAC) knee osteoarthritis was used.
48
 The WOMAC comprises of five 
items for pain (score range 0–20), two for stiffness (score range 0–8), and 17 for 
functional limitation (score range 0–68). Total WOMAC score and scores from the 
pain, stiffness and functional subscales were considered.  Higher scores on the 
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WOMAC indicate worse pain, stiffness, and functional limitations. The test-retest 
reliability (intraclass correlation coefficients range: 0.66 to 0.81), internal consistency 
(Cronbach's alpha range: 0.81 to 0.93), convergent validity (Pearson's coefficients 
range: -0.52 to -0.63) and responsiveness (standardized response mean range: 0.8 to 1.5) 
of the Spanish version of the WOMAC has been demonstrated in people with hip and 
knee OA.
48
  
 
Pain Catastrophizing Scale (PCS) 
The Pain Catastrophizing Scale (PCS) is a valid and reliable instrument to measure pain 
catastrophizing in older adults with knee OA.
49,50
 It comprises of 13 items each ranged 
on a 5-point scale with the end points (0) “not at all” and (4) “all the time” (range: 0-
52). Higher scores indicate a higher degree of pain catastrophizing. The Spanish version 
of the PCS showed appropriate internal consistency (Cronbach’s alpha=0.79), test-retest 
reliability (intraclass correlation coefficient=0.84) and sensitivity to change (effect 
size<or=2) in patients with fibromyalgia.
51
 
 
Tampa Scale of Kinesiophobia (TSK) 
The Spanish version of the TSK-11 was used.
52
 The TSK-11 is an 11-item questionnaire 
assessing fear of movement or fear of (re)injury during movement and eliminates 
psychometrically poor items from the original version of the TSK,
53
 thus creating a 
shorter questionnaire with comparable internal consistency. It is comprised of 11 items 
each ranged on a 4-point scale with the end points (1) “totally agree” and (4) “totally 
disagree” (range: 11-44). The TSK-11 has a 2-factor structure: activity avoidance and 
harm, and has demonstrated acceptable internal consistency and validity (convergent 
and predictive) in both subjects with acute (Cronbach’s alpha= 0.79) and chronic 
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musculoskeletal pain (Cronbach’s alpha= 0.79).52 Higher scores indicate more fear-
avoidance behavior. 
 
Pain Vigilance and Awareness Questionnaire (PVAQ) 
The Spanish version of the Pain Vigilance and Awareness Questionnaire (PVAQ) was 
used to evaluate participants’ preoccupation with or attention to pain associated with 
pain-related fear and perceived pain severity.
54
 The PVAQ comprises of nine items each 
rated on a scale from 0 (never) to 5 (always) (range: 0-45). Higher scores indicate a 
higher degree of pain vigilance and awareness. Psychometric properties of the PVAQ 
were previously reported in people with chronic back pain
54
 and fibromyalgia
55,56
 
showing good internal consistency,
55,56
 reliability
54,55
 and validity.
54,55
 A cutoff score of 
24.5 out of 45 was able to identify fibromyalgia women with worse daily functioning 
with a sensitivity of .71 and a specificity of .75.
55 
 
Chronic Pain Acceptance Questionnaire (CPAQ) 
The Chronic Pain Acceptance Questionnaire (CPAQ) is the questionnaire most often 
used to measure pain acceptance in chronic pain populations.
57
 It comprises of 20 items 
each rated on a scale from 0 (never true)  to 6 (always true) (range: 0-120) and it has a 
two-factor structure: activities engagement and pain willingness. The total score results 
from the sum of these two factors with higher scores indicating a higher degree of 
chronic pain acceptance. The Spanish version of the CPAQ, which is reliable (intraclass 
correlation coefficient=0.83) and has valid construct validity (Cronbach's alpha: 0.83) 
for people with fibromyalgia, was used in this study.
57
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Statistical analysis 
Distribution of the data was tested with the Shapiro-Wilk test and non-normally 
distributed data were identified. Descriptive statistics were used to describe the baseline 
characteristics of the individuals with knee OA pain. A Mann-Whitney U test was run to 
determine if there were differences in baseline clinical variables between males and 
females. Pain frequency maps were generated by superimposing the scores obtained 
with pain drawings considering men and women separately. TS was calculated as the 
difference percentage between the 10
th
 and the 1
st
 pain rating score before occlusion 
using the formula: ((TS10th-TS1st)/TS1st)*100.
58
 The outcome measure for CPM was 
calculated as the difference between the 10th pain rating score before occlusion and the 
10th during occlusion.
37
 Spearman’s correlation coefficients were computed to reveal 
possible correlations: (1) between the area of pain and direct measures of CS (i.e. PPT 
knee, PPT epicondyle, knee TS,  epicondyle TS, knee CPM, epicondyle CPM), (2) 
between the area of pain and indirect measures of CS (i.e. CSI and PD-Q) and (3) 
between the area of pain and clinical symptoms (i.e. VAS, WOMAC, WOMAC pain 
subscale, WOMAC stiffness subscale, WOMAC functional limitation scale, PCS, TSK, 
PVAQ, CPAQ). Statistical analyses were performed using SPSS 22 (SPSS INc, 
Chicago, IL, USA). The significance level was set at P < 0.05. 
 
RESULTS 
Fifty-three individuals with knee OA (34 woman and 19 men) were enrolled in the 
study. Subjects’ demographic data are reported in Table 1 and clinical characteristics 
and measurements of CS are detailed in Table 2. Mean and median scores for the area 
of pain, ROM for active knee flexion, Timed Up and Go test, WOMAC and WOMAC 
pain and functional limitation subscale, PCS, CPAQ, TSK, CSI, PD-Q and PPT at the 
knee were significantly different between males and females (p<0.05). Seven out of the 
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fifty-three subjects (13.2%) had scores that correspond to likely neuropathic pain (≥19 
on the PD-Q). 
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Table 1. Subjects demographic characteristics are reported. *P-values refer to potential 
differences between male and females.  
 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
Baseline demographic 
characteristics of OA patients 
All subjects (n=53) 
Mean (SD) 
Median (IQR) 
Female (n=34) 
Mean (SD) 
Median (IQR) 
Male  (n=19) 
Mean (SD) 
Median (IQR) 
P- value* 
Age (years) 
70.2 (7.4) 
72 (11.5) 
71.2 (7.8) 
73 (11.2) 
68.5 (6.3) 
70 (7) 
.130 
BMI (Kg/m2) 
29.9 (3.9) 
30 (5.5) 
30.4 (4.2) 
30 (6.2) 
28.9 (3.1) 
28 (5) 
.183 
Area of pain (number of 
pixels) 
12766 (13494) 
8272 (12190) 
15012 (14327) 
10314 (12382) 
8747 (11096) 
5816 (7083) 
.017 
Pain duration (years) 
 
7.5 (6) 
5 (10) 
6.7 (5.7) 
4 (10.3) 
9.1 (6.3) 
6 (11) 
.127 
Kellgren–Lawrence grade   
(tibiofemoral joint) grade 0 
n (%) 
0 (0) 
 
0 (0) 
 
0 (0) 
 
.115 
 
Kellgren–Lawrence grade 
(tibiofemoral joint) grade 1 
n (%) 
              0 (0) 
 
0 (0) 
 
0 (0) 
 
 
Kellgren–Lawrence grade 
(tibiofemoral joint) grade 2 
n (%) 
15 (28.3) 
 
7 (20.5) 
 
8 (42.1) 
 
 
Kellgren–Lawrence grade 
(tibiofemoral joint) grade 3 
n (%) 
22 (41.5) 
 
11 (32.3) 
 
11 (57.8) 
 
 
Kellgren–Lawrence grade 
(tibiofemoral joint) grade 4 
n (%) 
16 (30.1) 
 
8 (23.5) 
 
8 (42.1) 
 
 
Ahlbäck grade (patellofemoral 
joint) grade 1 
n (%) 
3 2 1 
 
.231 
 
Ahlbäck grade (patellofemoral 
joint) grade 2 
n (%) 
19 10 19  
Ahlbäck grade (patellofemoral 
joint) grade 3 
n (%) 
30 15 15  
Ahlbäck grade (patellofemoral 
joint) grade 4 
n (%) 
1 0 1  
Ahlbäck grade (patellofemoral 
joint) grade 5 
n (%) 
0 0 0  
BMI, Body Mass Index. 
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Table 2. Baseline clinical measurements are reported.  *P-values refer to potential 
differences between male and females. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Baseline measurements of OA 
patients 
All subjects (n=53) 
Mean (SD) 
Median (IQR) 
Female (n=34) 
Mean (SD) 
Median (IQR) 
Male  (n=19) 
Mean (SD) 
Median (IQR) 
P- value* 
NRPS (0-10) 
5.92 (17) 
5.9 (22.5) 
6.19 (17.2) 
6.05 (27.3) 
5.44 (15.8) 
5.8 (20) 
.217 
ROM active knee flexion (degree) 
115.5 (11.4) 
115.5 (10) 
113.9 (9.8) 
115 (8.7) 
118.3 (13.5) 
118.5 (9.2) 
.047 
ROM active knee extension (degree) 
-2.41 (6.3) 
-2 (7.9) 
-3.2 (6.7) 
-2.6 (7.96) 
-0.9 (5.4) 
-1.6 (5.3) 
.30 
Timed Up and Go test (seconds) 
11.4 (5.7) 
9.8 (5) 
13.4 (6.2) 
11.8 (5.5) 
7.9 (1.6) 
7.7 (2.6) 
.000 
WOMAC (0-96) 
49.4 (16.5) 
49 (25) 
54.1 (16.1) 
56 (24.5) 
40.9 (13.9) 
38 (20) 
.006 
WOMAC pain subscale (0-20) 
9.53 (3.31) 
10 (5) 
10.6 (3.1) 
10 (4) 
7.6 (2.9) 
7 (3) 
.001 
WOMAC stiffness subscale (0-8) 
3.79 (2.11) 
3 (3) 
4.1 (2.3) 
4 (3.8) 
3.2 (1.7) 
3 (2) 
.119 
WOMAC functional limitation scale 
(0-68) 
36.09 (12.66) 
36 (19) 
39.4 (12.5) 
42.5 (19.8) 
30.1 (10.7) 
29 (17) 
.010 
PCS (0-52) 
23.77 (12.51) 
25 (17) 
27.2(11.7) 
26 (15.5) 
17.7 (11.8) 
20 (19) 
.012 
PVAQ (0-45) 
28.66 (6.95) 
28 (9) 
28.6 (7.5) 
28 (10.8) 
28.8 (6) 
29 (6.5) 
.773 
CPAQ (0-120) 
52.83 (18.26) 
52 (28) 
48.5 (17.2) 
47.5 (27.8) 
60.6 (18) 
64 (23) 
.022 
TSK (11-44) 
33.68 (5.98) 
34 (9) 
35.1 (5.6) 
35 (7.8) 
31.2 (5.9) 
32 (8) 
.029 
CSI (0-100) 
36.21 (15.62) 
37 (23) 
40.1 (16.6) 
42 (22.5) 
29.2 (10.8) 
30 (19.5) 
 
.014 
 
PD-Q (-1-38) 
12.25 (6.3) 
11 (8) 
13.6 (6.6) 
12 (9) 
9.8 (5.1) 
10 (8.5) 
.041 
PPT knee (Kg/cm
2
) 
4.82 (2.62) 
4 (3.15) 
4 (1.6) 
3.8 (2.5) 
6.2 (3.4) 
6.1 (4.9) 
.018 
PPT epicondyle (Kg/cm
2
) 
4.03 (1.72) 
3.7 (2) 
3.7 (1.5) 
3.6 (1.3) 
4.6 (2) 
4.4 (2.4) 
0.55 
Knee TS (%) 
40.44 (23.11) 
43.75 (23.08) 
40.53 (24.16) 
42.46 (21.32) 
40.28 (21.76) 
44.44 (25.71) 
.853 
Epicondyle TS (%) 
43.39 (21.46) 
50 (32.14) 
3 (1.7) 
3 (2) 
43.19 (17.79) 
50 (29.56) 
.978 
Knee CPM (Kg/cm
2
) 
-0.44 (1.66) 
0 (2) 
-0.6 (1.6) 
-1 (1.5) 
-0.1 (1.8) 
0.50 (1.5) 
.054 
Epicondyle CPM (Kg/cm
2
) 
-0.43 (1.76) 
0 (3) 
-0.7 (1.7) 
-1 (2) 
0 (1.8) 
0 (2) 
.200 
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CPAQ, Chronic Pain Acceptance Questionnaire; CPM, Conditioned pain Modulation; CSI, Central Sensitization 
Inventory; NRPS, Numeric Rating Pain Scale; PCS, Pain Catastrophizing Scale; PD-Q, PainDETECT Questionnaire; 
PPT, Pressure Pain Threshold; PVAQ, Pain Vigilance and Awareness Questionnaire; ROM, Range of Motion; TS, 
Temporal Summation; TSK, Tampa Scale of Kinesiophobia; WOMAC, Western Ontario and McMaster Universities 
knee osteoarthritis index. 
 
The area of pain was 12766 ± 13494 pixels across the entire group of subjects whereas 
it was 15012 ± 14327 and 8747 ± 11096 pixels for women and men, respectively. Pain 
frequency maps for the individuals with knee OA are illustrated in Figure 1B and 
correlations between the area of pain and measures of CS and clinical symptoms are 
reported in Table 3.  
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Table 3. Spearman’s correlation coefficients between the area of pain (total pain area 
extracted from the dorsal and ventral body views) computed using pain drawings, and 
measures of CS and clinical symptoms for the entire cohort of individuals with knee OA 
pain (n=53). *Correlation is significant at the 0.05 level (2-tailed). **Correlation is 
significant at the 0.001 level (2-tailed).  
 
 
CPAQ, Chronic Pain Acceptance Questionnaire; CPM, Conditioned pain Modulation; CSI, Central Sensitization 
Inventory; NRPS, Numeric Rating Pain Scale; PCS, Pain Catastrophizing Scale; PD-Q, PainDETECT Questionnaire; 
PPT, Pressure Pain Threshold; PVAQ, Pain Vigilance and Awareness Questionnaire; TS, Temporal Summation; 
TSK, Tampa Scale of Kinesiophobia; WOMAC, Western Ontario and McMaster Universities knee osteoarthritis 
index. 
 
Area of pain and direct and indirect measures of CS 
Significant correlations were identified between the area of pain and PPT at the knee 
(rs= -.306, P < 0.05) and epicondyle (rs= -.308, P < 0.05) signifying lower PPT at both 
sites in individuals with larger pain areas. Figure 2 visualizes the relationship between 
the area of pain and the PPT for both knee and epicondyle. No significant associations 
  Correlation with pain area 
rs 
Direct measures of CS 
PPT knee (Kg/cm
2
) -.306* 
PPT epicondyle (Kg/cm
2
) -.308* 
Knee TS (%) -.0183 
Epicondyle TS (%) -.087 
Knee CPM (Kg/cm
2
) -.066 
Epicondyle CPM (Kg/cm
2
) -.040 
Indirect measures of CS CSI .456** 
PD-Q .266 
Clinical symptoms NRPS (0-10) .221 
WOMAC .259 
WOMAC pain subscale .325* 
WOMAC stiffness subscale .341* 
WOMAC functional limitation 
scale 
.183 
PCS .145 
PVAQ .100 
CPAQ -.195 
TSK -.195 
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were observed between the area of pain and TS (rs= -.0183 knee, -.087 epicondyle) or 
the area of pain and CPM (rs= -.066 knee, -.040 epicondyle). A significant correlation 
was identified between the area of pain and the CSI score (rs=.456, P < 0.01); subjects 
with higher scores on the CSI showed larger areas of pain.  
 
Figure 2. The two scatter plots illustrating the relationship between the area of pain and 
the PPT for both knee and epicondyle.  
 
 
 
Area of pain and clinical symptoms  
Higher scores on the pain (rs=.325, P < 0.05) and stiffness (rs=.341, P < 0.05) subscale 
of the WOMAC were significantly associated with larger pain areas. 
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DISCUSSION 
Several methods for illustrating the area of pain in people with chronic knee OA pain 
have been used. We explored, for the first time, the utility of a novel digital device 
using two-dimensional body charts for acquisition and analysis of the scores obtained 
with pain drawings
33
 in a sample of individuals with chronic knee OA pain. Through a 
digital tablet using a user-friendly digital device, participants reported their pattern of 
pain on a body chart. Other systems such as the photographic knee pain map have 
shown good validity and reliability for people with regional knee pain to identify its 
location.
20
 
 
 
Area of pain and direct and indirect measures of CS 
The results of this study showed a significant positive correlation between the area of 
pain and some direct and indirect measures of CS. On the one hand, a more expanded 
distribution of pain was correlated with a lower PPT at a remote site from the knee (i.e. 
epicondyle). Increased pain sensitivity distantly from the knee may reflect widespread 
hyperalgesia thus providing evidence of CS in people with knee OA.
9,10,12
 On the other 
hand, we found that a greater expansion of symptoms was associated with a higher 
degree of subjective CS pain descriptors as assessed with the CSI questionnaire. The 
CSI was recently shown to be a useful and a valid instrument for screening people with 
central sensitivity syndromes.
59
 In addition, individuals with knee OA pain with 
preoperative high levels of comorbid centrally mediated symptoms measured by the CSI 
showed severe pain, increased analgesic requirements and were at higher risk of 
persistent pain after total knee arthroplasty in the early postoperative period.
60
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Previous studies have established associations between the scores obtained with pain 
drawings and central pain mechanisms, although in non-OA populations. For instance, a 
significant correlation between non-organic pain drawings and higher scores with the 
Waddell's non-organic physical signs was found in people with chronic low back pain.
61
 
Waddell’s signs include physical signs or symptoms that are inconsistent with 
pathology and are suggestive of the presence of symptom magnification or pain 
behavior.
62
 Nonorganic pain drawings were defined as those with poorly defined pain 
patterns, bizarre or non-anatomical pain areas.
61
 In addition, nonorganic pain drawings 
were associated with maladaptive psychosocial factors (i.e. high levels of 
catastrophizing, anxiety and depression) in people with chronic neck-shoulder and 
lower-back/lower limb pain
63
 and chronic low back pain.
64
 However, maladaptive 
psychosocial factors including magnified symptom behavior as assessed with the 
Waddell's scale provide no direct evidence for CS. In fact, psychosocial factors were not 
included as essential criteria for classification of CS pain as they are also prevalent in 
nociceptive and neuropathic pain.
14
 
 
Based on results of the PD-Q, 13.2% of our sample had scores that correspond to likely 
neuropathic pain (≥19). These results are comparable to those reported by Valdes and 
colleagues
65
, where 14.8% of people with knee OA pain had likely neuropathic pain, 
and superior to the percentage obtained by Ohtori et al.
66
 (e.g. 5.4%). Some studies have 
inferred CS based on neuropathic-like descriptors of symptoms.
67,68
 Contrary to what 
may have been expected, we did not find an association between the presence of a more 
expanded distribution of pain and self-reported neuropathic pain scores. This lack of 
association may be either due to the small number of participants with likely 
neuropathic pain or to the fact that we used the PD-Q and not the modified version of 
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this questionnaire (mPD-Q) recently recommended for the OA pain population.
67
 Like 
the original PD-Q, the mPD-Q is comprised of nine items but with some modifications 
adapted to people with OA, such as framing of questions to ask about symptoms ‘in or 
around’ the worst knee, over a specific time frame. Also, the presence of more extended 
areas of pain in people with knee OA may reflect non-neuropathic CS rather than 
neuropathic pain, making the lack of association between the scores obtained from the 
pain drawings and the PD-Q plausible.  
 
No significant associations were observed between the area of pain and TS or the area 
of pain and CPM. Pain associated with knee OA is recognized as a complex 
phenomenon encompassing several mechanisms such as CS.
69,70
 The quantification of 
CS is in turn multidimensional by including several objective QST techniques such as 
pain and tolerance thresholds, spatial summation, TS or CPM.
9,10,12
 These QST 
techniques assess the same underlying biological concept (CS), but in its different 
manifestations related to the different aspects of sensitization. This could justify why 
the areas of pain as assessed with pain drawings were correlated with some (PPT) but 
no other pain biomarkers of CS such as TS and CPM. 
 
Area of pain and clinical symptoms  
A significant positive correlation between knee pain severity and stiffness and the area 
of pain reported by subjects was observed. Although the area of pain, pain intensity and 
stiffness are variables assessing different constructs, it could be expected that people 
with knee OA with more diffuse or more extended areas of pain would report higher 
pain intensity and stiffness scores. As seen in the pain frequency maps, the most 
common pattern of pain reported by our sample was anterior knee pain, in particular 
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medial knee and peripatellar pain, which is in accordance with previous 
research.
19,20,25,26
 Interestingly, besides local knee symptoms, many participants also 
perceived enlarged and distant pain areas as can be seen in Figure 1B. This expansion of 
pain to larger areas may reflect the presence of CS in these individuals.
12
 Although 
using an experimental pain design, Bajaj and colleagues also showed significantly 
larger referred pain areas after intramuscular hypertonic saline infusion in subjects with 
knee OA, when compared with controls.
71
 Referred pain is a phenomenon attributed to 
CS.
12,15
 In addition, enlarged areas of pain were observed in individuals with knee OA 
pain, in particular in those with more persistent and severe symptoms.
19
  
In our study, enlarged areas of pain were especially noticeable in women. This finding 
is consistent with previous research where the most sensitized-groups of subjects with 
knee OA pain contained more women than men.
72,73
 In addition, a recent study
74
 
looking at the moderator effect of sex in centrally-mediated changes in people with 
knee OA pain, found a greater number of pain sites reported by women relative to men 
(p=.001).  
 
Psychosocial variables were unrelated to the area of pain in our study. This lack of 
correlation is in accordance with previous research done in non-OA pain populations, 
where no correlation between the area of pain and the individual psychological state 
was demonstrated.
75
 Indeed, a systematic review on pain drawings did not support the 
assumption that unusual or extensive pain drawings indicate disturbed psychological 
state.
24
  
 
In this study, there are some methodological issues that should be considered. We didn’t 
collect information on the reliability or stability of pain location over time in our 
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sample. Reliability was assumed based on previous studies using this method for pain 
drawings analysis in other chronic pain populations (e.g. chronic low back and neck 
pain).
33
 Expanded distribution of pain (e.g. referred pain) may be more commonly 
observed in those populations as compared to individuals with knee OA pain, although 
no comparative data exist in that regard. Our assumption may thus have influenced the 
results of this study. Future research is therefore warranted to evaluate the clinimetric 
properties of pain drawings in people with knee OA pain.  
 
In addition, as positive and negative predictive values of pain drawings were not 
calculated and the study design was cross-sectional, firm conclusions about the 
predictive role of pain drawings on knee OA pain cannot be drawn. Future studies could 
for instance explore the possible association between the scores obtained with pain 
drawings and outcome measures after treatment (i.e. surgery), to determine the real 
clinical utility of pain drawings for people with knee OA pain. In this regard, Skou and 
colleagues found that subjects with pain after re-total knee arthroplasty demonstrated 
significantly more pain sites using a region-divided body chart when compared to 
participants without pain.
22 
 
 
Screening for the presence of concurrent comorbidities (e.g. hip joint or lumbar spine 
pathology, fibromyalgia) was not performed in this study. However, these comorbid 
conditions could have influenced the patterns of pain described by participants. For 
instance, referred pain from the lumbar spine may have contributed to the posterior 
areas of symptoms especially noted in female.  
Despite the associations between direct and indirect measures of CS and the area of 
pain, it must be noted that most associations were not statistically significant. Only two  
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(i.e. PPT and CSI) of the six measures of CS were significantly associated with an 
expanded distribution of pain. In addition, even though positive associations were 
observed, the strength of those associations was low as reflected by the small amount of 
the variance of CS (i.e. 9%) explained by the areas of pain.  
 
Examining TS directly before measurement of CPM is a challenge, as the TS 
measurement could potentially have an effect on the results of CPM testing. However, 
we performed the measurement of CPM five minutes after the TS procedure following 
the protocol described by others.
37
 TS is short-lasting; the effects last for no more than a 
couple of  seconds-to-minutes after stimulus application.
3
 Therefore, a 5 minute wash-
out period in between procedures was deemed appropriate to preclude a carry-over 
effect. 
 
In conclusion, this study has shown that the area of pain reported by individuals with 
knee OA pain is associated with some measures of CS. Given the significant role CS 
plays in a subgroup of people with knee OA pain and that CS can mediate treatment 
responses (i.e. after surgery
76,77
), classification of people with knee OA pain in terms of 
pain mechanisms is a research priority.
6,23,78
 However, since costly and unattainable 
laboratory equipment is usually necessary for diagnosis, identification of CS is 
clinically challenging. In this regard, pain drawings may constitute an easy and cheap 
way for the early identification of CS in people with knee OA pain. Clinicians should be 
attentive for individuals showing extended areas of pain as this may be an indicator of 
CS. However, further evaluation of the reliability and validity of pain area reported on 
pain drawings in this population is required before its use can be advocated in clinical 
practice. 
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CHAPTER 4 
Is a combined intervention of manual therapy addressing the 
knee and pain neuroscience education targeted to the central 
nervous system effective for people with knee osteoarthritis? 
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ABSTRACT 
Traditional understanding of osteoarthritis-related pain has recently been  challenged in 
light of evidence supporting a key role of central sensitization in a subgroup of this 
population. This fact may erroneously lead musculoskeletal therapists to conclude that 
hands-on interventions have no place in OA management, and that hands-off 
interventions must be applied exclusively. The aim of this paper is to encourage 
clinicians in finding an equilibrium between hands-on and hands-off interventions in 
patients with osteoarthritis-related pain dominated by central sensitization. The 
theoretical rationale for simultaneous application of manual therapy and pain 
neuroscience education is presented. Practical problems when combining these 
interventions are also addressed. Future studies should explore the combined effects of 
these treatment strategies to examine whether they increase therapeutic outcomes 
against current approaches for chronic osteoarthritis-related pain. 
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INTRODUCTION 
Osteoarthritis (OA) is the main cause of pain, disability and loss of quality of life in the 
elderly (Ma et al., 2014). Traditional management for OA mainly involves a 
combination of pharmacological and non-pharmacological interventions, such as 
physical therapy (Hochberg et al., 2012). As a consequence of their training and 
education, the majority of musculoskeletal therapists are educated in the biomedical 
model of pain (Nijs et al., 2013). This traditional model of pain assumes that there is a 
direct link between the amount of local tissue damage (i.e. structural joint degeneration) 
and the pain experienced by the patient (Haldeman, 1990).  
 
According to this biomedical model, addressing the underlying pathology should result 
in a reduction or (complete) resolution of symptoms and subsequent recovery of normal 
function. However, chronic OA-related pain does not always adhere to this biomedical 
model of pain. It is common to observe a discordance between the degree of structural 
joint damage and the amount of symptoms experienced by the patient (Bedson and 
Croft, 2008; Baert et al., 2013, 2014). In addition, local application of different 
modalities of treatment, including prosthetic substitution, is not always followed by an 
amelioration or complete resolution of symptoms (Skou et al., 2013a, 2013b).  
 
Recent evidence has established that central sensitization (CS) is the dominant pain 
mechanism in a subgroup of patients with chronic OA-related pain (Lluch et al., 2014). 
Recognition of subsets of OA patients with different pain mechanisms, including those 
with CS, has been suggested in order to tailor applied interventions and thus improve 
outcomes (Malfait and Schnitzer, 2013). Hence, in those OA patients with CS as their 
dominant pain mechanism, a broader therapeutic approach aiming to desensitize the 
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central nervous system (CNS) should be adapted (Nijs et al., 2011a; Lluch Girbés et al., 
2013).  
 
The question arises which CNS “desensitizing” strategies are available and how they 
can be applied when treating patients with chronic OA-related pain. These issues will be 
further discussed below and practical guidelines provided. 
 
Targeting the brain without ignoring the joints for treating central sensitization pain 
in patients with osteoarthritis 
In light of evidence regarding the role CS plays in a subgroup of patients with chronic 
OA-related pain (Lluch et al., 2014), musculoskeletal therapists might “swing the 
pendulum” too much away from the biomedical model of pain (Jull and Moore, 2012). 
Likewise, as psychosocial factors are of importance in OA (Somers et al., 2009), 
chronic OA-related pain might be envisioned as a merely psychosocial issue. One 
would then erroneously assume that management advocated for this subgroup of OA 
patients with CS as their dominant pain mechanism should radically be turned into 
psychosocial aspects and “hands-off” interventions, with little or no regard to biological 
features. However, CS in OA seems to be driven by ongoing peripheral joint pathology 
(Graven-Nielsen et al., 2012), which stresses the importance of reducing peripheral 
nociceptive input by means of locally applied interventions such as manual therapy 
(Moss et al., 2007; Courtney et al., 2010) or surgery (Aranda-Villalobos et al., 2013). 
Therefore, the authors propose not to completely abandon the “hands-on” approach for 
patients with chronic OA-related pain and CS, but to find an equilibrium between 
hands-on treatments and other interventions addressing CS (Jull and Moore, 2012). 
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Musculoskeletal therapists are probably in the best position to deliver such an 
individualized and combined approach to patients with chronic OA-related pain 
(Bennell et al., 2012; Hunt et al., 2013), because they are cognizant of both locally-
applied physical and non-physical centrally-oriented interventions (Louw et al., 2011; 
Nijs et al., 2011b).  
 
In order to inform clinicians about new avenues on combining different treatment 
strategies for chronic OA-related pain management, an example of the theoretical 
rationale for simultaneous application of an approach aiming to desensitize the CNS 
[here represented by pain neuroscience education (PNE) (Louw et al., 2011; Nijs et al., 
2011b)] and a local intervention (here represented by manual therapy), will be 
presented.  
 
Combining pain neuroscience education with manual therapy in patients with chronic 
OA pain and CS as their dominant pain mechanism 
Patient education is recommended by most of the current evidence-based guidelines for 
management of OA (Larmer et al., 2014). However, education by healthcare 
professionals is usually focused on biomedical information. This kind of education not 
only has shown limited efficacy in decreasing pain and disability (McDonald et al., 
2004; Louw et al., 2013), but also can induce fear, reinforce the patient’s belief on a 
patho-anatomical source of pain and consequently result in more pain (Greene et al., 
2005).  
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A more advantageous way to educate patients with chronic OA-related pain might be 
PNE (Louw et al., 2011; Nijs et al., 2001b). PNE is a cognitive-based educational 
intervention performed by musculoskeletal therapists that aims to desensitize the CNS 
and consequently reduce pain and disability, through a reconceptualization of pain 
(Louw et al., 2011). PNE is therapeutic on its own, with level A evidence (evidence 
from meta-analysis of randomized controlled trials) supporting its use for changing pain 
beliefs and improving health status in patients with CS pain (Louw et al., 2011). 
Evidence supporting the capacity of PNE to desensitize the CNS comes from a recent 
trial in patients with fibromyalgia (Van Oosterwijck et al., 2013). 
 
Though sometimes provided separately, PNE seems to be more effective when 
administered in conjunction with other physical therapy interventions (Louw et al., 
2011). Likewise, manual therapy is more beneficial for patients with OA if not used as a 
stand-alone treatment (Page et al., 2011). However, clinicians may encounter several 
practical problems when trying to combine PNE and manual therapy in the context of a 
patient with chronic OA-related pain.  
 
The problem of the “conflicting” messages or “contradictory” messages 
Manual therapy is often presented to a patient with chronic OA-related pain within a 
biomedical model of pain. Traditionally, the main objective of manual therapy has been 
to find the structure at fault, reproduce the patient’s pain if possible and fix that pain 
thorough joint mobilization/manipulation techniques (Bialosky et al., 2008). However, 
this “find it and fix it” model could perpetuate the notion of the joint as a single fault for 
Chapter 4  
 
 
Enrique Lluch Girbés 
211 
OA-related pain, fueling the biomedical beliefs (Nijs et al., 2013) and contradicting 
(when applied together) the PNE message that de-emphasizes a specific tissue as the 
solely cause of pain. To make the message provided during the combined application of 
manual therapy and PNE more consistent, musculoskeletal therapists may want to 
consider the following recommendations.  
 
Instead of “fixing a structure”, OA patients should be educated about manual therapy 
according to the current understanding of its mechanisms of action (Bialosky et al., 
2009). Besides peripheral effects (i.e. increase in range of motion), joint mobilization 
has shown to generate (temporal) activation of descending inhibitory pain mechanisms 
(Schmid et al., 2008). Hence, manual therapy should be presented to OA patients as a 
transient technique used to gain movement and activate endogenous analgesia found to 
be dysfunctional in chronic OA-related pain (Kosek and Ordeberg, 2000). Manual 
therapy might be a priori capable of restoring one of the mechanisms related to CS in 
chronic OA pain, namely the impaired descending inhibition, although this hypothesis 
has not been formally tested.  
 
Still, it is important for OA patients to understand that the central analgesic effects of 
manual therapy are short-lived. CS is a complex mechanism unlikely to be resolved by a 
single modality of treatment (Nijs et al., 2011a), so other “desensitizing” techniques 
such as exercise therapy may be required (Uthman et al., 2013) or PNE. That’s why the 
combination of manual therapy and PNE, which potentially targets CS through 
modulation of enhanced descending facilitatory mechanisms [i.e. inappropriate beliefs 
(Zusman, 2002)], could be worthwhile.   
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Moreover, several types of manual therapy interventions applied for chronic OA 
patients rely on pain relief as a guide for application and treatment outcome (Takasaki et 
al., 2013). Repetitive use of the word “pain” during the manual treatment may again 
come into conflict with the PNE message, where achieving functional gains is 
advocated over resolution of symptoms. A solution to this conflict may be to replace the 
use of threatening words such as “pain” during the application of manual therapy 
techniques by other less frightening terms such as “symptoms” or “loss of function”. 
This might improve the uniformity of the message provided and avoid confusion in 
patients. It is therefore crucial not to increase vigilance by a priori asking the patient to 
report any pain experienced (or aggravated) during the hands-on treatment. Relying on 
the joint end-feel or the baseline outcome of the joint examination (e.g. joint mobility 
tests) for guiding the hands-on treatment is preferred for patients with CS as a dominant 
pain mechanism.  
 
The problem of the order of interventions: should manual therapy precede PNE or vice 
versa? 
The question that may arise in the musculoskeletal therapists’ clinical reasoning when 
combining both interventions (i.e. manual therapy and PNE) is: What should I apply 
first? From the previous section on conflicting messages, maybe keen readers 
familiarized with both interventions have already deduced that PNE should be logically 
applied before manual therapy. Both explanation of the impaired descending pain 
inhibition and enhanced facilitatory mechanisms potentially addressed with this 
combined approach (with manual therapy and PNE, respectively), are part of the typical 
PNE message (Louw et al., 2011). Therefore, it would seem logical to first explain to 
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chronic OA patients that their pain system has become sensitized before presenting 
them desensitizing techniques, such as manual therapy, as potentially helpful.  
 
In addition, there are other reasons why the message from PNE should be introduced 
first. Unlike education focused on the biomedical model (Eschalier et al., 2013), PNE is 
beneficial in changing patients' cognition regarding their pain state resulting in 
decreased fear and, consequently, promoting better adherence to subsequent movement-
based approaches such as manual therapy (Louw et al., 2011). In line with this, the 
seemingly most logical choice when dealing with patients affected by chronic OA-
related pain would be to implement manual therapy after having educated the patient 
about modern pain neuroscience. Moreover, the occasional reproduction of symptoms 
when applying joint mobilizations (and the consequent “danger messages” arriving to 
the brain), would be interpreted differently by the patient if PNE was applied first. As 
one of the key messages of PNE is that in a chronic pain situation (like chronic OA-
related pain) pain is not a true reflection of what’s happening at the tissues, but is more 
related to hyperexcitability of the CNS and deconditioning of the tissues (Louw et al., 
2011), the threatening value of pain is decreased.  
 
The problem of cognitive and educational barriers when applying PNE to elderly 
people affected by chronic OA-related pain   
One of the factors associated with reporting more symptoms and responding less to 
treatment in people with chronic OA-related pain is the socioeconomic status, including 
low educational attainment (Callahan et al., 2010). In that sense, musculoskeletal 
therapists can encounter some problems when conveying the key messages of PNE to 
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elderly patients, mostly due to cognitive and/or educational barriers. In addition, as on 
average clinicians underestimate the ability of patients to understand the PNE message 
(Moseley, 2003), this may be more evident when dealing with elderly people affected 
by OA. Some elderly people with OA have blind faith in (bio)medical information, 
which often makes it more difficult to reconceptualize pain through PNE. This should 
be taken into consideration and clinicians are encouraged to adapt the information 
provided during the PNE to these patients, in order to make it more easily understood.  
 
An example of a musculoskeletal therapist discussing the patient’s perceptions about 
OA pain as part of a PNE session and the rationale of the combination of PNE with 
manual therapy can be found online at http://www.paininmotion.be/EN/sem-tools.html 
(Table 1). 
Table 1.  Example of the communication between a musculoskeletal therapist applying 
PNE with an elderly patient with chronic knee OA-related pain and CS as the main 
dominant pain mechanism. Note how the musculoskeletal therapist challenges the 
patient’s biomedical beliefs and presents the patient with a rationale for a combined 
application of manual therapy with PNE. 
 
- Therapist (T): ‘So, I would like to start this session asking you about the cause 
of the pain at your knee. Why do you think your knee is painful?’  
- Patient (P): ‘I think my knee pain is provoked by the cartilage degeneration in 
my knee. My surgeon explained it to me in that way. I was able to see it myself 
when he showed me the X-ray: there was no space between the two bones of my 
knee! Sorry, I can’t remember the names of the bones, but what I could see is 
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that they are rubbing together. That’s the reason of my pain.’ 
- T: ‘I totally understand you; it’s a logical way of thinking. But let me ask you 
one question. If your way of thinking was totally true, how would you then 
explain the fact that there are people with a lot of degeneration in their knees, a 
lot of friction, but without feeling any pain?’ 
- P: ‘I don’t know… does that actually happen? Gosh, maybe not everybody feels 
pain in the same way? I remember that I heard or read something like that. 
There are persons with more or less tendency to feel pain, no?’ 
- T: ‘That could be one of the reasons, yes. Each person experiences pain 
differently. But let me continue. If you were on the right way of thinking about 
your pain, then surgery, such as a total knee replacement, would be like a magic 
bullet for knee osteoarthritis. It should completely eliminate the knee pain. 
However, how would you then explain that some people continue experiencing 
pain even after surgery if it’s supposed that the source of pain has been 
eliminated?’ 
- P: ‘Perhaps because the surgery is not well-performed or there is some kind of 
complication? A good friend of mine had to be operated three times for the same 
knee due to loosening of the prosthesis and later because of an infection. And 
even now he is still very much in pain! I cannot understand…’  
- T: ‘A failed surgery or complications post-surgery could explain that persistent 
pain, absolutely. But there are people who underwent surgery without 
complication and even so still have pain. So, there must be other factors 
explaining the pain, don’t you agree?’ 
- P: ‘Yes, I suppose… but I don’t totally understand what you are trying to say. 
Do you mean that the surgeon’s opinion is not right, that my knee pain is not 
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due to cartilage loss?’ 
- T: ‘What I’m trying to say is that cartilage degeneration is in part responsible 
for your pain, but not the sole reason. That’s why we often find discordances 
between the degree of cartilage degeneration and the intensity of pain 
experienced, or why some people still feel pain even after surgery.’ 
- P: ‘Ok, but then… where is my pain coming from if it is not coming from my 
knee? I’m now becoming a little bit confused.’  
- T: ‘That’s what we are going to explain to you in this session. What we actually 
know is that in a chronic pain situation like yours your nervous system, which 
works like an alarm system of your body, is not working in the normal way. 
Specifically, nerves transmitting the message of damage from your knee to 
higher regions of your body, like the brain, have become too sensitive or 
overactive. These nerves have been working for a long time, day after day, 
sending up danger messages of what was happening at your knee. Now, after so 
much time working in this way, your nerves have turned into a sensitized state. It 
is as if the volume button of your nervous system is turned up’ 
- P: ‘And what can I or you do to get me better now? It doesn’t sound very good. 
You said sensi… what? Is there any cure for that?’   
- T: ‘Sensitization of your nerves. What we are going to do with treatment is to try 
to calm down this excess of sensitivity of your nervous system. To do that we will 
combine some educational sessions to explain in more detail the chronic pain 
you feel at your knee with a series of mobilizations applied to your knee. We 
currently know that both interventions are capable of decreasing the sensitivity 
of an overactive nervous system like yours so we will use them in combination. 
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Are you happy with that?’  
- P:  ‘Yes. Let’s try and see’.   
 
 
 
CONCLUSION  
The aim of this paper is to present a sound scientific rationale and practical guidelines 
for the application of a combined manual therapy and PNE approach in patients with 
chronic OA-related pain and CS as their dominant pain mechanism. Musculoskeletal 
therapists may find some practical problems when combining these two interventions in 
a clinical setting. Future studies should test these promising avenues for the treatment of 
chronic OA-related pain against current approaches, in order to determine if they can 
increase therapeutic outcomes.  
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ABSTRACT 
Objectives: To compare the effects of a pre-operative treatment combining pain 
neuroscience education (PNE) with knee joint mobilization versus biomedical education 
with knee joint mobilization on central sensitization (CS) in subjects with knee 
osteoarthritis (KOA). Secondarily, to investigate the effects of both interventions on 
knee pain, disability and psychosocial variables. 
Methods: Forty-four subjects with KOA were allocated to receive four sessions of 
either PNE combined with knee joint mobilization or biomedical education with knee 
joint mobilization before surgery. All participants completed self-administered 
questionnaires and performed quantitative sensory testing at baseline, after treatment 
and at one month follow-up (all before surgery) and at three months after surgery. 
Results: Significant and clinically relevant differences over time were found after both 
treatments for knee pain and disability and some measures of CS (i.e. widespread 
hyperalgesia, central sensitization inventory), with no significant between-group 
differences. Other indicators of CS (i.e. conditioned pain modulation, temporal 
summation) did not change over time in either treatment or even the observed changes 
were not in the expected direction. Subjects receiving PNE with knee joint mobilization 
achieved greater improvements in psychosocial variables (pain catastrophizing, 
kinesiophobia) at short and long follow-ups.  
Discussion: Pre-operative PNE combined with knee joint mobilization did not produce 
any additional benefits over time in knee pain and disability and CS measures compared 
with biomedical education with knee joint mobilization. Superior effects in the PNE 
with knee joint mobilization group were only observed for psychosocial variables 
related to pain catastrophizing and kinesiophobia. 
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INTRODUCTION 
The pain experience in knee osteoarthritis (KOA) is a multifactorial phenomenon 
comprising knee structural changes ocurring together with psychosocial and pain 
neurophysiology factors1. Regarding the latter, there is compelling evidence that central 
sensitization (CS) is a prominent phenomenon in a subgroup of people with KOA
2
. 
Despite the increased emphasis on the importance of CS in KOA
3
, current KOA 
treatments don’t usually specifically address altered nociceptive processing 
mechanisms4. Indeed most evidence-based recommendations for KOA management5,6 
don’t consider pain mechanisms and its possible modulation by treatment.  
 
Some studies have investigated the effects of treatments used for KOA on central pain 
modulation using outcome measures related to CS [e.g., the flexor withdrawal reflex7 
and conditioned pain modulation (CPM)8]. In those studies, CS was down-modulated 
after knee joint mobilization7-9, exercise10, TENS11, surgery12 or a combination of 
interventions13. Combined treatments consisting of locally-applied and centrally-
oriented interventions have been proposed for KOA14,15, aiming for synergistic effects 
and consequently an improvement of outcomes.  
 
Within this view of combined treatments, the rationale for applying pain neuroscience 
education (PNE) together with knee joint mobilization was recently presented14, but 
requires experimental testing. On one hand, knee joint mobilization may produce 
beneficial effects on pain and function in KOA16,17 as well as modulating effects on CS7-
9. On the other hand, PNE is a useful intervention for chronic pain populations 
characterized by CS, especially when administered with other physical therapy 
interventions18. Enhancement of CPM was shown following PNE19 and, when applied 
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before surgery, PNE produced favorable post-surgical outcomes in people with lumbar 
radiculopathy
20. As the pre-surgical presence of CS in KOA contributes to poor 
outcomes after total knee replacement21, preoperative PNE combined with other 
interventions
18
 might be beneficial.  
 
The primary aim of this study was to compare the effects of a pre-operative treatment 
combining PNE with knee joint mobilization versus biomedical education with knee 
joint mobilization on measures of CS in people with KOA. Secondarily, the effects of 
both interventions on knee pain, disability and psychosocial variables were investigated. 
We hypothesized that PNE with knee joint mobilization would result in significantly 
greater improvements in CS and psychosocial measures. 
 
MATERIALS AND METHODS 
Study design 
A two-arm, parallel group, assessor blinded, randomized controlled trial conforming to 
CONSORT guidelines
22
 was performed between January 2014 and February 2015, at 
the Hospital Universitario La Ribera (Alzira, Spain). The study was approved by the 
Human Research Ethics Committee of the Hospital Universitario La Ribera and 
conducted in accordance with the Declaration of Helsinki. The study was registered at 
ClinicalTrials.gov (Trial Registration NCT02246088). 
 
Participants 
People with KOA pain of more than 3 months duration and scheduled to undergo total 
knee replacement were enrolled. They were recruited from the Orthopedic Surgery 
Service of the Hospital Universitario La Ribera, Spain.  
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Individuals were included if they had symptomatic KOA according to the American 
College of Rheumatology classification criteria
23
. All participants underwent weight 
bearing, fixed flexion posteroanterior and lateral X-rays of their affected knee. 
Radiographic disease severity of the tibiofemoral (Kellgren–Lawrence 0–4 grading 
scale
24
) and patellofemoral (Ahlbäck 0-5 grading scale
25
) compartments were evaluated 
for each participant. 
 
Subjects were excluded if they had previous total knee replacement or any other lower 
limb surgery within the past six months of the affected knee, co-existing inflammatory, 
metabolic or neurological disease, cognitive impairment, illiteracy, or were unable to 
speak or write Spanish.Subjects were informed about the procedures and gave written 
informed consent prior to participation. 
 
Procedure 
Demographic information was first collected by self-report. Participants additionally 
completed an 11-point numeric rating scale to quantify their current pain intensity 
overall during the last week. 
 
They then completed the following self-administrated questionnaires: the Western 
Ontario and McMaster Universities Arthritis Index (WOMAC), Central Sensitization 
Inventory (CSI), Pain Catastrophizing Scale (PCS) and 11-item version of the Tampa 
Scale for Kinesiophobia (TSK-11). Finally, all participants were assessed by 
quantitative sensory testing to examine pressure pain thresholds (PPTs), temporal 
summation and CPM in one individual session. Participants were requested not to take 
analgesic medication 24h before the assessment.  
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A physical therapist, specifically trained in all aspects of assessments, was responsible 
for all the measurements. This assessor was blinded to questionnaire data and treatment 
allocation.  
 
Outcome Measurements 
The primary outcome measure was CPM which is a recognized objective biomarker of 
CS
3
.
 
Secondary outcomes were PPTs, temporal summation and results from the 
questionnaires. Every outcome was measured at baseline (2 months before surgery), 
immediately after four treatment sessions (1 month before surgery), at one month 
follow-up (just before surgery) and three months after surgery.  
 
Assessment of CS 
Pressure pain thresholds  
A standardized protocol for evaluating PPTs was used
26
. Two test sites in the 
peripatellar region (3 cm medial and lateral to the midpoint of the medial and lateral 
edge of patella, respectively) and one distant site on the ipsilateral extensor carpi 
radialis longus (5 cm distal to lateral epicondyle) were selected for measurement
27
. The 
PPT was measured using an analogue Fisher algometer (Force Dial model FDK 40) 
with a surface area of 1cm
2
. The algometer probe tip was applied perpendicular to the 
skin at a rate of 1kg/cm
2
/s until the first onset of pain.  Three measures were performed 
on each site with a 30 s interstimulus interval between each measurement and the mean 
was taken for analysis. For PPTs, a 1.62-1.53 kg/cm
2
 is the minimum detectable change 
required to be clinically meaningful in subjects with KOA
28
. 
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Temporal summation and Conditioned pain modulation  
The protocol described by Cathcart and colleagues was used for measuring temporal 
summation and CPM
29
, which are established ways of measuring excitability of 
nociceptive pathways and descending pain inhibition, respectively
30,31
. 
 
First, PPTs were measured at the local and distal sites as described above. Second, 
temporal summation was provoked by means of 10 consecutive pulses at the previously 
determined PPT at each location. For each pulse, pressure was gradually increased at a 
rate of 2 kg/s to the determined PPT and maintained for 1 s before being released (1 s 
interstimulus interval). Pain intensity of the 1st, 5th, and 10th pulse was rated on a 
numerical rating scale (0: no pain to 10: worst possible pain). Afterwards, a rest period 
of 5 min was given.  
 
Third, CPM was induced by combining the temporal summation procedure (test 
stimulus) and an inflated occlusion cuff around the subject’s arm, contralateral to the 
side of the affected knee, to a painful intensity (conditioning stimulus). The occlusion 
cuff was inflated at a rate of 20 mm Hg/s until ‘the first sensation of pain’ and 
maintained for 30 s. Following, pain intensity, as a result of cuff inflation, was rated on 
a numerical rating scale. Next, cuff inflation was increased or decreased until the pain 
intensity was rated as 3/10. Temporal summation assessment was then repeated during 
maintenance of the cuff inflation
29
. 
 
The details and data supporting the test-retest reliability and validity of the protocol for 
examining temporal summation and CPM are described elsewhere
29
. 
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Central Sensitization Inventory (CSI) 
The CSI is a self-report screening instrument that helps to identify key symptoms 
associated with CS
32
. Part A of the CSI assesses increased responsiveness to a variety of 
stimuli and is comprised of 25 items each ranged on a 5-point scale with the end points 
“never” (0) and “always” (4) (range: 0-100). It has high reliability and validity32. A 
cutoff score of 40 distinguished between individuals with central sensitivity syndromes 
and a non-patient comparison sample (sensitivity = 81%, specificity = 75%)
33
. The 
following CSI severity levels have been established for interpreting CSI scores: 
subclinical = 0 to 29; mild = 30 to 39; moderate = 40 to 49; severe = 50 to 59; and 
extreme = 60 to 100
34
. The Spanish version of the CSI was used in this study. 
 
Knee pain and disability  
The total WOMAC score (range 0-96) was considered with higher scores indicating 
worse knee pain and disability. Test-retest reliability, internal consistency, convergent 
validity and responsiveness of the Spanish version of the WOMAC has been 
demonstrated in people with KOA
35
. A 7.9-point change is required for the result of 
WOMAC to be clinically meaningful
36
. 
 
Psychosocial variables 
Pain catastrophizing  
The Pain Catastrophizing Scale (PCS), which is a valid and reliable instrument to 
measure pain catastrophizing, was used
37
. It consists of 13 items each ranged on a 5-
point scale with the end points (0) “not at all” and (4) “all the time” (range: 0-52). 
Higher scores indicate higher pain catastrophizing. The Spanish version of the PCS 
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showed appropriate internal consistency, test-retest reliability and sensitivity to 
change
38
. 
 
Kinesiophobia 
The Spanish version of the TSK-11 was used to measure fear of movement
39
. It is 
comprised of 11 items each ranged on a 4-point scale with the end points (1) “totally 
agree” and (4) “totally disagree” (range: 11-44). The TSK-11 has demonstrated 
acceptable internal consistency and validity (convergent and predictive)
39
. Higher scores 
indicate more fear-avoidance behavior. The minimal detectable change score for the 
TSK-11 is 5.6
40
. 
 
 Interventions 
An equal number of participants were randomly allocated by the computer program 
EPIDAT version 3.1, to receive either PNE plus knee joint mobilization (experimental 
treatment) or biomedical education plus knee joint mobilization (control treatment). The 
researcher administering the randomization schedule was different from those who 
recruited the participants. 
 
In both groups, the educational part of the intervention preceded knee mobilization
14
 
and participants were blinded to the type of education they received. Both programmes 
involved a total of four treatment sessions (one session per week), starting two months 
prior to surgery and finishing one month prior to surgery in all participants. All 
interventions were applied by a physiotherapist experienced in providing educational 
and knee joint mobilization procedures. This therapist was blinded to the results of the 
measurements and questionnaires which were used as outcome measures. 
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All participants were instructed to continue to take any current medications but not to 
start new medications or initiate new treatments during the treatment period. 
 
PNE with knee joint mobilization  
PNE and knee joint mobilization were applied following previous published 
guidelines14. The therapist avoided conflicting or contradictory messages between these 
two interventions, for instance, not using pain relief as the guide and threatening words 
such as “pain” during knee joint mobilization14. In addition, key messages of PNE were 
adapted to elderly patients in order to make it more easily understood
14
. 
 
PNE was provided in accordance with published guidelines
41
. Educational information 
was presented verbally and visually with the aid of a computer. The content and pictures 
of the sessions were based on the book Explicando el dolor
42 
and a booklet designed for 
patients having knee replacement surgery
43
.  
 
Four sessions on pain neurophysiology were delivered. The first session was a longer 
session lasting 50 to 60 minutes whereas the second, third and fourth follow-up sessions 
lasted 20-30 minutes. After the first session, participants were asked to read Explicando 
el dolor
42
 at home.
 
During the second, third and fourth sessions the therapist answered 
questions that had arisen after the first session and reading the book, tailoring these 
sessions and emphasizing the topics needed additional explanation. 
 
Knee joint mobilization was applied using Mulligan's mobilization with movement 
following the protocol from Takasaki et al
16
. Mobilization with movement during active 
knee flexion and/or extension, depending on which was the limited/painful movements 
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for each patient, was applied progressing from non-weight-bearing to weight-bearing 
positions
16
. 
 
All the mobilizations were performed for three sets of 10 repetitions and 
patients were asked to perform self-applied mobilizations at home involving four series 
of 20 movement repetitions per day
16
. Home treatment adherence was recorded by 
means of a timetable.  
 
Biomedical education with knee joint mobilization 
Individuals assigned to this group received information regarding anatomy and 
biomechanics of the knee, and etiology, symptoms, recommended treatments and 
surgical procedure of KOA. That information was provided through visualization of 
several videos which were presented on a computer. No information about mechanisms 
underlying pain was included in order to establish a clear difference with information 
provided from the PNE. The total duration of education was the same as PNE. After the 
education, these participants received the same mobilization protocol as the other group, 
except that all the mobilization techniques were pain-guided. 
 
Statistical analysis 
Sample size 
The required sample size was calculated using G*Power 3.0.18 Software based on CPM 
as the primary outcome measure. The effect size for the CPM was considered at 0.25. 
The correlation between repeated measurements assumed was assumed in 0.5. 
Considering four measures in two treatment groups, the sphericity correction was 
determined at 0.5. We estimated a sample size of 44 participants with a statistical power 
of 0.95 and an alpha level of 0.05. Considering a possible loss to follow-up of up to 
20%, a total of 53 patients with KOA were recruited.  
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Analysis 
Descriptive statistics were used to describe the baseline characteristics of individuals in 
each group. Student’s t-test or Mann-Whitney U-test (for continuous variables) and chi-
square or Fisher exact tests (for categorical variables) were applied to determine if there 
were baseline differences between groups. 
 
Temporal summation was calculated as the difference in percentage between the 10
th
 
and the 1
st
 pain rating score before occlusion using the formula: ((Temporal 
summation10th temporal summation1st)/temporal summation1st)*100
44
. CPM was 
calculated as the difference between the 10th pain rating score before occlusion and the 
10th during occlusion
29
. 
 
In order to analyze the effectiveness of the two interventions, a per protocol analysis 
was performed. Analysis of variance (ANOVA) was performed for each of the patient-
related outcomes. Three-way ANOVA was used to evaluate differences in PPTs, CPM 
and temporal summation. The between subject factor was treatment (experimental 
treatment, control treatment), with time (baseline, immediately post treatment, 1 month 
post treatment, 3 months post-surgery) and location (lateral knee, medial knee, 
epicondyle) as within subject factors.  
 
Data from the self-administration questionnaires were each analyzed with a two-way 
ANOVA with treatment (experimental treatment, control treatment) as the between-
subject factor, and time (baseline, immediately post treatment, 1 month post treatment, 
3 months post-surgery) as the within subject factor. In each case, significant differences 
revealed by ANOVA were followed by post-hoc Student-Newman-Keuls (SNK) pair-
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wise comparisons. The effect size was calculated as the Partial Eta Squared (ƞ2p) when 
significant. An effect size of 0.01 was considered small, 0.06 medium and 0.14 large
45
. 
 
Statistical analyses were performed using SPSS 22 (SPSS INc, Chicago, IL, USA). The 
significance level was set at p < 0.05. 
 
RESULTS 
The participant flow and retention is depicted in Figure 1. A total of 44 participants 
were finally analyzed [experimental treatment (n=22); control treatment (n=22)]. All 
these participants completed the four treatment sessions including the home task 
performance of mobilizations with movement and reading of the book if allocated to 
PNE. 
Baseline characteristics of both groups are presented in Table 1. There were no 
significant differences in baseline variables between the groups (all p>0.05). 
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Figure 1. Participants flow and retention. 
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Table 1. Baseline characteristics of the patient groups. Values are presented as Mean ± 
SD. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Baseline demographic 
characteristics of OA patients 
Biomedical 
education with 
knee joint 
mobilization 
Pain 
neuroscience 
education with 
knee joint 
mobilization           
 
Age (years) 72.8 ± 5.6 67.7 ± 7.8 
 
Gender (% female) 68 59  
Height (cm) 160.9 ± 7.4 163.5 ± 7.6  
Weight (kg) 80.0 ± 10.3 79.1 ± 14.9  
Duration of Pain (years) 7.2 ± 5.2 8.3 ± 6.1  
Numeric Rating Pain Scale 
(0-10) 
 
Kellgren–Lawrence grade 
(tibiofemoral joint)  
n (%) 
5.4 ± 1.6        6.2 ± 1.5 
 
 
 
 
0 
1 
2 
3 
4 
0 (0) 
0 (0) 
6 (27.3) 
11 (50) 
5 (22.7) 
0 (0) 
0 (0) 
6 (27.3) 
10 (45.4) 
6 (27.3) 
 
Ahlbäck grade (patellofemoral 
joint) 
n (%) 
 
1 
2   
3 
4    
5                                                                                                              
 
 
 
 
          2 (9.1) 
         6 (27.3) 
        13 (59.1) 
          1 (4.5)  
           0 (0)  
 
 
 
 
        3 (13.6) 
        7 (31.8) 
       12 (54.6) 
           0 (0) 
           0 (0) 
 
    
 
 
  
 
    
    
    
5 0 (0) 0 (0)  
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Primary outcome: conditioned pain modulation 
CPM scores differed across locations (F=4.92, p=0.007, ƞ2p: 0.02) and were significantly 
lower at both the lateral knee (SNK: p<0.01) and epicondyle (SNK: p<0.05) compared 
to the medial knee. Regardless of the location, there was an interaction between 
treatment and time (F=4.66, p<0.01, ƞ2p: 0.02; Figure 2). However, the only significant 
change was observed for the experimental treatment between baseline CPM value and 
the value measured 3 months post-surgery (SNK: p<0.05) with lower values of CPM 
noted 3 months after surgery. No other changes were observed for the experimental 
treatment and no statistically significant changes were observed for the control 
treatment. 
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Figure 2. Mean ± SE of  conditioned pain modulation at baseline, immediately post-
treatment, 1 month post treatment and 3 months after surgery for individuals with knee 
osteoarthritis performing pain neuroscience education with knee joint mobilization 
versus subjects receiving biomedical education with knee joint mobilization 
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Figure 3. Mean ± SE of temporal summation of pain at baseline, immediately post-
treatment, 1 month post treatment and 3 months after surgery for individuals with knee 
osteoarthritis performing pain neuroscience education with knee joint mobilization 
versus subjects receiving biomedical education with knee joint mobilization. 
 
 
 
 
 
 
 
 
 
 
 
PPTs differed across locations (F=18.28, p<0.0001, ƞ2p: 0.06) with higher PPTs at the 
lateral knee compared to the medial knee (SNK: p<0.01) and epicondyle (SNK: 
p<0.0001) and higher values at the medial knee compared to the epicondyle (SNK: 
p<0.0001). PPTs did not differ between treatments but changed over time (F=11.28, 
p<0.0001, ƞ2p: 0.06). For both treatments there was a significant increase in PPTs at all 
locations immediately post treatment (percent change in PPTs averaged across all sites: 
experimental treatment: 40.6 ± 31.2%; control treatment: 27.3 ± 41.7%), at 1 month 
after treatment (experimental treatment: 49.6 ± 30.3%; control treatment: 24.4 ± 34.2%) 
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and at 3 months after surgery (experimental treatment: 53.4 ± 45.3%; control treatment: 
17.1 ± 30.5%) compared to baseline (SNK: all p<0.00001, Figure 4). However, there 
was no significant change for either treatment between the time points of immediately 
post treatment, at 1 month after treatment and at 3 months after surgery.  
 
Figure 4. Mean ± SE of the pressure pain thresholds at baseline, immediately post-
treatment, 1 month post treatment and 3 months after surgery for individuals with knee 
osteoarthritis performing pain neuroscience education with knee joint mobilization 
versus subjects receiving biomedical education with knee joint mobilization. 
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Secondary outcomes: symptoms of central sensitization, knee pain and disability 
Table 2 shows results from the questionnaire data at each measurement time.  The CSI 
score improved over time with both treatments (F=5.51, p<0.001, ƞ2p: 0.09), with no 
significant difference between treatments (F=0.80, p=0.49). For both treatments, the 
CSI score did not change from baseline to immediately post treatment or 1 month post 
treatment (all SNK: p>0.05). However it was significantly lower with both treatments 
when measured 3 months post-surgery compared to baseline, immediately post 
treatment, and 1 month after treatment (all SNK: p<0.05). The percent change at 3 
months compared to baseline was -37.3 ± 24.0% and -11.7 ± 80.1% for the 
experimental and control treatment, respectively.  
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Table 2. Scores obtained in the questionnaire data at each time point for the experimental treatment (pain neuroscience education plus knee joint 
mobilization) and control treatment (biomedical education plus knee joint mobilization). All values are expressed as Mean ± SD.  
 
 
 
 
 
 
 
 
 
 
VARIABLE TREATMENT Baseline Immediately post 
treatment 
1 month post treatment 3 months post surgery 
CSI 
(0-100) 
Experimental 
treatment 
N=22 
37.6±17.2 30.3±10.2 27.8±11.1 21.5±10.1 
Control treatment 
         N=22 
38.3±15.6 38.1±15.7 36.2±15.7 30.3±16.1 
WOMAC  
(0-96)  
Experimental 
treatment 
N=22 
52.4±14.6 41.4±13.7 38.1±11.6 21.1±10.9 
Control treatment 
         N=22 
52.1±18.4 50.1±18.5 46.0±18.0 32.6±20.6 
PCS 
(0-52) 
Experimental 
treatment 
N=22 
22.6±11.5 12.5±10.3 10.7±8.4 6±5.3 
 Control treatment 
         N=22 
25.9±13.6 24.5±13.6 25±13.6 22.7±13 
TSK-11 
(11-44) 
Experimental 
treatment 
N=22 
34.3±7 25.9±5.9 24±5.4 21.5±5.1 
Control treatment 
         N=22 
33.7±5.6 33.6±6.7 33.6±6.6 30.8±6 
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The WOMAC total score decreased over time (F=19.46, p<0.0001, ƞ2p: 0.26) for both 
treatments but was not dependent on the interaction between treatment and time 
(F=1.07, p=0.35). For both treatments, the WOMAC score decreased 3 months post-
surgery compared to baseline (experimental treatment: -58.3 ± 21.9%; control 
treatment: -38.6 ± 31.5%), immediately post treatment and at 1 month after treatment 
(all SNK: p<0.0001). The WOMAC score was also lower for both treatments 1 month 
after treatment compared to baseline (SNK: p<0.01; experimental treatment: -24.6 ± 
21.9%; control treatment: -9.7 ± 23.9%).  
 
Secondary outcome: psychosocial variables 
There was an interaction for the PCS score between treatment and time (F=7.26, 
p<0.001, ƞ2p: 0.11). For the experimental treatment, there was a significant reduction in 
the PCS 3 months post-surgery, immediately post treatment and at 1 month after 
treatment (all SNK: p<0.001) compared to the baseline scores. Whereas for the control 
treatment, PCS score were the same three months post-surgery as they were at baseline 
(SNK: p=0.59). The only reduction in PCS score with control treatment was noted at 1 
month after treatment versus baseline and immediately post treatment (SNK: both 
p<0.0001), but by three months post-surgery the PCS score had returned to baseline 
values. Significantly lower values of the PCS were seen with the experimental 
compared to control treatment immediately post treatment and at 3 months post-surgery 
(all SNK: p<0.01). 
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The TSK-11, which was dependent on the interaction between treatment and time 
(F=6.81, p<0.001, ƞ2p: 0.11), also showed no improvement with the control treatment. 
However, the TSK-11 score decreased with the experimental treatment immediately 
post treatment, at 1 month after treatment and 3 months post-surgery (all SNK: 
p<0.0001) compared to baseline score. The TSK-11 score was also significantly lower 3 
months post-surgery compared to immediately post treatment (SNK: p<0.05). The 
reduction of the TSK-11 score with the experimental treatment resulted in significantly 
lower values compared to the control treatment immediately post treatment, at 1 month 
after treatment and at 3 months post-surgery (all SNK: p<0.00001).  
 
DISCUSSION 
This study showed that a pre-operative treatment combining PNE with knee joint 
mobilization did not produce any significant superior effect in CS measures and knee 
pain and disability compared to biomedical education plus knee joint mobilization in 
people with KOA. Greater improvements in the PNE with knee joint mobilization group 
were observed for psychosocial variables related to pain catastrophizing and 
kinesiophobia, which confirms part of our hypothesis. Regarding CS measures, only 
some CS correlates (i.e. widespread hyperalgesia, CSI score) achieved significant 
improvement after both interventions with no additional benefits for the experimental 
group, while other indicators of CS such as CPM and temporal summation did not 
change over time in either treatment or even the observed changes were not in the 
expected direction.  
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Central sensitization 
A significant increase in local and remote PPTs was demonstrated with both treatments 
over time with a moderate effect size. However, as seen in Figure 4, these changes were 
only clinically meaningful 
28
 for the local PPTs. The increase in remote PPTs after both 
interventions may provide evidence of modulation of central pain mechanisms
3
. Our 
findings are consistent with previous studies using knee joint mobilization
8,9
 or PNE
46
 
in isolation, where both a local and global increase of PPTs was demonstrated after 
treatment. In studies assessing knee joint mobilization
8,9
, passive oscillatory 
mobilization techniques were applied and only immediate effects on PPTs were 
evaluated. The current study expands the knowledge regarding the neurophysiological 
effects of manual therapy techniques for KOA, by showing short and long-term 
peripheral and central modulatory improvements over time when using mobilization 
with movement techniques preceded by education, regardless of the type of education 
provided.  
 
To our knowledge, this is the first time that CSI has been used in a trial as an outcome 
measure. A decrease in symptoms of CS, as reflected by lower CSI scores, was 
observed after both treatments at all measurement times with a medium effect size. On 
the contrary, other variables related to CS did not change over time with either 
intervention, or the changes were in the opposite direction to our a priori hypothesis (i.e. 
CPM). Conflicting results on CS measures were also reported by Skou et al
13
 who 
concluded that, when assessing treatment effects through multiple pain-related measures 
including CS, results may differ depending on what measures are being evaluated
13
.  
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Our results regarding CPM differ with previous research showing an enhancement of 
CPM after knee joint mobilization
8
 or PNE
19
. We found no enhancement of CPM after 
either intervention. Differences in the nature of the mobilization technique (mobilization 
with movement versus passive oscillatory mobilization
8
) may have accounted for this 
discrepancy. Passive oscillatory mobilizations might be a preferable option for 
activation of descending nociceptive inhibitory pathways for KOA, either alone or in 
combination with other interventions such as PNE. In addition, unlike previous 
research
8,19
, mobilization with movement was always combined with prior education in 
the current study.  
 
Knee pain and disability 
Measures related to knee pain and disability improved for both treatments at all-time 
points with large effect sizes, but no significant differences were observed between 
treatments. Compared to baseline, improvements in knee pain and disability for both 
groups (Table 2) were not only statistically significant, but also clinically meaningful
36
 
at one month after treatment and three months post-surgery. These results are important 
as function of people waiting for surgery is significantly worse than that of the reference 
population
47
.
 
Previous research showed beneficial effects in pain and disability 
following knee joint mobilization
8,9,16,17
 and biomedical education
48
.  
 
 Psychosocial variables  
Only the experimental treatment achieved significant improvements in psychosocial 
measures, with overall medium effect sizes. In addition, changes observed in the TSK-
11 were clinically meaningful
40
 immediately post-treatment and 3 months after surgery 
when compared to baseline. Our results are consistent with known favorable effects of 
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PNE on decreasing catastrophism and kinesiophobia observed in other chronic pain 
populations
18-20,46
. In addition, the post-surgical benefits observed after pre-operative 
PNE are in line with other studies
20
.
 
 
 
Pre-operative educational programs for KOA, as applied in the control group, are 
centered on a biomedical model and don’t normally include a pain science education 
component. This type of education was ineffective for changing psychosocial factors in 
people with KOA. One possible reason may be that threatening terminology 
characteristic of this kind of education had elicited negative emotional responses.  
 
Limitations 
The main limitation of this study is the lack of a control group not receiving any pre-
operative intervention and undergoing surgery which would have allowed us to compare 
the results of both interventions with the natural history of KOA. In addition, given the 
small sample size, definitive conclusions cannot be extracted so further replication in a 
bigger sample is warranted. The per protocol analysis may have introduced bias as 
participants who underwent surgery earlier were not included in the analysis. Minimal 
clinically important difference was only established for some variables, but not for 
others. Therefore, firm conclusions about clinical relevance of findings related to the 
variables where no data existed could not be made. 
 
Due to the multimodal setup of the two interventions investigated, it is not possible to 
determine individually the efficacy of each treatment. In addition, treatment was not 
matched to pain phenotype the participants presented when entering the study. 
Individuals with a higher degree of CS might have responded better if assigned to the 
Chapter 4  
 
 
Enrique Lluch Girbés 
251 
experimental treatment, as PNE is especially indicated when the clinical picture is 
dominated by CS
18,41
. Future studies could define subgroups of people with KOA 
having similar pain phenotype and evaluate whether matching interventions to 
subgroups improve outcome.   
 
In conclusion, a pre-operative treatment for people with KOA combining PNE with 
knee joint mobilization did not produce any additional benefits in knee pain and 
disability and CS measures, when compared to biomedical education with knee joint 
mobilization. Superior effects were observed in the PNE and knee joint mobilization 
group for psychosocial variables related to pain catastrophizing and kinesiophobia. 
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GENERAL DISCUSSION 
 
Our understanding of the pathophysiology of pain has increased substantially over the 
last years. Nowadays pain is no longer considered a proxy to nociception but a 
conscious experience that can be associated with nociception, but that it is always 
modulated by a myriad of neurobiological, environmental, and cognitive factors [1]. 
Historically, pain in knee OA has been attributed to peripheral nociception possibly 
because the majority of physiotherapists have received a biomedical-focused training or 
education [2]. However, the poor association between objective measures of disease 
severity and clinical symptoms [3,4], the lack of complete resolution of symptoms in 
some patients even after eliminating the nociceptive source (i.e., knee replacement 
surgery) [5-8] or changes observed in some biomarkers of CS such as temporal 
summation of pain or conditioned pain modulation [9] suggests that non-local factors, 
such as altered central processing of painful stimuli , also contribute to clinical pain in 
knee OA.  
 
In this dissertation, central pain mechanisms related to the pain experience of people 
with osteoarthritis including those affected by knee OA were studied. The first part of 
the dissertation focused on revising the existing evidence regarding the presence of CS 
in people with osteoarthritis pain and current interventions addressing pain sensitization 
in this population. The second part consists of a study assessing whether the area of pain 
assessed using pain drawings relates to CS and clinical symptoms including the level of 
pain, disability and psychosocial factors in people with knee OA. In the third part, the 
theoretical rationale of a combined intervention comprising PNE together with knee 
joint mobilization and the clinical effectiveness of this combined approach when 
applied pre-operatively in people with knee OA was investigated.  
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The following research questions were addressed in the general introduction of this 
dissertation: 
 
- What is the role central sensitization plays in people with osteoarthritis including 
those with knee OA and which options do we have for treatment? 
- Are measures of central sensitization associated with the area of pain and 
clinical symptoms in subjects with knee osteoarthritis? 
- Is a combined intervention of manual therapy addressing the knee and pain 
neuroscience education targeted to the central nervous system effective for 
people with knee osteoarthritis? 
 
In this final chapter, we will answer these research questions, and discuss the 
main findings and conclusions of the studies included in the dissertation. In addition, 
recommendations for further research will be formulated. 
 
Main findings and discussion of the research questions 
 
What is the role central sensitization plays in people with osteoarthritis including 
those with knee OA and which options do we have for treatment? 
In addition to the pathological changes in the knee joint, changes in central pain 
processing or CS appear to be involved in osteoarthritis pain. This is reflected by the 
great number of narrative reviews regarding CS in osteoarthritis published in the 
scientific literature [10-14]. However, prior to the initiation of the present dissertation, a 
study that systematically reviewed the literature related to the presence of CS in 
osteoarthritis pain was unavailable. Likewise, the scientific literature offered hardly any 
information addressing the (conservative) treatment of CS specifically in osteoarthritis 
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patients. It seemed therefore valuable to conduct a systematic review on this topic and 
to explore rehabilitation options for patients with OA pain having CS as their dominant 
mechanism. 
 
A non-systematic review of the literature was performed aiming to summarize current 
evidence regarding CS in osteoarthritis pain [15]. In that review, it was concluded that a 
significant proportion (approximately 30%) of patients with OA show signs of CS. In 
addition, it was recognized that osteoarthritis pain is a heterogeneous pathology 
characterized by a complex and multifactorial nature so strategies to allow reliable and 
systematic recognition of the subgroup of patients with OA whose pain has a CS 
component were needed. Since that review, researchers have put a lot of effort into 
profiling clinical pain phenotype within the knee OA population as indicated by the 
high number of studies looking at classification of patients with knee OA in terms of 
pain mechanisms [16-22]. Distinct clinical phenotypes in the knee OA population have 
been recognized based on several factors such as serological biochemical and pain 
biomarkers [17,18], biomarkers confirming the presence of CS such as PPTs, temporal 
summation or conditioned pain modulation resulting in a pain sensitivity index [19], 
psychological, health and sensory assessments [20] or contribution of different domains 
to pain experience (i.e. knee joint, psychosocial factors, altered pain neurophysiology) 
[21]. Overall all these classifications systems have supported the presence of a subgroup 
of chronic knee OA pain in which central mechanisms (e.g., CS) are prominent. 
Kittelson et al. [21] found that 24% of their sample was composed of subjects with 
higher knee joint sensitivity. The pain sensitivity index developed by Arendt-Nielsen et 
al. [19] was able to classify 27-38% of the patients with knee OA and 3% of the 
controls as highly sensitive with no association to radiographic knee joint degeneration. 
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In addition, higher scores in this index were found in those subjects with high knee pain 
intensities and long pain duration. A high matrix metalloproteinase (MMP)-mediated 
breakdown of CRP (CRPM) level, a serologic biomarker measured in serum, was 
associated with CS measures (temporal summation and CPM) in another study [17]. 
Finally, Wright et al. [22] identified a specific subgroup of patients with knee OA who 
exhibited widespread, multimodality hyperalgesia (to cold, heat and pressure stimuli), 
more pain, more features of neuropathic pain, and greater functional impairment. All 
these findings are in accordance with conclusions raised in the non-systematic review 
[15] that altered central processing of pain is particularly characteristic of some 
individuals with knee OA pain. Based on results from a systematic review [9] and later 
research [21] the percentage of people with a dominant CS pain in knee OA seems to be 
around 30%.  
 
After the publication of the narrative [15] and systematic review [9] that form part of 
this dissertation, other authors have performed similar research reaching comparable 
conclusions. For instance, Akinci et al. [23] wrote a narrative literature review on 
clinical studies, systematic reviews and narrative reviews regarding the evidence for CS 
in chronic OA pain. They also concluded that there is good evidence for a role of CS in 
chronic OA pain in a subgroup of patients and raised the issue of a lack of diagnostic 
criteria for CS specific to OA. These authors recommend the use of pain biomarkers for 
confirming the presence of CS and alert clinicians to be aware of CS in patients with 
chronic OA pain, especially in subjects presenting with severe pain with unusual 
features [23].  
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Unlike the systematic review comprising this dissertation [9] which was focused in knee 
OA, a recent systematic review and meta-analysis conducted by Fingleton and 
colleagues [24] examined the evidence for pain sensitization specifically in people 
with knee OA and the relationship between pain sensitization and symptom severity. 
Only studies using QST measures of central hyperexcitability were considered for 
inclusion. Authors pointed to evidence supporting the presence of pain sensitization in 
people with knee OA and an association between pain sensitization with knee OA 
symptom severity [24]. In line with the latter, altered central processing of pain has been 
shown to be particularly characteristic of individuals with moderate to severe 
symptomatic knee OA [25] and especially if high knee pain is associated with an 
absence of moderate-to-severe radiographic evidence of pathologic changes at the knee 
[4,19]. It is currently known that CS dominates the clinical picture in a subgroup of the 
musculoskeletal pain population including, not only people with knee OA, but also 
patients with other complaints ranging from tennis elbow over shoulder pain to 
whiplash [26]. Physical therapists should therefore implement modern pain 
neuroscience including the role of CS in amplifying and explaining the pain experience 
of people with knee OA within their clinical reasoning framework.  
 
Optimum treatment for people with knee OA pain requires determination of how 
peripheral and central factors are contributing to pain in each patient, to enable 
individualization of treatment strategies [15]. In this regard, physical therapists are 
considered to be in a good position to deliver such individualized intervention because 
they are cognizant of the need for a biopsychosocial approach to management [15]. A 
recent study has accounted for this issue investigating the effects of a combined 
intervention addressing physical and psychological impairments associated with knee 
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OA [27]. In particular, a 12-week physical therapist-delivered combined pain coping 
skills training and exercise program was compared with either treatment alone. 
Significantly greater improvements in function but not pain were found for the 
combined intervention at the end of treatment that persisted at long-term follow-up. In 
addition, benefits favoring the combined intervention were seen on several secondary 
outcomes [27]. Interestingly, physical therapists were intensively trained in this study to 
deliver the pain coping skills training program, which is a psychological intervention 
belonging to the group of cognitive-behavioral therapies, by a psychologist [28, 29]. 
Therefore physical therapists are probably in the best position to deliver treatments that 
integrate physical and psychosocial elements for people with knee OA. 
 
Are measures of central sensitization associated with the area of pain and clinical 
symptoms in subjects with knee osteoarthritis? 
Despite growing awareness of the important contribution of central pain mechanisms to 
knee OA pain, routine evaluation of CS is yet to be incorporated into clinical practice. 
This is partly due to the historically laboratory-based focus of CS research, where the 
equipment and protocols used to identify features are relatively sophisticated, time-
consuming, expensive and not well-suited for clinical settings. Insight in clinical 
screening tools for assessing pain sensitization in people with knee OA is thus needed. 
With this in mind, an experimental study was performed to investigate whether the area 
of pain assessed with a novel method for obtaining and quantifying the area of pain had 
any association with direct (QST) and indirect (self-reported questionnaires, neuropathic 
pain) measures of CS in people with knee OA [30]. In addition, the association between 
pain drawings and clinical symptoms was also studied. Pain frequency maps showed 
enlarged areas of pain, especially in women. An expanded distribution of pain is a well-
recognized sign of CS [31-33]. Our finding agrees with other reports of greater 
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spreading of pain in women with knee OA as compared to men [17,34].  Bartley et al. 
[34] found that women with knee OA exhibited greater sensitivity to multiple pain 
modalities and greater widespread pain when compared to men, although no sex 
differences in clinical pain were observed. Overall, these findings provide evidence for 
greater pain sensitivity in women with symptomatic knee OA compared to men, 
suggesting that enhanced central sensitivity may be an important contributor to pain in 
this group. 
 
In our study [30] enlarged areas of pain were associated with widespread mechanical 
hyperalgesia (lower pressure pain thresholds at the epicondyle) and higher scores with 
the Central Sensitization Inventory, considered direct and indirect biomarkers of CS, 
respectively. Pain drawings were proposed as a simple way for identifying CS in people 
with knee OA waiting for further research. In line with our investigation, a recent study 
by Visser et al. [35] explored the hypothesis that chronic widespread pain drawn by 
patients on a body diagram could be used as a screening tool for some variables 
including increased pain sensitization, psycho-social load, and utilization of pain 
management strategies. The percentage pain surface area drawn on the body diagrams 
of a total of 144 patients attending a chronic pain outpatients' clinic was calculated. 
Outcomes were measured using the painDETECT Questionnaire and other indices and 
compared. Significantly more subjects with chronic widespread pain defined as a 
percentage pain surface area ≥ 20% reported high (≥ 19) PD-Q scores (suggesting pain 
"sensitization" or neuropathic pain), high anxiety scores on the Depression, Anxiety and 
Stress Scale-21 Items Questionnaire, ≥ 5 psycho-social stressors, ≥ 5 significant life 
events and used ≥ 7 pain management strategies, compared to control subjects with a 
lower percentage pain surface area. In additions, significant and independent 
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associations were observed between the presence of chronic widespread pain and 
Widespread Pain Index score ≥ 7, PD-Q score ≥ 19 and use of ≥ 7 pain management 
strategies. The authors concluded that calculating percentage pain surface area on a 
body diagram is an optimal "snapshot" screening tool to identify patients with an 
increased likelihood of pain sensitization, maladaptive psycho-social factors, and 
utilizing pain management resources [35]. In another study, Cruz-Almeida et al. [20], 
using a hierarchical cluster analysis, determined the presence of a subgroup of subjects 
with knee OA with a psychological profile consisting on high levels of pain vigilance, 
reactivity, negative affect, anger, and depression. These individuals experienced the 
highest levels of widespread pain and were the most sensitive to mechanical, pressure, 
and thermal stimuli thus reflecting CS mechanisms [20]. Skou et al. [8] reported 
significantly more pain sites in participants with pain after revised total knee 
arthroplasty as compared to participants without pain, and Dave et al. [36] found that 
pre-operative widespread pain as assessed by a pain diagram was associated with 
greater pain at 12-months post total knee arthroplasty. Overall, findings from the above-
mentioned studies and from this dissertation [30] support a role for pain drawings in 
order to record pain distribution in people with knee OA and to raise suspicion about the 
presence of altered central processing mechanisms in case of an expanded distribution 
of symptoms. 
 
Different alternatives to experimental pain sensitivity for assessing CS in patients with 
knee OA have been suggested in the literature. Besides the Central Sensitization 
Inventory, PainDETECT questionnaire or pain drawings used in this dissertation, other 
screening tools for assessing pain sensitization in knee OA have been explored. For 
instance, assessment of exercise-induced hipoalgesia has recently been proposed as a 
novel preoperative screening tool for predicting chronic postoperative pain in people 
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with knee OA [37]. In a normal physiological situation, pain sensitivity should decrease 
(i.e., increase of PPTs) during physical activity and stay in that way for up to 30 min 
post-exercise as a result of endogenous opioid release and related activation of several 
(supra)spinal anti-nociceptive mechanisms [38]. Oppositely, reporting of an strong 
increase in symptoms and a decrease of PPTs in response to low to moderate exercise 
may point towards impaired anti-nociceptive mechanisms during exercise and hence CS 
[39]. Vaegter et al. [37] found that hypoalgesia after aerobic exercise assessed 
preoperatively was associated with pain relief six months after total knee replacement in 
knee OA patients. The assessment of PPTs in response to exercise could be of great 
value in the future for recognizing CS in people with knee OA, but evidence at this 
point is limited.  
 
An expanded distribution of pain has been linked to the presence of CS [31-33]. One 
term used to describe the presence of enlarged referred areas of pain in people with 
musculoskeletal pain disorders is widespread pain including the definition of a measure 
of the number of painful body regions, the so called widespread pain index [40].  The 
American College of Rheumatology (ACR) defines widespread pain as concurrent pain 
in the axial region, above and below the waist, and pain on the right and left sides of the 
body [41]. According to this definition the pain frequency maps determined in our 
sample of patients with knee OA [30] cannot be considered widespread as participants 
don’t report pain above the waist or in the axial region. The ACR originally defined 
widespread pain as a diagnostic criterion for recognizing people with fibromyalgia, but 
widespread pain also has been found in patients with knee OA among other disorders 
[12]. Especially subjects with bilateral knee OA pain with high levels of knee pain but 
either no or minimal knee OA are at high risk for simultaneously occurring widespread 
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pain [42]. Different theories have been proposed to explain the relationship between 
widespread pain, abnormal pain processing and rheumatic disorders including OA [11, 
32, 43, 44]. For instance, Gerhardt et al. [45] found that chronic localized pain and 
chronic widespread pain were produced by different mechanisms in people with chronic 
low back pain. In particular, patients with chronic widespread pain show widespread 
ongoing pain and hyperalgesia for different stimuli that was generalized in space, 
suggesting the involvement of descending control systems, as also suggested for 
patients with fibromyalgia. Currently however the underlying mechanisms of 
widespread pain remain unknown as well as validated cutoff scores for inferring 
whether pain is widespread or not are not available [46]. Given that widespread pain is 
associated with psychologically based impairments, abnormal pain processing, and poor 
outcomes [42], some authors have recommended assessment for the presence of 
widespread pain in people with knee OA [42]. Concretely, identifying the presence of 
widespread pain in people with knee OA seeking physical therapy may assist in 
establishing prognosis and in considering the use of psychologically based interventions 
[42].  
 
Is a combined intervention of manual therapy addressing the knee and pain 
neuroscience education targeted to the central nervous system effective for people 
with knee osteoarthritis? 
Conventional rehabilitation of patients with chronic pain including people with chronic 
knee OA pain is often not successful and is frustrating for physical therapists dealing 
with these patients [47]. One solution for people with late stage knee OA is total knee 
replacement (TKR) surgery, which has been traditionally thought to be an effective and 
cost-effective intervention for severe symptomatic OA of the knee joint [48]. However, 
recent evidence suggests that although treatment with TKR followed by 12-weeks of 
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nonsurgical treatment (exercise, education, dietary advice, use of insoles, and pain 
medication) resulted in greater pain relief and functional improvement after 12 months 
than did nonsurgical treatment alone, TKR was associated with a greater number of 
serious adverse events than nonsurgical treatment. Furthermore, most patients who were 
assigned to receive nonsurgical treatment alone did not undergo TKR before the 12-
month follow-up [49]. In addition to this high-quality evidence regarding TKR 
utilization, there are currently no clear indications for surgery (it is difficult to know 
when in the course of knee OA is best to operate) [48] and a significant proportion of 
patients (≈ 20%) experience chronic knee pain, functional disability, a poor quality of 
life and dissatisfaction after TKR [5,6]. Outcomes can be even worse after revision 
TKR in comparison with primary TKA surgery [50]. It has been proposed that a 
biological explanation for continuing pain after TKR could involve a dysfunction of 
pain modulation by the central nervous system (i.e. CS) [5,7,8, 50-54]. As the pre-
surgical presence of CS in knee OA contributes to poor outcomes after TKR [51-57], 
treatment strategies addressing CS in the pre-operative phase seemed valuable to be 
investigated [58]. Affected knee OA patients therefore require effective management to 
address their knee pain while waiting for TKR [58] as intense and continued nociceptive 
input proceeding from knee OA joint may cause CS [59-61]. 
 
In order to address the aforementioned necessity, a randomized controlled trial 
investigating the effects of a pre-operative treatment combining PNE with knee joint 
mobilization, both having previously demonstrated a modulating effects on CS [62,63], 
in subjects with knee OA was performed [64]. Guidelines for application of this 
combined intervention (i.e., the published treatment protocol), which also form part of 
this dissertation, were adhered [65]. The experimental group receiving PNE with knee 
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joint mobilization was compared with another treatment group where biomedical 
education with knee joint mobilization was combined, as we were especially interested 
in revealing differences if any between two totally opposite types of education. On one 
hand, preoperative biomedical education was centered on anatomy and pathoanatomy as 
well as procedural information regarding TKR. This kind of education has shown 
limited effects in reducing postoperative pain after TKA surgery [66]. On the other 
hand, PNE aims to shift one's conceptualization of pain from that of a marker of tissue 
damage or disease to that of a marker of the perceived need to protect body tissue [67]. 
Knee joint mobilization was selected as a treatment modality due to supporting 
evidence for endorsement in subjects with knee OA [68]. After four sessions of either 
PNE combined with knee joint mobilization or biomedical education with knee joint 
mobilization before surgery, significant and clinically relevant differences over time 
were found for both treatments in knee pain and disability and some measures of CS 
(i.e., widespread hyperalgesia, Central Sensitization Inventory), with no significant 
between-group differences. However, other indicators of CS (i.e., conditioned pain 
modulation, temporal summation) did not change over time in either treatment or even 
the observed changes were not in the expected direction. Reductions in pain pain-related 
measures were not parallel to changes in pain processing in other similar studies [69], 
indicating that mechanisms other than pain sensitization may contribute to the perceived 
pain of people with knee OA. This may justify the conflicting results encountered on CS 
measures in our randomized controlled trial [64]. When assessing treatment effects 
through multiple pain-related measures including CS, results may be different 
depending on what measures are being evaluated [69]. 
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Concurrently with our research and responding to the call for evidence on treatment of 
CS in osteoarthritis patients [15], interest in research has grown regarding the 
application of treatments addressing CS in subjects with knee OA [62, 69-73]. In 
particular, the effects on pain sensitization of multimodal treatments combining 
interventions applied locally at the knee and addressing the CNS have been planned 
[73] or have been already investigated [69,72]. This paradigm shift in management of 
knee OA (combining CNS interventions with peripheral) is also being observed for 
other chronic musculoskeletal pain disorders such as chronic low back pain, where the 
effects achieved with most available physical therapy treatments is moderate at best 
[74]. Our research [64] is in accordance with previous studies by Skou and colleagues 
who found positive effects in reducing clinical pain and pain sensitization with 
application of a 3-month multimodal treatment program (neuromuscular exercise, 
education, diet, insoles and pain medication) [69] and when combining TKR with that 
same multimodal treatment [72] in people with knee OA. It has been argued that due to 
the complex multidimensional nature of knee OA pain and the moderate effects that 
physical therapies have in isolation in knee OA, combination of treatments addressing 
both the knee and the CNS may bolster each other thus further improving outcomes 
[73]. It is unlikely that a single modality of treatment is identified as being capable of 
treating such a complex mechanism as CS when dominant in subjects with knee OA so 
using a combination of different strategies, each targeting a different “desensitizing 
mechanism”, could be useful [75]. Further studies using combination of treatments 
addressed to subgroups of people with knee OA characterized by a dominant CS pain 
mechanism are warranted. 
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Currently there is insufficient quality evidence to support the efficacy of any 
preoperative physiotherapy in older adults who undergo TKR due to knee OA, as found 
in a recent systematic review [76]. Of the ten studies which were included in that 
review, no studies included any intervention addressing specifically CS and pain 
sensitization measures were not considered as outcome measures but knee strength, 
ambulation, and pain [76]. The most used intervention was preoperative exercise (n = 5) 
followed by combined exercise and education applied in two studies. Previous 
systematic reviews also agree with these conclusions showing that evidence for 
implementation of either pre-operative education or physiotherapy programmes in 
people with knee OA is insufficient [77-80]. Regarding the content of education, no 
consensus exists about the optimal content of preoperative patient information for 
people with knee OA waiting for surgery [81]. Explaining pain biology to patients is not 
included within the contents of education programs for subjects with knee OA [79] and 
indeed is not considered a key issue to convey such kind of education to patients with 
OA pain [82]. In line with this, Louw et al. [66] evaluated the content and methods of 
delivery of preoperative education addressing postoperative pain targeted to people 
waiting for a total joint arthroplasty of the hip and knee. They found that most of the 
educational models for OA were based on a biomedical model discussing aspects such 
as anatomy, biomechanics and pathoanatomy. Concretely, the content of education was 
mainly centered on descriptions of preparation for surgery, hospital stay, surgical 
procedure, expectations following surgery, rehabilitation, reassurance, and answering 
common question associated with the surgical procedure [66]. It was concluded that 
preoperative education centered on a biomedical model has limited effect in reducing 
postoperative pain after total hip or knee arthroplasties. But importantly, not only have 
these models shown a limited efficacy in minimizing OA pain and disability, but they 
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may increase anxiety and fear having a negative impact on patient prognosis [83-85]. 
The terminology used to describe pathophysiology of knee OA within the biomedical 
model can be provocative for the patient with knee OA and may induce 
misunderstandings, unintended meanings and negative emotional responses [83]. 
Physiotherapists should therefore be careful with the words they use to explain OA to 
their patients. Instead of using a biomedical model, educational sessions administered 
before surgery aiming to increase patient knowledge of pain science (PNE) as used in 
this dissertation may be more effective in managing postoperative pain [66]. Further 
research with large samples could evaluate the role PNE when applied before knee OA 
surgery to reduce postoperative pain and CS in the same way as has been demonstrated 
for other conditions such as lumbar radiculopathy [86,89] 
 
A better understanding of the neural mechanisms underpinning chronic pain including 
chronic pain related to knee OA has favored the development of new therapeutic 
approaches, one of these is PNE. In fact, the scientific interest in PNE for treating 
chronic musculoskeletal pain has grown over the last years as reflected by the great 
number of publications in this topic [67, 86-99], despite this rise in popularity of PNE 
has not still been corresponded with improved care [89]. Strong evidence is now 
available for effectiveness of PNE for treatment of several chronic pain conditions and, 
interestingly, the effectiveness of PNE is greater when it is combined with movement-
based interventions versus education-alone [67, 93,95]. However, as recently stated by 
Blickenstaff and Pearson [99] and published guidelines [65], in order to integrate PNE 
with exercise and movement, messages given to patients with PNE and those of other 
therapeutic interventions should be consistent. In this sense, aligning the 
communication than surrounds the application of other physical therapies (i.e. manual 
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therapy) is recommended [26, 65]. When inconsistent messages exist between education 
and movement therapies, patient outcomes may be adversely impacted [65, 99]. In order 
to be compliant with these recommendations, PNE and knee joint mobilization were 
combined in our randomized controlled trial in such way that the therapists avoided 
contradictory messages between these two interventions, for instance, not using pain 
relief as the guide for treatment and threatening words such as “pain” during knee joint 
mobilization [64]. This balanced approach between PNE and manual therapy that we 
rationally presented [65] and used experimentally for knee OA [64], has been now 
suggested by other authors for treating other chronic pain conditions such as chronic 
low back pain [91].Further guidelines for application of PNE including not only 
merging PNE with movement but also other key elements such as examination, 
educational content, delivery methods, goal setting, and progression have been recently 
discussed [100]. 
 
Future research 
In this dissertation, we attempted to broaden the framework for understanding the role 
of CS in people with OA pain and exploring new avenues for treating patients with 
chronic knee OA pain. While our results raised important issues in this regard, there are 
still many questions that remain unanswered and that would be valuable to investigate 
in future research. 
 
Only superior effects pre and post-operatively for psychosocial variables related to pain 
catastrophizing and kinesiophobia were observed when using PNE with knee joint 
mobilization as compared to biomedical education and knee joint mobilization [64]. 
These results reported in people with knee OA are consistent with known favorable 
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effects of PNE on decreasing catastrophizing, excessive attention to pain and activity-
related fear observed in other chronic pain populations [93,101]. In addition, the post-
surgical benefits observed from pre-operative PNE are in line with recent reports 
applying PNE before surgery for lumbar radiculopathy [86, 88]. However, no attempt 
was made to understand the mechanisms underpinning these effects. One possible 
reason for the less beneficial effect in psychosocial variables in the group receiving 
biomedical education may be that the use of threatening and provocative terminology 
characteristic of this kind of education may have elicited negative emotional responses 
thus having a negative impact in psychosocial variables. In contrast, PNE may have 
targeted the cognitive emotional component of pain in the other group and therefore 
reducing pain catastrophizing and kinesiophobia. Despite clinical effectiveness of 
various treatments including PNE in chronic pain disorders characterized by CS has 
been proven, little is known about the effect of those treatments on the mechanism of 
CS [75]. The mechanisms underlying treatment effects of PNE are not totally 
understood but some recent studies are enquiring into this issue. For instance, Lee and 
colleagues explored into the mechanisms why improvement in pain biology knowledge 
was associated with a reduction in pain intensity and function using mediating analysis 
[102]. Mediation analysis of clinical trials can estimate how much the total effect of a 
treatment on the outcome is carried through an indirect path. Change in catastrophizing 
in a cohort of 799 patients who were exposed to a pain education intervention did not 
mediate the effect of pain knowledge acquisition on change in pain or function [102]. 
Same authors have planned a study to determine whether the effect of pain education on 
pain and disability is mediated by changes in self-efficacy, catastrophisation and back 
pain beliefs in people with acute low back pain [97]. Puentedura and Flynn [91] 
hypothesized that providing manual therapy within a PNE context as done in this 
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dissertation, besides producing local mechanical effects, can be a form of meeting or 
enhancing patient expectations and refreshing body schema maps within the brain. To 
our knowledge, the mechanisms underlying treatment effects of PNE, or the effect of 
PNE on an intermediate factor and its subsequent effect on outcome, have not been 
investigated in any clinical trial related to OA pain. Future research may estimate the 
causal mediation effects of a pain education intervention for people with chronic knee 
OA pain. Further examination of combination of treatments addressed to the periphery 
and the CNS for synergistic effects in people with knee OA is also warranted.  
  
Classification of patients in terms of pain mechanisms including CS pain is considered a 
research priority in chronic musculoskeletal pain [103]. Identifying the specific 
mechanisms operating in the nervous system to produce chronic pain in individual with 
knee OA could provide the basis for a targeted and rational individualized approach to 
pain therapy. Participants from our randomized controlled trial were not previously 
stratified as having CS dominant pain and thus being optimal to be included for instance 
in the group receiving PNE with knee joint mobilization. PNE is especially indicated 
when the clinical picture of a patient is dominated by CS [104]. Diener et al. [96] have 
developed an interview process within a pain science framework in order to screen 
patients, establish maladaptive psychosocial barriers for poor prognosis and enquire into 
pain mechanism including altered pain processing mechanisms. Furthermore, Wijma et 
al. [98] recommend prior to PNE to perform an exhaustive biopsychosocial assessment 
in order to allow proper explanation of pain biology. They propose to follow a model 
[i.e. Pain - Somatic factors - Cognitive factors - Emotional factors - Behavioral factors - 
Social factors - Motivation - model (PSCEBSM-model)] that aims to determine the 
dominant pain mechanism of the patient (predominant nociceptive, neuropathic, or non-
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neuropathic central sensitization pain) and evaluate the main provoking and 
perpetuating biopsychosocial factors. Therefore, future studies may use this model to 
specifically classify patients with chronic knee OA pain and tailor the plan of care, 
including PNE, to individual patients. Future research should also implement pain 
phenotyping as an inclusion or stratification criteria. This would reduce heterogeneicity 
by defining subgroups of people with knee OA with a similar pain phenotype and would 
allow to evaluate whether matching interventions to these subgroups improve outcome.   
 
Detection of altered central pain processing in humans is a challenge as there is no 
diagnostic gold standard [105, 106]. This implies that the construct validity of clinical 
screening tools for CS, such as determining the presence of extended areas of pain with 
pain drawings, cannot be tested. In addition, it is still unclear to what extent 
disturbances in central pain processing are relevant for the determination of symptoms 
in individual patients [105, 106]. Despite classification criteria of pain types have been 
published for musculoskeletal pain in general [107], people with low back pain [108] 
and pain following cancer treatment [109], no guidelines exist in relation to knee OA. A 
group of osteoarthritis researchers from different countries have currently adapted these 
criteria for knee OA pain [110]. Although based on research data, the psychometric 
properties (i.e. inter- and intra-examiner reliability, sensitivity, specificity) of the criteria 
proposed for identifying CS [107-110] should be the subject of future research. 
Furthermore, other easily applicable and user-friendly clinical screening tools such as 
pain drawings that permit clinical identification of pain mechanisms including CS in 
patients with knee OA pain are needed. 
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Several neurophysiological changes across different areas of the peripheral and central 
nervous system have been recently detected in people with knee OA. For instance, 
differences in the organization of the motor cortex (i.e. a shift in the cortical 
representation of the knee and a swap of the relative position of the knee and ankle 
representations in the motor cortex), were found in subjects with knee OA [111]. 
Disrupted representation of the knee in primary sensory cortex has also been found in 
patients with knee OA as manifested by a decrease in tactile acuity [112]. These 
findings may provide direction for future treatments addressing these specific 
neuroplastic changes such as sensory discrimination training or graded motor imagery, 
because there are documented associations between treatments that normalize cortical 
organization and improvement of symptoms in other chronic pain musculoskeletal 
conditions [113-115].  
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CONCLUSIONS 
General conclusions achieved after this Doctoral Thesis are:  
 
1. Substantial scientific evidence indicates a role for central sensitization in 
osteoarthritis pain including those with knee osteoarthritis, yet it is necessary to develop 
strategies to allow reliable and systematic recognition of patients with osteoarthritis 
whose pain has a (predominant) central sensitization component. 
 
2. Optimum treatment for people with knee osteoarthritis pain requires a 
biopsychosocial approach and determination of how peripheral and central factors are 
contributing to pain in each patient in order to enable individualization of treatment 
strategies. Physical therapists are well positioned to deliver an individualized 
intervention because they are cognizant of the need for a biopsychosocial approach to 
management. 
 
3. The area of pain reported by individuals with knee osteoarthritis pain is associated 
with some measures of central sensitization. Clinicians should be attentive for 
individuals with knee osteoarthritis showing extended areas of pain as this may be an 
indicator of altered nociceptive processing mechanisms. Pain drawings may constitute 
an easy and cheap way for the early identification of central sensitization in people with 
knee osteoarthritis pain. 
 
4. Physical therapists are encouraged to find an equilibrium between hands-on and 
hands-off interventions in patients with knee osteoarthritis-related pain dominated by 
central sensitization. In light of evidence supporting a key role of central sensitization in 
a subgroup of patients with knee osteoarthritis pain, physical therapists are urged to 
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reconsider (their communication surrounding) hands-on interventions for the 
management of osteoarthritis, and emphasize the use of hands-off interventions for 
improving pain coping, self-efficacy and pain cognition. 
 
5. Sound scientific rationale and practical guidelines have been developed for the 
application of a combined manual therapy and pain neuroscience education approach in 
patients with chronic osteoarthritis-related pain and central sensitization as their 
dominant pain mechanism. 
 
6. In subjects with knee osteoarthritis waiting for knee joint replacement, pre-operative 
pain neuroscience education combined with knee joint mobilization did not produce any 
additional benefits over time in knee pain and disability and central sensitization 
measures compared with biomedical education with knee joint mobilization. Superior 
effects in the pain neuroscience education with knee joint mobilization group were only 
observed for psychosocial variables related to pain catastrophizing and kinesiophobia. 
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